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Summary  
Microbial populations constantly face pressures imposed by 
exposure to host immune systems and antibiotics. Thus it is important to 
have a better understanding of how they can adapt to such pressures. In 
this context, studying the process of adaptation of commensal bacteria 
towards becoming a pathogen and how resistance to antibiotics affects 
bacterial fitness are pressing questions. 
 In this thesis I explored the adaptive strategies that commensal 
Escherichia coli can evolve to escape the first cellular line of defence of the 
innate immune system – macrophages. I described that in only a few 
hundred generations, bacteria can evolve and acquire specific adaptations 
such as increased intracellular survival and increased escape of 
engulfment by macrophages. These are strategies commonly found in 
clinical isolates, such as in small colony variant or mucoid clones isolated 
in many infections caused by different bacteria species. I also show the 
process of emergence of mucoid clones, in an in vitro experimental 
evolution setup with E. coli, and characterize them. Importantly, it is found 
that they exhibit increased pathogenesis by in vivo colonization and 
intraperitoneal infection assays. Furthermore, I determined the genetic 
basis of E. coli pathoadaptation and showed that transposable element 
insertions into both coding and regulatory regions drive the evolutionary 
process. This process is characterized by clonal interference, as indicated 
using both experimental evidence and a mathematical model. I also show 
that mucoid clones bear a selective advantage when interacting with other 
predators that E. coli can encounter in nature, such as protozoa and 
phages. I also show that small colony variant clones can have a 
competitive advantage in colonizing the mouse gut.  
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Finally, I estimated fitness effects of different antibiotic resistant 
mutations in the context of an interaction with macrophages. I showed that 
67% of the mutants survive better than the sensitive bacteria in the 
intracellular niche of the macrophages. In particular, all streptomycin 
resistant mutants exhibit an intracellular advantage, due to specific 
environmental stresses that macrophages impose on bacteria, such as 
nutrient limitation and oxidative stress.  
This thesis provides a test of the basic evolutionary hypothesis that 
biotic interactions increase rates of adaptation and a demonstration of the 
power of sentinels of the innate immunity as a selective pressure to help us 
understand the diversity of microorganisms in terms of evolution of 
antibiotic resistance and virulence. 
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Sumário 
 As populações microbianas enfrentam constantes pressões 
impostas pelo sistema imunitário do hospedeiro e pela utilização de 
antibióticos. Assim, à luz da notável capacidade de adaptação dos 
micróbios a novos nichos ecológicos é crítico que se entenda o processo 
de adaptação das bactérias comensais no seu percurso até se tornarem 
patogénicas e os efeitos da resistência a antibióticos. 
Nesta tese, eu exploro diferentes tipos de estratégias de adaptação 
que a Escherichia coli comensal consegue evoluir, de forma a escapar à 
primeira linha de defesa das células do sistema imunitário inato – os 
macrófagos. Descrevo como, em apenas algumas centenas de gerações, 
estas bactérias conseguem evoluir e adquirir adaptações específicas. Uma 
das adaptações observadas foi o aumento de sobrevivência intracelular e 
outra o aumento da capacidade de escapar à fagocitose pelos 
macrófagos. Estas estratégias são normalmente encontradas em isolados 
clínicos, tais como os clones "small colony variant" (SCV) ou os clones 
mucóides (MUC). Além disso, os clones MUC evoluídos apresentam 
características patogénicas, tal como mostro pela colonização in vivo e em 
ensaios de infecção intraperitoneal. Adicionalmente, determino a base 
genética da adaptação patogénica da E. coli e mostro que inserções de 
elementos transponíveis, tanto nas regiões codificantes como nas 
regulatórias, conduzem o processo evolutivo. Este processo é 
caracterizado por interferência clonal, indicado tanto pelas evidências 
experimentais como pelo modelo matemático. Também demonstro que os 
clones MUC possuem uma vantagem selectiva quando interagem com 
outros predadores que a E. coli encontra na natureza, tais como 
protozoários e fagos. Para além disso, os clones SCV possuem vantagem 
na colonização do intestino dos mamíferos.  
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Finalmente, estimo os efeitos da aptidão (fitness) de diferentes 
mutações de resistência a antibióticos no contexto da interacção com os 
macrófagos. Cerca de 67% dos mutantes sobrevivem melhor do que a 
bactéria sensível no nicho intracelular dos macrófagos. Em particular, 
todos os mutantes resistentes à Estreptomicina exibem vantagem 
intracelular devido ao stress ambiental específico que os macrófagos 
impõem à bactéria, tais como a limitação dos nutrientes e o stress 
oxidativo. 
Esta tese constituiu um trabalho interdisciplinar que fornece um 
teste da hipótese evolutiva e a demonstração do poder das sentinelas da 
imunidade inata como pressão selectiva de forma a nos ajudar a 
compreender a diversidade dos microrganismos em termos da evolução 
da resistência antibiótica e à virulência na natureza. 
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Chapter 1 
Introduction 
 
Microorganisms as models to study evolutionary 
processes   
A vast diversity of microorganisms exists in our planet, from 
microbes that inhabit soil, fresh waters or the depths of our oceans, to 
those that colonize different animal species, including humans. With 
advances in molecular biology and increased accessibility of high-
throughput sequencing techniques, it became evident that microbial cells 
outnumber human host cells by up to one order of magnitude. A 
tremendous diversity of microbes prevails across individuals and their body 
habitats (Li et al. 2012). One of the most intriguing questions in the field of 
evolutionary biology, emerging from those observations, is how such 
microorganisms adapted to particular niches, some living in mutual or 
symbiotic relationship with the human body, while others acquired means 
to harm their hosts. 
For decades, evolutionary biologists tried to describe phenotypic 
variation of different traits in natural populations and to understand the 
evolutionary processes that shape them. This was mainly done using 
paleontology and comparative studies that are useful in order to 
understand evolution of a particular trait in a given phylogenetic context. 
However, by using such approaches it is difficult to unravel which type of 
selective pressures were responsible for acquisition of such traits and 
which evolutionary forces generated them.  Experimental evolution has 
proven to be a powerful approach in evolutionary and experimental biology, 
because it allows to study evolutionary processes, such as diversification, 
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adaptation, natural selection, genetic drift, recombination, amongst others, 
under controlled conditions  and in real time (see reviews (Mitchell-Olds et 
al. 2007, Bennett and Hughes 2009, Kawecki et al. 2012).  Additionally, 
another highly useful experimental feature of this methodology is the ability 
to preserve evolved populations for a long time, making it relatively easy to 
compare evolved populations to its ancestors (for more details see Elena 
and Lenski 2003).  
Using microorganism in experimental evolution became widely 
adopted due to their fast generation times, relatively simple handling, 
accessible genetic manipulations and the possibility of having several 
replicate populations (for more details see (Elena and Lenski 2003)). 
Additionally, genomic science brought the possibility of sequencing 
microbial genomes in little time and relatively low costs. This allows the 
prompt identification of arising de novo beneficial mutations in a population 
as well as estimating their effect on fitness and the tracking of their fate 
over thousands of generations. Once a beneficial mutation escapes 
genetic drift and gets established, it will get fixed in a population, provided 
that another mutation with larger fitness effect will not interfere, in a 
process called clonal interference (Gerrish and Lenski 1998). In 
accordance to these theoretical predictions, are the results on recent 
studies demonstrating, that clonal interference is one of the most likely 
forces for generating diversity in microbial populations adapting to novel 
environments (Hughes et al. 2012, Herron and Doebeli 2013, Traverse et 
al. 2013).  
E. coli in experimental evolution studies 
Escherichia coli has been frequently used as a model organism to 
study many important questions regarding evolution, such as how 
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organisms adapt to different selective pressures (Cullum et al. 2001, Riehle 
et al. 2001, Alcantara-Diaz et al. 2004, Lee and Palsson 2010), the extent 
to which evolutionary change is reproducible (Ibarra et al. 2002, Wick et al. 
2002, Fong et al. 2005, Oxman et al. 2008), the relationship between 
phenotypic and genotypic changes during evolution, the distribution of 
fitness effects of beneficial mutations (Papadopoulos et al. 1999, Cooper et 
al. 2001, Perfeito et al. 2007, Herron and Doebeli 2013) among many 
others. Common to all these evolutionary processes is the result that 
environmental complexity affects the evolutionary outcome.  
Numerous evolutionary studies have been carried in the simplest 
abiotic conditions with a constant environment (Lenski et al. 1998, 
Maharjan et al. 2006, Barrick et al. 2009). One of the most important and 
insightful set of experiments was initiated by Lenski et al., by tracking 
adaptation (and genetic changes) in 12 initially isogenic populations of E. 
coli, since 1988, to a constant minimal glucose medium. The study of this 
long-term evolution experiment (E. coli populations passed over 57,000 
generations as of March 2013) has demonstrated that the rate of 
adaptation decreases as populations adapt (Lenski 1991), that similar 
phenotypic traits emerge in parallel populations (Philippe et al. 2009) and 
that an entirely novel trait can be acquired (Blount et al. 2008). Lenski’s 
group also tackled several other questions, such as the emergence of 
mutators (Sniegowski et al. 1997), changes in gene expression and DNA 
sequence evolution (Cooper et al. 2003) and the genetic basis of evolved 
phenotypic changes (Blount et al. 2012). 
An additional level of complexity in evolutionary studies was added 
when abiotic environmental conditions changed over time and space 
(Reboud and Bell 1997, Habets et al. 2006, Beaumont et al. 2009, Cooper 
and Lenski 2010, Quan et al. 2012). In one of those studies, by Cooper 
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and Lenski (2010), 42 populations of E. coli were propagated for 2,000 
generations either on single sugars or in combination of two sugars 
presented together or fluctuating daily. Interestingly, they showed that 
populations adapting to fluctuating environments showed greater fitness 
variation among populations than in constant environments.  
Even though, abiotic factors are very important components of the 
environment in which microbes occur, they are not the only important 
aspect. In the real environments, many abiotic as well as biotic factors 
shape the environment to which microbes adapt. Biotic interactions, such 
as competition and predation, are not only overwhelmingly present in the 
real world, they also represent some of the strongest selection pressures to 
which organisms have to adapt. Therefore, increased selective pressures 
become important. Despite the importance of such interactions , only 
recently have they been incorporated into experimental evolution studies 
(Buckling and Rainey 2002, Mizoguchi et al. 2003, Yoshida et al. 2003, 
Yamada et al. 2008, Hillesland et al. 2009, Vos et al. 2009, Paterson et al. 
2010). These studies demonstrated that bacteria can adapt to different 
biotic environments and antagonistic co-evolution between species is an 
important driver of fast diversification of bacterial populations. 
In the real world, many abiotic as well as biotic factors shape the 
environment to which microbes adapt. Given E. coli’s potential to adapt to 
simple abiotic and complex biotic environments, seen above, it is important 
to understand which type of selective pressures E. coli encounters in its 
natural habitats.  
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E. coli in its natural ecosystems 
Free-living bacteria are often exposed to environmental fluctuations 
in nature. While most enteric bacteria are obligate anaerobes and can 
survive only inside specific niches in the host, E. coli during its life-cycle 
can experience a transition between its primary host environment and its 
secondary external environment, which differ in the biotic and abiotic 
conditions and resources (Savageau 1983). Consistent with this 
observation, E. coli can be isolated from several environments including 
water, soil and sediments; however its primary habitat is the 
gastrointestinal tract (Gordon et al. 2002) of mammals, birds and reptiles. It 
is found in 56% of mammalian hosts and 23% of birds, and to a lesser 
extent in fish (10%), frogs (12%), lizards (10%), turtles (4%) or snakes 
(2%). In humans, E. coli can be detected in 95 to 100% of individuals. More 
recent studies observed that some strains of E. coli are primarily adapted 
in the human intestine, while others are better adapted to the external 
environments (Sampson et al. 2006). 
E. coli usually colonizes the gastrointestinal tract of newborns in the 
first 40 hours after the birth, and colonization mode is influenced by the 
mode of delivery, infant diet, hygiene levels and medication (Grönlund et 
al. 2000, Magne et al. 2005). Some strains remain present for months to 
years while others are more transient and remain only for few days 
(Gordon 2004). E. coli is mainly a facultative anaerobe that resides in the 
large intestine. It is accustomed to a pH of 7 to 8 and a body temperature 
of 37 oC. In the large intestine, bacteria grow on nutrients acquired from the 
mucus layer (Duggan et al. 2008) and, in turn, performs useful functions for 
the host (i.e. fermentation of undigested carbohydrates, synthesis of 
vitamin K2 and B12 and some amino acids, protection against invading 
pathogens, control the development and homeostasis of the immune 
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system, regulation of epithelial cells (IECs) proliferation and others 
(Oginsky 1952, Bragg 1964, Guarner and Malagelada 2003, Baez-Viveros 
et al. 2004, Macdonald and Monteleone 2005).   
It is possible, that due to the complexity of environmental niches 
and various lifestyles of E. coli, a wide diversity of E. coli phenotypes 
emerged during adaptive diversification. Therefore, a better understanding 
and characterization of particular E. coli phenotypes is needed in order to 
understand how they adapted to a particular niche and acquired unique 
and important traits.  
Diversity and pathogenic potential of E. coli strains  
Currently, E. coli strains present in human and animal populations 
are divided into four major recognized phylogenetic subgroups: A, B1, B2 
and D. This separation is based on the analysis of genetic, phenotypic and 
ecological data. The distributions of the four E. coli subgroups are similar in 
mammalian herbivores and omnivores and differ from carnivores. A and B1 
strains are closely related and occur in all vertebrate hosts and in the 
water; B2 subgroup is found in warm-blooded vertebrates with hindgut 
fermentation; subgroup D is found in warm-blooded vertebrates (Gordon 
2004). In humans, considerable variation has been observed in the 
proportions of E. coli subgroups during the past 20 years (Tenaillon et al. 
2010). However, it has been shown that socioeconomic factors, such as 
dietary habits and the level of hygiene, are presumably one of the main 
conditioners for phylogenetic group distribution, rather than geographical, 
climatic or host genetic conditions (Tenaillon et al. 2010). 
E. coli is not just a commensal. According to the pathophysiology of 
a particular disease, E. coli strains are divided into several pathotypes, such 
as enterohemorragic (EHEC), enteropathogenic (EPEC), enterotoxigenic 
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(ETEC), enteroinvasive (EIEC) and extraintestinal (ExPEC) pathogenic 
E.coli (Denamur 2010). Pathogenic strains of E.coli can cause urinary tract 
infections, gastroenteritis, neonatal meningitis, hemorrhagic colitis, 
multifactorial hemolytic uremic syndrome (HUS), peritonitis, mastitis, 
septicemia and other diseases (Donnenberg and Whittam 2001). Within 
the different types of E. coli, commensal E.coli represents the most 
abundant bacterial flora in the colon where it normally does not cause 
disease (Denamur 2010). Nevertheless, even commensal E. coli can 
become an opportunistic pathogen if it breaks hosts physiological barriers, 
causing urinary tract infections or sepsis (MacFie et al. 1999, Russo and 
Johnson 2003). 
Several studies have tried to address the genotypic and phenotypic 
differences between commensal and pathogenic E. coli strains (Dobrindt et 
al. 2003, Brzuszkiewicz et al. 2006, Zdziarski et al. 2010, Leimbach et al. 
2013). DNA-DNA hybridization results have shown that genome contents 
of different E. coli isolates (22 pathogenic and commensal strains) differ 
distinctly from the laboratory strain K-12 MG1655 mainly in open reading 
frames (ORFs). Amongst these differences are virulence-related genes on 
mobile genetic elements, such as bacteriophages, plasmids and 
pathogenicity islands (PAIs). Also, pathogenic strains of E. coli differ from 
non-pathogenic ones in phenotypic traits such as antibiotic resistance, 
outer membrane permeability, growth rate, stress resistance and others 
(Levert et al. 2010, Lino et al. 2011). These results demonstrate that, in 
general, pathogenic E. coli strains exhibit a greater genotypic and 
phenotypic polymorphism than nonpathogenic E. coli strains. However, it is 
difficult to distinguish if this diversity in the pathogenic E. coli strains was 
generated due to a high selection pressure imposed by the hosts’ immune 
system or due to other environmental factors inside and outside the host.  
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Over the past decades, global statistics on pathogenic E. coli 
strains reflect increasing recognition and surveillance to study emergence 
of disease outbreaks. Worldwide, ETEC strains are estimated to cause 600 
million cases of diarrhea, 840 million gastrointestinal infections annually 
and 700,000 deaths in children younger than 5 years, predominantly in 
developing countries  (Stamm and Norrby 2001, Dobrindt and Hacker 
2008). According to the Centers for Disease Control and Prevention, 
several outbreaks of EHEC E.coli strain O157:H7, were observed during 
last decade. Though E. coli O157:H7 is a mutant form of EHEC pathotype, 
found mainly in the intestinal tract of cattle, it could be transmitted via many 
food vectors. As the population of EHEC O157 strains has increased in 
frequency and spread geographically, it has also genetically diversified. 
SNP (single nucleotide polymorphism) genotyping has shown that diverse 
lineages of O157 strains are associated with clinical infections and that 
some lineages have recently acquired novel factors that contribute to 
enhanced virulence (Zhang et al. 2007, Manning et al. 2008). Evolutionary 
changes in some of the E.coli strains could explain their emergence in 
several recent foodborne outbreaks. The most recent outbreak, in May 
2011 in Germany, was caused by a new mutant EHEC E.coli strain 
O104:H4, resulting in 44 deaths and 3,792 infected people. 
E. coli strains are extensively studied and can be viewed as rapidly 
evolving, capable of generating new pathogenic variants that have the 
ability to deceive host protective mechanisms. Thus it becomes crucial 
importance to understand which strategies can emerge when these 
microorganisms adapt in the presence of the immune system.  
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Immune system as selective pressure in bacterial 
populations 
Infectious diseases caused by various microorganisms are a 
leading cause of morbidity and mortality worldwide, hence it is important to 
understand how the host immune system recognizes and responds to a 
microbe. After a microbe successfully overpasses the hosts’ physiological 
barriers, it confronts the cells and mechanisms of the first line of defense 
against invading organisms - innate immune system. Among the variety of 
tissue cells involved in the innate immunity of the vertebrate hosts (e. g. 
neutrophils, eosinophils, basophils, dendritic cells) macrophages are key 
players in host defense by recognizing, engulfing and killing 
microorganisms (see Figure 1.1A).  
Interaction between E. coli and macrophages  
Recognition 
Innate immune recognition is mediated by pattern-recognition 
receptors (PRRs), which are germline encoded. Each receptor recognizes 
specific molecular structures of different microbes. PRRs are unique to the 
host cells (e.g. epithelial cells or macrophages) and most extensively 
studied in macrophages. The main targets for PRR mediated recognition 
are called pathogen-associated molecular patterns (PAMPs). The best 
known PAMPs of bacteria are lipopolysaccharides, lipoteichoic acids, 
peptidoglycans, some lipoproteins and lipopeptides, CpG-DNA, 
carbohydrates, endotoxins and others (Medzhitov 2007). After many 
ligands and their receptors were discovered, it became obvious that the 
receptors do not distinguish “pathogens” per se, but rather invariant 
structures of microbial structure in general. The outcome of this foreign 
structures recognition, resulting either in activation of 
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proinflammatory/immunogenic responses or sometimes resulting in 
tolerance, remains to be explained. 
All PRRs can be broadly categorized into three different functional 
groups (see summary in Table 1.1): signaling PRRs that initiate “pro-
inflammatory” signaling pathways, phagocytic (or endocytic) PPRs that 
mediate microbe uptake to phagocytes and secreted PRRs which activate 
complement and facilitate phagocytosis (Miller et al. 2005, Medzhitov 2007). 
Engulfment and phagosome maturation 
After bacteria are recognized by phagocytic PRRs, different 
signaling cascades are activated depending on the nature of signaling 
receptors engaged in the activation. The following events result in physical 
and chemical changes in the macrophage cell that triggers the engulfment 
(Figure 1.1A). 
Following the attachment, polymerization and then 
depolymerization of actin filaments take place, macrophages send 
pseudopods (also called pseudopodia or “false feet” – see Figure 1.1B) out 
to engulf the microbial particle and place it into endocytic vesicles called 
phagosomes (see Figure 1.1A and 1.1C).   
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Table 1.1.  Different classes of PRRs and their best characterized PAMP ligands. 
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TLR 
TLR1      
TLR2                       
TLR4      
TLR5          
TLR6      
TLR9 
LP                                                         
LTA, PGN, lipoproteins, LPS           
LPS                                                 
Flagellin                                              
diacyl lipoproteins                                             
CpG - DNA 
(Miller et al. 2005, 
Medzhitov 2007, 
Ehlers and Rook 
2011) 
NLR 
NOD1    
NOD2 
meso-DAP                                           
MDP 
(Medzhitov 2008) 
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SR 
SR-A 
MARCO 
LDL, LPS, LTA, poly(IC)                    
LPS, LTA 
(Elshourbagy et 
al. 2000, 
Pluddemann et al. 
2009) 
 MR carbohydrates 
(Cotena et al. 
2007) 
 Dectin-1 glucans 
(Cotena et al. 
2007) 
S
e
c
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R
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s
 
collectins 
SP-A           
SP-D 
mannose, fucose and N-
acetyl glucosamine 
(Zamze et al. 
2002) 
pentraxins PTX3 OmpA (James 2002) 
 LPD LPS (James 2002) 
 BPI LPS and endotoxin (Medzhitov 2008) 
PGRP  PGN 
(Medzhitov 
2008) 
 
Upon formation of the early phagosomes, just after the microbe is 
ingested inside the macrophage, phagosomes undergo sequential fusion 
with early endosomes, late endosomes and lysosomes (Figure1.1A). The 
latter terminal step, when phagosomes fuse with lysosomes forming 
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phagolysosomes, is accompanied by acute changes in the composition of 
phagolysosomes lumen, which becomes a highly acidic, oxidative and 
degradative milieu. There are two major models that describe this 
endocytic pathway. The “vesicle shuttle model” stating that transport 
vesicles connect pre-existing endocytic organelles, and the “maturation 
model”, suggesting that the formation of endocytic vesicles occurs because 
of gradual maturation into the later stages vesicles (Tjelle et al. 2000). 
 
 
Figure 1.1. Interactions between macrophage and bacteria. (A) – recognition 
(1), engulfment (2), phagosome fusion with early endosomes (3) and late 
endosomes (4), phagolysosome formation (5), intracellular killing and digestion (6), 
formation of residual body containing indigestible material (7), discharge of waste 
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materials (8). (B) Pseudopod formation (indicated by arrows) during exposure of 
the macrophages to E. coli. DIC (interference contrast) picture was imaged with 
DeltaVision Core Olympus microscope equipped with EM-CCD camera with 60× 
oil immersion objective. (C) E. coli K-12 derivative which consitutively expresses 
yellow fluorescent protein (yfp, shown in green) inside endocytic vesicles of the 
macrophages. Macrophages (RAW 264.7) were labeled with LysoTracker Red 
(LTR) (in red) and imaged on a Nikon Eclipse Ti-E microscope with 100× oil 
immersion objective with Yokogowa CSU-x1 confocal scanner. 
 
 
During the formation of early phagosomes, phagosomes fuse with 
early sorting and recycling endosomes making their lumen become mildly 
acidic (pH 6.1 - 6.5) and poor in hydrolytic activity.  After several recycling 
processes, phagosomal lumen becomes more acidic (pH 5.5-6.0) with the 
help of proton- pumping V-ATPases. The final fusion of phagosome and 
late endosomes results in the maturation of phagolysosome, where 
intracellular killing of the microorganisms occurs. Insertion of additional V-
ATPases increases pH dramatically, up to pH of 4.0. Phagolysosomal 
structure provide an enclosed space in which macrophages can direct high 
local concentrations of reactive oxygen species (ROS), reactive nitrogen 
intermediates  and antimicrobial peptides to eliminate internalized 
microbes. 
Oxygen-dependant and oxygen-independent killing mechanisms 
After phagolysosome maturation, within few minutes of engulfment, 
bacterial physiology changes dramatically, resulting in the loss of viability 
due to microbicidal activities of the macrophages. The latter are divided 
into oxygen-independent and oxygen-dependent killing events. 
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The main mechanism by which phagocytes eliminate internalized 
bacteria is through ROS or through reactive nitrogen species (RNS). ROIs 
(reactive oxygen intermediates), ROS or ROMs (reactive oxygen 
metabolites) mainly contain oxygen (O2), hydrogen (H2) and halogen (Cl2, 
Br2). Some examples of ROIs include: free oxygen radicals (O2
-), hydroxyl 
radical (•OH), peroxyl radical (RO2
•), perhydroxyl radical (HOO•); some 
oxidants, such as hypochlorous acid (HOCl), ozone (O3), peroxide (H2O2) 
and singlet oxygen (1O2). Macrophages destroy pathogens in part through 
ROS generated directly or indirectly by the NOX2 NADPH oxidase. NOX2 
transfers electrons from the NADPH to the molecular oxygen and 
generates NADP+, protons and superoxide anions: 
2O2 +NADPH → 2O2
- +NADP+ + H+ 
This rapid reaction is called “respiratory burst” or “oxidative burst” which 
leads to the accumulation of large amounts of ROIs. Within the phagosome 
O2
- can dismutate to H2O2, which can in turn react with O2
- to generate 
hydroxyl radicals and singlet oxygen. H2O2 can also be converted by 
myeloperoxidase into hipochlorous acid and cloraminesin (Flannagan et al. 
2009). NOX2 is part of the Phox multiprotein complex, which can be 
modulated by increasing concentrations of molecular oxygen, acidic pH 
and NADPH, Ca2+ depletion by store-operated calcium entry (SOCE) 
mechanism which in turn causes influx of extracellular Ca2+. This process 
can be primed by LPS of gram-negative and gram-positive bacteria 
(Flannagan et al. 2009). 
The second oxygen-dependent killing mechanism employs reactive 
nitrogen intermediates (RNIs), RNS and reactive nitrogen metabolites 
(RNM), which are composed mainly from nitrogen, oxygen and sometimes 
halogen or sulfur group. Some of the examples of RNS, RNI and RNM 
include: nitrite (NO2
-), nitrate (NO3
-), nitogen monoxide (•NO), nitrogen 
19 
 
dioxide (•NO2), nitrosonium cation (NO
+), nitroxyl (NO-) and peroxynitrite 
(ONOO-) anions, dinitrogen trioxide (N2O3), nitryl chloride (NO2Cl) and 
various S-nitrosothiols. The main enzymes in RNIs production are (NOS) 
nitric oxide synthases that generate NO• from L-arginine. There are three 
isoforms of NOS: endothelial NOS , neuronal NOS (nNOS) and inducible 
nitric oxide synthase (iNOS or NOS2), which is induced only after exposure 
to pathogens, microbial ligans and/or cytokines (Bogdan 2010).  iNOS 
functions as a dimer: one subunit transfers electrons from NADPH to FAD, 
then to flavin mononucleotide (FMN) and to the haem iron of the adjacent 
subunit, to produce NO• and citrulline from L-arginine and oxygen (Bogdan 
2010). NO• is synthesized on the cytoplasmic side of phagolysosomes and 
freely diffuses across the membrane where it encounters ROS. 
 Collectively, highly reactive and toxic ROS and RNS effectively kill 
microorganisms as they interact with numerous microbial targets, such as 
thiols, metal centers, protein tyrosine residues, nucleic acids and lipids 
(Stuehr 1997). Moreover, the rate of spontaneous and intracellularly 
induced mutagenesis is at least 10-fold higher in the macrophage cells 
than in the absence of the macrophages (Schlosser-Silverman et al. 2000). 
Indeed, upon macrophage entry, the majority of E. coli cells are viable, but 
the mutagenic macrophage environment leads to an immediate arrest of 
gene expression and to DNA damage of E.coli. DNA damage generated is 
characterized by the DNA strand breaks and the modification 8-oxo-2*-
deoxyguanosine, which are typical of oxidative damage.  
The oxygen-independent killing process involves many 
antimicrobial proteins and peptides secreted by the phagocytes (Ganz 
2003).  Cationic host defense peptides (HDPs) include two major classes 
of antimicrobial peptides - defensins and cathelicidins. HDPs recognize 
LPS or LTA in the bacterial membrane, but exact mechanisms of their 
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action are not known (Jenssen et al. 2006). Several models propose 
different targets for antimicrobial peptides action, which include disruption 
of membrane integrity, interference with essential processes dependent on 
membrane-bound enzymes (cell division, cell wall synthesis), or 
translocation across the membrane to access cytosolic targets (Yang et al. 
2001). 
Antimicrobial proteins are larger molecules than antimicrobial 
peptides (more than 100 amino acids) with a well defined tertiary structure. 
Like HDPs, they exhibit antimicrobial activities and immunomodulatory 
properties. Only three antimicrobial proteins are found in the mature 
macrophages: lysozyme, lactoferrin (Lf) and natural resistance-associated 
macrophage protein 1 (NRAMP1). Lysozyme can act only on very 
restricted range of bacteria as it kills bacteria by increasing osmotic stress 
that leads to the disruption of the peptidoglycan that composes bacterial 
cell wall. Gram-negative bacteria are generally more resistant to lysozyme 
activity due to stabilizing effect in the outer membrane and only higher 
levels of this protein can be antibacterial (Madera et al. 2010). Lf acts as 
bacteriostatic agent by sequestrating iron required for growth of many 
bacteria and as bactericidal agent by damaging the outer bacterial 
membrane and increasing membrane permeability (Madera et al. 2010). 
Another antimicrobial protein, NRAMP 1, an integral membrane protein 
expressed in late endosomes and lysosomes, exerts a bacteriostatic effect 
by extruding divalent cations, such as Fe2+, Zn2+ and Mn2+. Since those 
cations are cofactors for many microbial enzymes (e.g. Mn2+ is required for 
superoxide dismutase) it inhibits bacterial metabolism (Puddu et al. 2009).  
In general, oxygen-independent (phagolysosome acidification, 
action of antimicrobial proteins and peptides) and oxygen-dependent killing 
mechanisms (ROS and RNS) are always interdependent. For example, 
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acidification of phagolysosomes by V-ATPases enhances the activity of 
many proteases that converts H2O2 into highly toxic halides and 
participates in ROI production.  
Possible adaptive strategies that bacteria can evolve in the 
presence of macrophages 
Just as the body has evolved mechanisms to defend itself from 
intruders, bacteria have evolved their own strategies to circumvent immune 
recognition at its initial steps. If bacteria breach the host's physical 
defenses, it must then overcome the host's phagocytic response to 
succeed in the following infection. Many bacterial pathogens have evolved 
to escape, resist or even kill phagocytic cells upon their encounter 
(Rosenberger and Finlay 2003). Altogether, several intracellular and 
extracellular strategies exist to fool innate immune system cells, in 
particular macrophages. Extracellular strategies include avoidance of 
detection and engulfment inhibition mechanisms. Intracellular strategies 
comprise of survival inside macrophages and escape from phagosomes 
mechanisms. The ultimate strategy that pathogens evolved can be 
classified either as intracellular or as extracellular, because pathogens can 
kill host cells by secretion of toxins either before or after engulfment of 
macrophages.  
 
Avoidance of contact with macrophages 
For some bacteria that do not have sophisticated genetic tools to 
interfere with macrophage functions, it is advantageous to remain 
extracellular in order to avoid being internalized and killed. To avoid 
detection by macrophages, some bacteria modify their surface by 
camouflaging or directly modifying the molecules that trigger TLR signaling. 
For instance, some extracellular pathogens (Streptococcus pneumonia, E. 
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coli K1, Neisseria meningitides and many others) mask bacterial surfaces 
by expressing a carbohydrate capsule, hereby avoiding opsonization and 
phagocytic clearance (Finlay and McFadden 2006). Many bacterial 
pathogens (Salmonella enterica serovar Typhimurium, Brucella abortus, 
Yersinia pestis), instead of hiding their bacterial surface, simply modify 
their LPS in such a way that they are less well recognized by macrophage 
receptors (Diacovich and Gorvel 2010, Pastelin-Palacios et al. 2011). For 
example, Salmonella modifies its lipid A structure by including 3-O-
deacylase (PagL) and a lipid A palmitoyltransferase (PagP). As a result, 
modified lipid A is up to 100-fold less actively recognized by TLR4 receptor 
(Kawasaki et al. 2004). 
Although several observations on filament forming bacteria 
suggested that bacteria undergo such morphological changes in order to 
avoid internalization (Garcia-del Portillo et al. 1993), this might not be true. 
For instance, several authors observed filamentous UPEC during bladder 
infections, a phenomena that is now described as being transient in the 
different stages of infection and insufficient to confer protection from 
phagocytosis in vitro (Justice et al. 2006). However, filamentous bacteria 
may show an advantage in the face of extracellularly excreted antimicrobial 
peptides, because such trait contributes to survival in different 
environmental stresses (Chen et al. 2005, Justice et al. 2006). 
 
Inhibition of phagocytic engulfment 
Several reviews discuss how bacterial pathogens, such as Y. 
pestis, Pseudomonas aeruginosa and EPEC or EHEC deliver specific 
proteins to interfere with bacterial uptake into host cells (Rosenberger and 
Finlay 2003, Bhavsar et al. 2007, Schmid-Hempel 2008). For example, 
Yops proteins by Y. pestis are deployed to macrophages to interfere with 
cytoskeleton to block proper phagocytosis (Hornef et al. 2002). Some 
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extracellular pathogens (for example, EPEC and EHEC) manipulate the 
actin cytoskeleton to generate actin-rich pedestal structures on the host-
cell surface, where pathogen resides without being internalized (Bhavsar et 
al. 2007). 
 
Escape from phagolysosomes 
One way to avoid the harsh environment of phagolysosome is to 
rapidly escape maturing phagosomes or to arrest/reprogram phagosomal 
maturation. Various “professional” intracellular pathogens, such as 
Mycobaterium tuberculosis, S. typhimurium, Coxiella burnetti, Legionella 
pneumophila, Listeria monocytogenes E. coli, and others, survive 
intracellularly in different recycling early endosomes, late endosomes, 
lysosomes or endoplasmic reticulum (Underhill and Ozinsky 2002, Flynn 
and Chan 2003).  For example, some strains of E. coli adhere to host cells 
with FimH type 1 pilus, actively enter macrophages through specific lipid 
rafts and persist inside membrane-bound compartments that are protected 
from oxidative and acidic stresses (Baorto et al. 1997).  Bacteria such as 
Shigella spp, or L. monocytogenes produce proteins that allows bacteria to 
escape from vacuolar compartments into the cytoplasm (Portnoy et al. 
2002). Recently, it was demonstrated that L. monocytogenes not only can 
enter cytoplasm and replicate rapidly (every 30 min) following fast 
dissemination, but it can also reside inside Listeria-containing vacuoles, 
where bacteria can replicate slowly (every 8 hours), without destroying the 
infected cell (Flannagan et al. 2009). Such switch between mechanisms 
could explain different outcomes of L. monocytogenes active and chronic 
infections. Other examples to escape from mature phagolysosomes are 
represented by M. tuberculosis and Mycobacterium avium. M. tuberculosis 
uses an array of effector molecules to survive inside macrophages by 
arresting phagosomal maturation (Flannagan et al. 2009). And M. avium 
24 
 
inhibits acidification of Mycobacterium-containing vacuoles thus enabling 
activation of lysosomal degradative enzymes.  
  
Increased survival in the phagolysosome 
If a pathogen is captured and reaches a phagolysosome, it can still 
survive by withstanding the microbicidal properties of the phagolysosome. 
Several studies have focused on the interactions that occur between 
macrophages and bacteria in this degradative milieu, where pH can 
decrease up to 4.0 and multiple antimicrobial peptides, ROS and RNS are 
present. Many intracellular pathogens (M. tuberculosis, C. burnetti, 
Rhodococcus equi, Staphylococcus aureus, Bacillus anthracis and others) 
survive this stress and some of them can even replicate inside the 
macrophages (Howe and Mallavia 2000, Pieters and Gatfield 2002, 
Toyooka et al. 2005). For example, M. tuberculosis survives and even 
replicates inside phagolysosomes, probably by excluding proton-pumping 
V-ATPases, however the exact mechanism is not known (Smith 2003).  
Moreover, M. tuberculosis cell wall contains mycolic acids and other lipids 
that protect bacteria from lysosomes. Other pathogens (for example S. 
aureus and B. abortus) produce enzymes, such as catalase and 
superoxide dismutase (SOD) that partially neutralizes reactive oxygen and 
nitrogen species (Kim et al. 2000, Das and Bishayi 2010). 
 Another astonishing obligate intracellular pathogen, C. burnetti, the 
causative agent of Q fever, shows a biphasic developmental cycle of 
infection (Flannagan et al. 2009). In the first phase of infection, C. burnetti 
displays dormant small-cell variant (SCV) morphology and delays 
phagosome fusion with lysosome. In the second phase of infection, small-
cell variant transits to replication-competent large-cell variant (LCV), that 
behaves similarly to acidophile. It is believed that acidic environment of 
phagolysosome is required for many C. burnetti metabolic functions and 
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unknown virulence factors encoded in T4SS can protect from antimicrobial 
effects.     
 
Killing of macrophages 
Many most dreadful diseases, such as diphtheria, tetanus, botulism 
or cholera are caused by pathogens that are able to secrete toxins and kill 
macrophages (Lahiri 2000). Bacterial toxins can be divided into three 
groups according to their site of action: toxins that act at the plasma 
membrane and interfere with transmembrane signaling pathways (E. coli 
enterotoxin ST); that alter membrane permeability (E. coli hemolysin); or 
that modify cytosolic targets inside the macrophages (E. coli CNF) (Finlay 
and Cossart 1997). Toxins can also be divided in several groups according 
with the effect that impose on macrophage cells, from blockage of 
exocytosis or protein synthesis, actin depolymerization and cell shape 
changes to increase in cAMP and even cell death.  
Traits selected in E. coli clinical isolates 
Overall, many bacterial species evolved diverse mechanisms for 
interacting with, and manipulating, host cells and for evading host innate 
immune responses. Presumably, bacterial pathogens have evolved such 
strategies because they provide a selective advantage in the environments 
where pathogens can be found. 
Several E. coli strains were isolated in clinics from patients, 
suffering from urinary infections, chronic chest infections, catheter-related 
infections, pyelonephritis, breast cancer, alcoholic cirrhosis, inflammatory 
bowel disease, diabetes, Crohn`s disease and other diseases (Taylor 
1976, Borderon and Horodniceanu 1978, Vejborg et al. 2011). It is possible 
that many of those diseases resulted from evolution of E. coli to escape 
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immune surveillance in the host. Vidal et. al (1998) have shown that two 
clinical  strains isolated from patients with catheter-related infections were 
able to form a thick biofilm and this phenotype could be explained by a 
single point mutation, resulting in the replacement of leucine by an arginine 
amino acid at position 43 in the regulatory protein OmpR (Vidal et al. 
1998). While selection pressure responsible for the appearance of this 
phenotype could not be identified, it is striking that only one point mutation 
can be sufficient to acquire a pathogenic trait, such as adherence and 
biofilm formation. Other frequently sampled E. coli clinical isolates exhibit 
decreased growth ability, because of defections in the respiratory chain. 
Those metabolically deficient bacterial strains, previously called dwarfs 
(Borderon and Horodniceanu 1978) and later SCVs (for small colony 
variants), are more resistant to certain antibiotics and are responsible for 
various persistent infections (Proctor et al. 2006).  
In order to combat pathogens that are able to overrun crucial host-
cell mechanisms, it is important to disentangle the causes of the underlying 
disease. Despite progress towards understanding the molecular 
mechanisms that underlie microbial pathogenesis, further steps towards 
understanding how such traits evolve in the presence of selective 
pressures imposed by the host, are indispensable.  
Bacterial adaptation to other environmental niches can 
result in increased survival in the presence of the 
macrophages 
Many bacterial species are not solely obligatory human pathogens 
but rather versatile lodgers that can transit to other environmental niches. 
In such ecosystems as soil, freshwater and sea, microbes are confronted 
with a range of environmental predators and parasites (Finlay et al. 1998, 
Ronn et al. 2002, Chibani-Chennoufi et al. 2004, Fayer et al. 2004), and 
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thus, have to learn how to avoid, tolerate or defend against them. Because 
traits that bacteria evolve in the outside-host environment sometimes 
correlate with an increased survival to resist host’s immune system 
(Wildschutte et al. 2004, Friman et al. 2009, Adiba et al. 2010, Chrisman et 
al. 2010), it is not clear which type of selective pressures are responsible 
for the acquisition of such traits. The coincidental evolution hypothesis 
suggests that some bacterial strategies, which are advantageous in the 
presence of immune system does not necessary result from directional 
selection in the host, but can be a by-product of adaptation to other 
ecological niches.  
Such relationship between bacterial strategies to escape hosts 
immune system and increased survival in the presence of some simple 
eukaryotes and prokaryotes is very intriguing. It is believed that some traits 
that enhance the survival of bacterial pathogens in the presence of immune 
system by providing protection against environmental predators and 
parasites, such as bactevorous protozoa, bacteriophages, nematodes or 
even other bacterial species.  
Protozoa 
It is believed that some of the adaptations that evolved as defense 
mechanisms against protozoa may be important in the adaptation of 
bacteria to the immune system (for example, in Legionella pneumophila, 
Pseudomonas aeruginosa, Cryptococcus neofarmans, Salmonella 
enterica, E. coli O157:H7 and others) and one of their primary 
environmental predators – protozoa (Matz et al. 2004, Wildschutte et al. 
2004, Steinberg and Levin 2007, Chrisman et al. 2010, Messi et al. 2013). 
Indeed, pathogen detection mechanisms involved in innate immunity and 
prey detection by free-living protozoa are very similar (Jousset 2012). 
Moreover, protozoa and macrophages share similar mechanism by which 
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bacteria are uptaken and killed (Horwitz and Maxfield 1984, Rechnitzer and 
Blom 1989, Gao et al. 1997). In fact, many studies have shown that 
protozoa are able to select for bacterial virulence traits that help to survive 
in the presence of macrophages (Harb et al. 2000). 
It is thought that adaptation of Legionella pneumophila to survive 
within environmental amoebae may have primed this pathogen to survive 
within macrophages (Cirillo et al. 1994, Brieland et al. 1997). Indeed, L. 
pneumophila grown within amoebae are several fold more invasive both for 
epithelial and macrophage cells and are 1000-fold more resistant to 
antimicrobial compounds (Barker et al. 1995). Moreover, several genes 
that enhance survival within macrophages are also required for survival 
within amoeba (Gao et al. 1997, Liles et al. 1999, Segal and Shuman 
1999, Clark et al. 2013). Recently, however, it was also demonstrated that 
L. pneumophila grown within macrophages can become less invasive in 
protozoa (Ensminger et al. 2012). Examples from other bacterial species, 
such as production of toxins and biofilms in P. aeruginosa (Matz et al. 
2004), O-antigen variation among Salmonella serovars  (Tezcan-Merdol et 
al. 2004, Wildschutte et al. 2004) and advantage of E. coli Shiga toxin (Stx)  
(Steinberg and Levin 2007), were also observed during protozoan grazing. 
Altogether, there are, in fact, a variety of mechanisms that bacteria use to 
either evade or survive protozoan predation (Matz and Kjelleberg 2005). 
Such mechanisms resemble several adaptive strategies that bacterial 
pathogens evolved to circumvent recognition, engulfment or killing by 
macrophages (see previous chapter).  
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Nematodes 
Little is known about bacterial evolution in nematodes, despite the 
vast body of studies using the nematode Caenorhabditis elegans as a 
model organism (Kurz and Ewbank 2003). This is disappointing given the 
fact that  C. elegans and other nematode species are found in the same 
ecosystems as bacterial species, and form the second main group of 
bacterivorous predators (Abada et al. 2009). Only recently, however, C. 
elegans was recognized as a valuable model to study bacterial 
pathogenesis and even evolution of innate immunity (Schulenburg et al. 
2004). It is known that when C. elegans encounters pathogenic bacteria, 
innate immune responses are mounted, such as production and release of 
different antimicrobial peptides (Irazoqui et al. 2010), very similarly to those 
observed in many eukaryotic cells in the human body, including 
macrophages. Moreover, there is an ever growing list of bacterial 
pathogens that are able to infect C. elegans and invade innate immune 
responses of the human host, such as P. aeuruginosa, Vibrio cholera, S. 
typhimurium, Streptococcus pneumonia, Burkholderia pseudomallei and 
many others (Darby et al. 1999, Aballay et al. 2000, Aballay and Ausubel 
2002, Garsin et al. 2003, Vaitkevicius et al. 2006, Diard et al. 2007, 
Bhargava et al. 2009). For instance, toxins of P. aeuruginosa involved in 
the killing of C. elegans are also required for pathogenesis in mammals 
(Tan et al. 1999). And E. coli causing urinary tract infections in humans can 
cause digestive tract infections in C. elegans (Diard et al. 2007). 
Bacteriophages and other bacterial species 
Several other traits that are advantageous in the presence of the 
macrophages can be selected when bacteria are subjected to 
bacteriophages or even other bacterial species. It is known that some 
bacteriophages encode virulence factors that can be integrated into 
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bacterial genome (for explicit reviews see(Casas et al. 2010)). However, 
such phages provide direct advantage and thus cannot be applied to 
coincidental evolution theory. Indirectly, however, phages-mediated 
selection can shape several bacterial traits, such as motility and growth 
(Koskella et al. 2011) and even indirectly modulate bacterial pathogenesis 
(Friman et al. 2011, Laanto et al. 2012). Interestingly, Friman et al. (2011) 
demonstrated that after exposure of bacteria Serratia marcescens to 
predation by lytic bacteriophage PPV (Padoviridae), bacterial pathogens 
were less virulent in the in vivo insect model.  
Curiously, other bacterial species, as Myxobacteria or Bdellovibrio 
bacteriovorus, can also display predatory behavior. Soil living bacteria, 
Myxobacteria, aggregate in motile swarms to concentrate enzymes that 
digest other bacterial species (Shimkets 1990). Or B. bacteriovorus kill 
other bacterial cells by entering in the prey’s periplasm between its inner 
and outer membranes and utilizing the prey’s macromolecules for 
replication (Nunez et al. 2003). Though, it is not known if such predatory 
mechanisms can select for traits that enhance survival of bacteria in the 
human host. 
Overall, traits that affect ability to resist to environmental predators 
and parasites should be under strong selection in many bacterial 
pathogens. Hence, a number of virulence factors likely evolved in response 
to selective pressure within environment filled with predators and parasites. 
Therefore, it is important to ascertain which bacterial traits selected in the 
presence of phagocytes, could be advantageous when facing other 
ecological interactions and vice versa, in order to understand and predict 
evolution and maintenance of virulence in the complex inside-host and 
outside-host ecosystem.  
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Antibiotics as tools to eradicate bacterial populations  
In terms of evolution and ecology, bacterial survival and adaptation 
to the innate immune system and to antibiotics is always interconnected. In 
the context of infection, bacteria are frequently exposed to multiple drugs 
and to hosts’ immune system, sequentially or even simultaneously. Hence, 
it is important to understand how such interaction between immune system 
and antibiotics affects evolution of major public threats – antibiotic 
resistance and virulence.  
In the course of evolutionary arms-race between hosts immune 
system and microbes, many different pathogens have emerged, such as 
M. tuberculosis, S. aureus, Klebsiella pneumonia, Yersinia spp., Clostridia 
spp. and others, that can cause serious illnesses and even death to the 
host.  The discovery of antibiotics decreased morbidity and mortality of 
human population worldwide; however the use of drugs was compromised 
by the development of tolerance or resistance to those compounds. There 
are many many excellent reviews on the genetics, evolution and 
mechanism of antibiotic resistance (Lenski 1998, Martinez 2008, Allen et 
al. 2010, Andersson and Hughes 2010, Kohanski et al. 2010b, MacLean et 
al. 2010, D'Costa et al. 2011, Andersson and Hughes 2012), however in 
my thesis I will focus on the cost of antibiotic resistance.  
Generally, several studies have shown that antibiotic resistant 
strains have a lower fitness in antibiotic-free environment although 
resistance to some antibiotics can be neutral or even beneficial (reviewed 
in. (Andersson and Hughes 2010)) On first consideration it may seem that 
the most reasonable approach in clinical practice would be to prescribe 
antibiotics that carry the largest biological fitness cost for bacteria. 
However, two major difficulties exist here. Firstly, many in vivo and in vitro 
observations have shown that bacteria evolve very rapidly to compensate 
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such fitness costs (Bjorkholm et al. 2001, Sousa et al. 2012). Secondly, 
several studies have demonstrated that fitness effects of antibiotic resistant 
mutations vary when measured in different genetic backgrounds (Gagneux 
et al. 2006) or in different environmental conditions (Giraud et al. 2003, Hall 
and MacLean 2011, Trindade et al. 2012). While many of those studies 
determined the effects of resistance in diverse environments, only very few 
of those were conducted in the conditions relevant for the host, namely 
during the infection process in the host macrophages. This poses a 
challenge to both evolutionary biologists and microbiologists, as antibiotics 
are still fundamental tool to combat pathogens inside the host environment. 
Similarities between ROS generated by macrophages and 
action of antibiotics 
During entry into innate immune system cells – macrophages –  
bacteria experience a set of environmental stresses, such as host-induced 
nutrient limitation, acidification, toxic peptides, osmotic stress and reactive 
oxygen species (ROS), of which the latter is believed to be a major cause 
of bacterial killing (Schlosser-Silverman et al. 2000). 
Several studies have tried to link oxidative stress and antibiotic-
induced ROS formation (Kohanski et al. 2007, Dwyer et al. 2009).  
Kohanski et al. (2009) revealed that treatment of bacteria with different 
bactericidal antibiotics induces formation of hydroxyl radicals via common 
mechanism that affects tricarboxylic acid (TCA) cycle metabolism. Other 
studies reported that single point mutations in soxR gene, that protect E.  
coli from cytotoxicity of nitric oxide-generating macrophages (Nunoshiba et 
al. 1993), contributed to multiple-antibiotic resistance phenotypes 
(Koutsolioutsou et al. 2005). Moreover, Wang and Zhao showed that the 
combined activity of superoxide dismutases SodA and SodB were 
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important to killing by fluorquinolones and peroxidase AhpC was critical to 
killing by β-lactams and aminoglycosides antibiotics (Wang and Zhao 
2009). A recent study has also shown that increase in mutation rate after 
addition of sublethal concentrations of various bactericidal antibiotics 
positively correlate with increase in ROS formation in bacterial cells 
(Kohanski et al. 2010a). However, it is also surprising, that the same 
phenomenon was not observed under anaerobic growth conditions, 
suggesting that antibiotic induced ROS-dependent killing is only important 
in aerobically respiring bacteria. Unfortunately, it may not be relevant inside 
human body, where oxygen may be limited in some micro-environments.  
Taken together, these results suggest that bactericidal antibiotics, 
irrespective of the drug target of the applied antibiotic, may, in certain 
conditions, induce formation of ROS which in turn kills bacterial cells. In 
contrast, there is also very recent evidence to suggest that such unified 
mechanism of antibiotic killing may be incorrect (Keren et al. 2013).  Keren 
et al. (2013) demonstrated that killing by antibiotics is unrelated to 
production of ROS at higher doses of antibiotics. Undoubtedly, there is a 
further need to investigate if antibiotics induce ROS formation in bacterial 
cells. Whichever is the correct answer for this dilemma; this does not 
change a fact that antibiotic resistance and virulence are commonly 
associated traits in many species of microbes and can influence evolution 
of each other.  
In conclusion, the evolutionary and ecological mechanisms that 
select and maintain bacterial traits to resist hosts defenses or antibiotic 
pressure are fundamental to understand the emergence of diseases, as 
well as the causality and possible outcomes. Hence, this thesis tries to add 
some knowledge on the understanding the effect of immune system on the 
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evolution of bacteria in the context of pathogenesis and antibiotic 
resistance.  
Thesis objectives 
The main purpose of this thesis is to understand the process of 
adaptation to the complex biotic interaction between commensal strain of 
Escherichia coli and presence of innate immune system, namely 
macrophages.  
In Chapter 2, I described different strategies that E. coli can evolve 
in the presence of innate imunity and revealed the nature of possible 
pathoadaptive mutations by which E. coli adapt to better resist 
phagocytosis by macrophages.  
In Chapter 3, I tested if the rate of adaptation in the presence of this 
biotic environment is higher than in the abiotic environment and determined 
if clones adapted to macrophages also bear an advantage in other 
ecosystems. 
Finally, in Chapter 4 I estimated fitness effects of antibiotic resistant 
mutations to address whether antibiotic resistant E. coli can have an 
advantage or disadvantage in the context of an interaction with 
macrophages.  
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Internet Resources 
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/nczved/dfbmd/disease_listing/stec_gi.html 
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Summary 
Antagonistic interactions are likely to be important determinants of 
the diversity observed in bacteria and the complexity of their genomes. An 
important trait, relevant for bacterial pathogenesis, is the ability to escape 
innate immunity. Here, we use a combination of experiments, genome 
sequencing and mathematical modeling to address the question of how 
fast and through how many adaptive steps a commensal strain of 
Escherichia coli acquires such a trait. Using a novel setup of experimental 
evolution, we show that less than 500 generations are sufficient for E. coli 
to evolve clones able to better escape macrophage phagocytosis and 
acquire in vivo pathogenicity. We show that transposable elements drive 
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this pathoadaptive process. Particularly, we find that a single insertion into 
the promoter region of yrfF emerges in all lines, which potentiates three 
main adaptive walks. Strikingly, in one-third of the evolved lines evidence 
was found for increased mutagenesis driven by an insertion of IS186 into 
the promoter of the Lon protease, which likely accelerated the 
pathoadaptive process. Finally we show that clonal interference dominates 
the dynamics of new genotypes during evolution, using both direct 
experimental evidence, and a mathematical model, which is able to 
reproduce the dynamics observed in the experiment.  
 
Introduction 
Bacteria are currently used to study evolution in real time, in 
controlled environments through experimental evolution (Elena and Lenski 
2003). Different studies have demonstrated that bacterial populations have 
an enormous potential to adapt to relatively simple and abiotic challenges 
in laboratory environments (Perfeito et al. 2007, Sniegowski and Gerrish 
2010). On the other hand our knowledge on how biotic interactions shape 
adaptive evolution is still in its infancy. Antagonistic interactions (predation, 
parasitism) are likely to be important determinants of the rate of adaptive 
change observed in bacteria, their trait diversity and the complexity of their 
genomes (Matz and Kjelleberg 2005, Young 2007, Stern and Sorek 2011). 
The most studied antagonistic interaction in an evolutionary laboratory 
setting is that between bacteria and their phages. This has been shown to 
increase rates of bacterial adaptation and diversification (Buckling and 
Rainey 2002, Meyer and Kassen 2007, Paterson et al. 2010), 
demonstrating that biotic interactions can have an important role in 
bacterial evolution. Another common antagonistic interactions bacteria face 
is with the cells of the immune system. Yet, the short-term adaptive 
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process in this ecological context has not been studied. Here, we 
determine the strategies E. coli can evolve to overcome the hosts’ first 
defense line – the macrophages. E. coli is both a commensal and a 
versatile pathogen, killing millions of humans each year (Tenaillon et al. 
2010). Moreover, there is evidence that some pathogenic strains evolved 
from commensal E. coli (Crossman et al. 2010, Denamur 2010). This 
makes E. coli an ideal organism to study the transition from commensalism 
to pathogenicity. E. coli colonizes the infant gastrointestinal tract within 
hours after birth, and typically builds a mutualistic relation. However non-
pathogenic strains of E. coli can become pathologic, when the 
gastrointestinial barrier is disrupted as well as in immunosuppressed hosts 
(Sanz-Garcia et al. 2009, Sharma et al. 2011, Janny et al. 2012). Finally 
pathogenic strains of E. coli are able to cause disease in healthy.  
Macrophages (MΦs) are a key component of host defense 
mechanisms against pathogens. They can cause a direct bactericidal 
response through generation of reactive oxygen species and phagocytosis, 
a process by which bacteria are engulfed into phagosomes. Yet many 
bacterial species are capable to escape, resist and even kill eukaryotic 
cells, such as macrophages (MΦs) (Amer and Swanson 2002, Schmid-
Hempel 2008), suggesting that several defense strategies could evolve 
when bacteria encounter MΦs. Strategies to resist outside MΦs include 
surface masking and capsule formation (to avoid engulfment and 
phagocytosis), increased mobility, filamentation and biofilm formation. 
Strategies to resist inside MΦs include toxin release and even intracellular 
growth. Within the species of E. coli alone, there are examples of several 
different strategies (Hunstad and Justice 2010). 
In this study we have established a system in which E.coli is 
allowed to evolve to the continuous selective pressure of MΦs. Using this 
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system, we ask which types of adaptive strategies emerge in a commensal 
strain of E. coli to avoid killing by one of the sentinels of the innate immune 
system-the MΦs. 
 
Materials and Methods 
Ethics statement 
All experiments involving animals were approved by the Institutional 
Ethics Committee at the Instituto Gulbenkian de Ciência (project nr. 
A009/2010 with approval date 2010/10/15), following the Portuguese 
legislation (PORT 1005/92) which complies with the European Directive 
86/609/EEC of the European Council. 
Strains and media  
The RAW 264.7 murine macrophage cell line was maintained in an 
atmosphere containing 5% CO2 at 37
oC in RPMI 1640 (Gibco) 
supplemented with 2mM L-glutamine (Invitrogen), 1mM sodium pyruvate 
(Invitrogen), 10mM hepes (Invitrogen), 100U/ml penicillin/streptomycin 
(Gibco), 50µM 2-mercaptoethanol solution (Gibco), 50µg/ml gentamicin 
(Sigma), with 10% heat-inactivated FCS (standard RPMI complete 
medium). Before infection assays, MΦs were cultivated for 24h in the same 
medium as before except for the three antibiotics which were now replaced 
by 100µg/ml Streptomycin antibiotic (RPMI-Strep medium). All bacterial 
cultures were also done in RPMI-Strep medium, except if stated otherwise.  
Escherichia coli strains were MC4100-YFP and MC4100-CFP 
(MC4100, galK::CFP/YFP, AmpRStrepR) which contain the yellow (yfp) and 
cyan (cfp) alleles of GFP integrated at the galK locus in MC4100 (E.coli 
Genetic Stock Center #6152) and differ only by YFP/CFP locus that is 
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constitutively expressed (Hegreness et al. 2006). MC4100-CFP strain was 
used for the evolution experiment and MC4100-YFP as a reference strain 
for the fitness assays. 
Evolution experiment 
Twelve populations were founded from a single MC4100-CFP clone 
and were therefore genetically uniform in the beginning of the experiments. 
All populations were evolved in RPMI, 6 populations in the presence of the 
MΦs (M1-M6) and the other 6 (C1-C6) in the absence of MΦs. Before each 
infection cycle, MΦs (0.7×106 to 1.3×106/ml) were centrifuged at 1200 rpm 
for 5 min, resuspended in RPMI-Strep medium and activated with 2 µg/ml 
CpG-ODN 1826 (5´TCCATGACGTTCCTGACGTT 3´ - Sigma) for 24 h 
(Utaisincharoen et al. 2002). Cells were then centrifuged (1000 rpm for 5 
min), resuspended in 3 ml of fresh RPMI-Strep medium and seeded in 12-
well microtiter plates (0.8×106 to 1.6×106/). Subsequently they were 
incubated at 37oC for 2 h, washed in RPMI-Strep and infected with a MOI 
of 1:1 (106 bacteria to 106 MΦs). After 24 hours of infection, MΦs were 
detached with cell scraper and the whole culture was centrifuged at 4000 
rpm for 10 min to pellet cells. This procedure lyses MΦs releasing 
intracellular bacteria. Then these were washed twice with phosphate-
buffered saline (PBS) and counted by flow cytometry using a 
FACscan cytometer (Becton Dickinson). Approximately 106 of recovered 
bacteria were used to infect new activated MΦs in the same manner as 
before. The same procedure was applied to control populations, except 
that 104 bacteria were transferred daily. This is so, because after 4 hours of 
infection with the MΦs bacteria drop to 104. This adjustment allows the 
same number of generations in both environments. In both treatments (with 
and without MΦs), bacteria were allowed to propagate for approximately 
15 generations per day. Generation time is estimated as: G=log2(Nf/Ni), 
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where Ni is the initial number of bacteria and Nf is the final number of 
bacteria. Nf was approximately 6×108 in both treatments. Evolution 
occurred during approximately 450 generations in both environments.  
Dynamics of infection at 3 h post infection 
Bacterial uptake was measured by the gentamicin protection assay 
as previously described (Glasser et al. 2001), with modifications, as 
follows. MΦs were infected at MOI 1:1 as described above to determine 
the number of intracellular and extracellular bacteria after 3 h of incubation. 
The number of extracellular bacteria at 3h of incubation was estimated by 
taking a sample of the culture medium (without detaching the MΦs), 
centrifuging (4000 rpm for 10 min) to pellet the cells and finally washing 
these in PBS prior to plating on LB agar plates. The number of intracellular 
bacteria was estimated by washing infected MΦs twice with PBS and 
adding fresh medium containing 100 µg of gentamicin/ml to kill 
extracellular bacteria. After incubation for an additional hour, the medium 
was removed, the monolayer of macrophages was washed 3 times with 
PBS, detached using a cell scraper and centrifuged (4000 rpm for 10 min) 
to pellet the cells. These were further resuspended in PBS and the 
appropriate dilution was plated on LB agar plates to determine the number 
of intracellular bacteria. Relative abundance (Rr) of evolved clones to that 
of the ancestral in intracellular or extracellular environment of MΦs was 
estimated as: 
Rr = (N3he/Nie)/(N3ha/Nia),  
where N3he and N3ha are the numbers of evolved (e) and ancestral (a) 
bacteria at 3 hours post infection (in the intracellular or extracellular niche 
of MΦs) and  Nia and Nie are the initial numbers of evolved (e) and 
ancestral (a) bacteria used for inoculation.  
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Colanic acid purification and quantification 
The method used to extract colanic acid was based on a procedure 
described previously (Obadia et al. 2007). Briefly, 50 ml of a bacterial cell 
culture was heated for 15 min at 100°C to denature EPS-degrading 
enzymes, cooled down and centrifuged at 13,200 rpm at 4°C for 30 min. 
Then 40 ml of the supernatant was precipitated by addition of three 
volumes of ethanol. The mixture was maintained at 4°C overnight and 
centrifuged again at 13,200 rpm at 4°C for 30 min. The resulting pellet was 
dissolved in 5 ml of distilled water, dialyzed for 48 h against distilled water 
(membrane MWCO, 3500 Da) and dried in SpeedVac. Residual 
polypeptides were removed by precipitation with 5 ml of 10% (v/v) 
trichloroacetic acid and centrifuged at 13,200 rpm at 4°C for 30 min. The 
supernatant was dialyzed for five days against distilled water and dried. 
The resulting preparation was resuspended in 1 ml of distilled water. 
Quantification of colanic acid was carried out by measuring non-dialyzable 
methylpentose (6-deoxy-hexose), namely fucose, which is a specific 
component of this exopolysaccharide. 10 to 100 μl of the colanic acid 
preparation were diluted to 1 ml with distilled water, and mixed with 4.5 ml 
of H2SO4/H2O (6:1; v/v). The mixture was prepared at room temperature, 
then heated at 100°C for 20 min, and finally cooled down to room 
temperature. For each sample, absorbance at 396 nm and 427 nm was 
measured either directly (control sample (A-co)) or after addition of 100 μl of 
0.3% freshly prepared cysteine hydrochloride (cysteine sample (A-cy)). The 
absorption due to the unspecific reaction with H2SO4 was subtracted from 
the total absorption of the sample: A396-co and A427-co were subtracted from 
A396-cy and A427-cy, respectively, to obtain ΔA396 and ΔA427. Values of (ΔA396–
ΔA427) were directly correlated to methylpentose concentration by using a 
standard curve obtained with a fucose concentration ranging from 2 μg/ml 
to 100 μg/ml. 
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SCV reversion rate and auxotrophy to hemin 
To determine the reversion frequency of SCV to the ancestral 
phenotype, single colonies grown on LB agar plates were resuspended in 
PBS the appropriate dilution was plated on LB agar plates and incubated 
at 37oC. After 48 h small and large colonies were counted (Roggenkamp et 
al. 1998). To test for the auxotrophy to hemin, individual SCV colonies 
were isolated, resuspended in PBS and plated on M9 minimal medium 
agar plates containing 2% glucose with and without hemin 50 µg/ml 
(Sigma-Aldrich).  After incubation at 37oC for 48 h, CFUs were counted to 
estimate the ratio between the number of cells able to grow in presence 
and in absence of hemin. 
MIC determination 
Minimal inhibitory concentrations  for aminoglycosides (gentamicin- 
10 µg/ml, kanamycin – 30 µg/ml, amikacine –30 µg/ml, tobramycin – 10 
µg/ml, netilmycin – 10 µg/ml) and other type of antibiotics (nalidixic acid – 
30 µg/ml, tetracycline - 30 µg/ml) were determined for the small and large 
colonies using antibiotic disc tests (LIOFILCHEM s.r.l., Italy) following 
manufacturer`s instructions.  
Whole Genome re-sequencing and mutation prediction 
Both the ancestral and 7 isolated MUC clones (M3s_d19 sampled 
from population M3 after 19 days of evolution with macrophages and M1s 
to M6s_d30 sampled from M1 to M6 pops after 30 days of evolution) were 
grown overnight in 10 ml of RPMI-Strep at 37ºC. DNA isolation from these 
cultures was done following a previously described protocol (Wilson 2001). 
The DNA library construction as well as the sequencing procedure was 
carried out by BGI. Each sample was pair-end sequenced on an Illumina 
57 
 
HiSeq 2000. Standard procedures produced data sets of Illumina paired-
end 90bp read pairs with insert size (including read length) of ~470bp. 
Mutations in the two genomes were identified using the BRESEQ 
pipeline (Barrick et al. 2009). To detect potential duplication events we 
used SSAHA2 (Ning et al. 2001) and the paired-end information to map 
reads only to their best-match on the genome. Sequence coverage along 
the genome was assessed with a 250 bp window and corrected for GC% 
composition by normalizing by the mean coverage of regions with the 
same GC%. We then looked for regions with high differences (>1.4) in 
coverage. We did not find any such difference between the ancestral and 
evolved clones. See Table 2.2 for the identity and precise location of 
mutations identified in the sequenced clones. All mutations were confirmed 
by direct target sequencing. 
Mutation frequency estimation  
The clone M3_D19 was tested for increased mutagenesis, due to 
increased transposition, in comparison with the ancestral strain. For that, 
fluctuation assays were performed and the number of bacteria resistant to 
D-cycloserine (resistance can occur due to mutations or transpositions into 
the cycA gene) and to rifampicin (to which resistant mutants typically carry 
point mutation in rpoB, without involving transposition) were assayed. D-
cycloserine resistance assays were performed as previously described 
(Feher et al. 2006), with slight modifications. Briefly 50 tubes with 1 ml 
RPMI medium were inoculated with 5x104 each which grew for 24 hours. 
100 µl of different dilutions from each tube were then spread on M9 
minimal medium (MM) agar plates supplemented with 0.2 % glucose and 
D-cycloserine at the final concentration of 0.04 mM. The frequency of 
mutagenesis was estimated as the number of mutants observed on D-
cycloserine plates, over the total number of cells (measured by Flow 
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cytometry). Clones were tested for increase in spontaneous single point 
mutation rate by plating 100 μl of an overnight culture of both ancestral and 
MUC_M3_D19 in LB supplemented with rifampicin at the end-
concentration of 100 μg/mL. 
EPS quantification 
To quantify the total amount of exopolysaccharides (EPS), bacterial 
cultures were grown for 24 hours in 1 ml RPMI media, heat-inactivated at 
100 oC for 15 min, centrifuged at 14000 rpm for 15 min and the 
supernatant collected for colorimetric assay to measure the binding of 
Congo red (adapted from Black and Yang (Black and Yang 2004)). A total 
of 450 µl supernatant was mixed with 50 µl of a dye (stock solution 150 
µg/ml in deionized distilled water). All samples were vortexed briefly and 
incubated in the dark at room temperature for 30 min. The absorbances of 
the supernatants were measured at 490 nm in triplicate. Relative amount of 
EPS was estimated per bacterial cell by calculating CFUs by Flow 
Cytometry. 
Detection of mutations 
In order to determine the frequency of the mutations in clones 
sampled along the experiment, DNA was amplified by PCR (to identify IS 
insertions) and sequencing PCR was performed (to identify SNPs). DNA 
was amplified by PCR in a total volume of 50 µl containing 1 µl bacterial 
culture, 10 µM of each primer, 200 µM dNTPs, 0.5 U Taq polymerase and 
1× Taq polymerase buffer. The amplification profile was 15 min at 95°C, 
followed by 35 cycles at 94°C for 30 s, 60°C for 90 s, 72°C for 2 min with a 
final extension at 72°C for 10 min. All gene fragments were amplified using 
these conditions and oligonucleotide primers (Appendix A, Table A2). The 
same primers were used for sequencing straight from the PCR product. 
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LD50 – test for increase of pathogenesis  
We maintained male C57/BL6 mice, aged 8-10 weeks (in house 
supplier, Instituto Gulbenkian de Ciência), on ad libitum food (RM3A(P); 
Special Diet Services, UK) and water, with a 12 hour light cycle, at 21 ºC. 
We initiated infections by intra-peritoneal inoculation of bacteria in 100 l 
saline. Four groups of 5 mice per bacterial strain were injected with doses 
ranging from 7x105 to 7x107. The inoculum for ancestral bacteria consisted 
of a single clone and the inoculum for the mucoids consisted of a mixture 
of equal numbers of the 6 sequenced clones from day 30 (M1s-M6s; see 
Figure 2.3). Furthermore, as a control, we injected a group of 3 mice with 
only 100 l of saline (these did not display any signs of disease). We 
monitored mice for a period of 10 days (twice a day for the first two days 
and daily for the remainder 8 days). Upon death (or at the end of the 
experiment for survivors), we obtained blood from each animal by hearth-
puncture, performed peritoneal lavages and plated bacteria from both 
samples in LB media with streptomycin (100µg/ml). We analyzed the 
survival data by fitting a binomial generalized linear model for each 
morphotype, using survival as a response variable and log10 bacterial dose 
as explanatory variable and estimated LD50 following KERR AND 
MEADOR 1996 (Kerr and Meador 1996).  
Growth parameters of Ancestral-looking bacteria  
We tested for changes in growth of 36 clones exhibiting an 
ancestral morphotype (4 replicates/clone) compared with the original 
ancestral clone (20 replicates). Growth rate measurements were obtained 
by following OD600nm using a Bioscreen C system (Oy Growth Curves Ab). 
60 
 
Cultures were done by seeding 150 l RPMI MOI media with 104 bacteria, 
covered with oil, and low speed agitation (5s every 30min). 
Mathematical model of clonal interference  
We assume a simple model for the interaction between bacteria 
and macrophages: 

dB
dt
Br
B
K
amM0e
t





, where B represents the 
number of bacteria along time, r their growth rate, K their carrying capacity 
and δ the death rate of macrophages. For the experimental conditions 
used M0=10
6 and B(0)=106. During a 24 hour period the infection dynamics 
expected under this model are similar to those obtained experimentally, 
with r=2.3 (per hour), K=108 and δ=0.1 (per hour) (Appendix A, Figure A2). 
As in the experiments, every 24 hours bacterial population numbers are 
reduced to B(0) and macrophage numbers increased to M0. Having these 
initial conditions, we then assume that new mutants arise and are not 
stochastically lost at a given rate. More specifically, the ancestral clone can 
mutate to two new types of adapted clones: one by transposition (upstream 
of yrfF) and another by point mutation. These mutations can cause 
changes in both r and am, i.e., the growth rate of mutant bacteria (rm) can 
change and their ability to interact with macrophages (amm) can also 
change. Given the experimental evidence in Figure 2.2 and in Appendix A, 
Figure A5, we assume that mucoid bacteria will exhibit an increased ability 
to escape macrophages amm < am but also a decreased growth rate rm < r, 
due to the cost of producing exopolysaccarides. The following equations 
determine the evolution of a population where 3 new haplotypes can 
successfully emerge:   
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where U and Uis are the rates of occurrence of successful beneficial 
SNPs and transpositions, respectively. Note that U is the spontaneous rate 
of mutation times the probability that such mutation is not lost by drift. B 
represents the number of ancestral genotype, M of the first mucoid 
genotype that emerges, B’ of a derived genotype exhibiting a non-mucoid 
phenotype and M’ of a derived mucoid genotype. The solutions of these 
equations for a given set of parameters were obtained using Mathematica 
8.0 and are given in Figure 2.5. 
Statistical analysis 
The statistical analysis was performed using the R software: 
http://www.r-project.org/. 
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Results 
Emergence of morphological diversity during the evolution 
experiment 
We followed the evolution of six E. coli populations (all founded 
from the same ancestral clone), when adapting to the antagonistic 
interaction with MΦs. The bacterial populations (M1 to M6) evolved in 
RPMI medium with MΦs and were propagated at a multiplicity of infection 
(MOI) of 1:1 (106 E. coli to 106 MΦs). In parallel we also evolved E. coli in 
the absence of MΦs. All populations were evolved for a period of 30 days, 
which corresponds to approximately 450 generations, given the increase in 
CFUs observed during a 24 hour infection.  
Adaptation of the bacterial lines to the presence of MΦs was 
characterized by the emergence of phenotypic variation within populations. 
After 4 days of evolution, corresponding to approximately 60 generations 
only, diversity started to be observed in the populations. This diversity was 
detected in all populations, by the appearance of distinct colony 
morphologies, when plating on LB plates (Figure 2.1A). Such 
morphological diversity was never observed in control populations that 
were evolved in the absence of MΦs for 30 days (n=6). Two distinct 
heritable morphs could be clearly identified and scored: small colony 
variants (SCV) and large translucid mucoid colonies (MUC).  
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Figure 2.1. Emergency of morphological diversity in the bacterial 
populations adapting to MΦs. (A) Examples of the variability for colony 
morphology that emerged in E. coli populations adapting to MΦs, from the left to 
the right – ANC stands for morphology of ancestral, SCV for the small colony 
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variants morphology and MUC for mucoid colony morphologies. (B) Dynamics of 
frequency change of the evolved morphs in each replicate evolution experiment 
M1 to M6 populations: white squares indicate ANC, black triangles SCV, black 
circles MUC morphs. 
 
We followed the frequency of these morphs over time (Figure 2.1B). While 
SCVs could be observed in five out of six populations, this morph remained 
at low frequency and was detected transiently. The observed parallelism 
for the emergence of SCVs, indicates that this phenotype constitutes a 
possible initial adaptive strategy in the interaction of E. coli with MΦs. On 
the other hand, the MUC rose in frequency in all populations, reaching 
fixation in 5/6 populations by day 30. These results show that 
morphological diversity in E. coli can emerge very rapidly as a result of 
their adaptation to MΦs. 
Dynamics of phenotypes and phenotypic characterization of SCV and 
MUC morphs 
The changes in frequency of each of the emerging morphs (SCVs 
and MUCs) showed a complex dynamics (Figure 2.1B). In the populations 
where both morphs were detected, whenever one morph (which gives rise 
to SCVs) decreased in frequency the other morph (MUC) tended to 
increase (see population M2 and M3 where the emergence of SCV is 
followed by the emergence of MUC). This suggests that MUC morphs are 
able to outcompete SCV morphs, thus having a larger fitness advantage.  
SCVs emerged in at least 80% of the independent evolving 
populations, though their frequency was always low. This strongly suggests 
that these morphs have a selective advantage but can be outcompeted. To 
better understand the selective advantages of the SCVs we performed two 
assays: 1) an infection with SCVs to test for possible change in their 
abundance inside and outside MΦs, relative to that observed in the 
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ancestral strain; 2) a competitive fitness assay to test for SCV ability to 
outcompete the ancestral strain, in the presence of MΦs. While we did not 
observed any difference in SCV relative abundance, either intracellularly 
(Rr= 0.99+0.16 (2SE)) or extracellularly (Rr= 1.01+0.13 (2SE)), an 
advantage was found in the competitive fitness assay (Figure 2.2A). 
Interestingly, SCV clones SCV_M1_D8 and SCV_M3_D5, exhibited an 
advantage relative to the ancestral inside MΦs in the early phase of 
infection. However, after 2 hours of infection, the SCV tested showed a 
disadvantage in relation to the ancestral outside MΦs (Figure 2.2A). This 
may explain why these SCV clones increased in frequency in the 
populations but never reached fixation (see Figure 2.1B).  
We tested SCVs for resistance to different antibiotics, catalase 
activity and their ability to use hemin. These are common properties of 
SCV clones sampled in natural populations (Proctor et al. 2006b). Indeed, 
the evolved E. coli SCV clones showed an increased resistance to 
aminoglycosides, but not to other antibiotics (see Table 2.1), and were 
catalase negative, just as found for clinical isolates of SCVs in several 
bacterial species (Proctor et al. 2006a). Furthermore, SCVs showed a 
remarkable plasticity because in rich medium they reverted to a phenotype 
of large colony forming bacteria at a frequency of 9x10-4 (2SE=4x10-4), a 
property similar to that of clinical isolated SCVs (Roggenkamp et al. 1998). 
Supplementation with hemin enhanced growth of the SCVs tested when 
compared to the ANC clones (SCV_M1_D8: 2.9 ± 1 (2SE) and 
SCV_M3_D5: 2.5 ± 0.7(2SE)). In a clinical setting it is hard to define the 
selective pressures that lead to the acquisition of such pathogenic traits. 
But in our experimental system the selection pressure is readily identified 
since only in the presence of MΦs were these traits observed. 
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Table 2.1. Increased resistance of SCVs to aminoglycoside antibiotics. 
 
Minimal inhibitory concentration (MIC) of each clone was measured in triplicate by 
a disc diffusion assay. S indicates sensitive clones and R resistant clones. 
SCV_M1_D8, SCV_M2_D4, SCV_M3_D5 and MUC_M2_D19, MUC_M3_D19, 
MUC_M4_D19 clones are shown. 
 
To better understand the selective advantages of the MUCs, we 
tested if they exhibited an increased ability to escape MΦ engulfment. 
Figure 2.2B shows the abundance of MUC inside and outside MΦs, 
relative to that observed for the ancestral clones, after 3 hours of infection. 
The figure clearly shows that the abundance of all MUC clones inside MΦs 
is much smaller than that of the ancestral strain from which the MUCs 
evolved. Moreover, the abundance of 4/6 MUC clones is higher outside 
MΦs. To further complement this finding we performed 1:1 population 
mixture of evolved MUC (MUC_M3_D19 that is marked with CFP) and 
ancestral bacteria (marked with YFP) and checked for intracellular bacteria 
after infection using confocal microscopy. As shown in Figure 2.2C, only 
ANC clones and not MUC clones, are detected inside MΦs. Taken 
together, these results strongly suggest that MUC clones are better 
 Mean zone diameter (mm) 
Antibiotic (µg) ANC SCV1 SCV2 SCV3 MUC2 MUC3 MUC4 
Kanamycin (30) 24S 11R 12R 10R 23S 20S 21S 
Gentamicin (10) 20S 10R 10R 10R 16S 16S 18S 
Amikacine (30) 24S 12R 11R 11R 20S 17S 18S 
Tobramycin (10) 18S 11R 10R 10R 17S 17S 17S 
Netilmycin (10) 24S 16S 15S 15S 19S 17S 21S 
Tetracycline (30) 29S 33S 31S 32S 30S 33S 32S 
Nalidixic acid (30) 27S 34S 32S 33S 34S 34S 36S 
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adapted to escape MΦs. MUCs also have a visible overproduction of 
exopolysaccharides when plated on LB plates. Since colanic acid is 
present in most natural E. coli isolates (Majdalani and Gottesman 2005), 
and this capsule is made in mutants of E. coli that emerge under stress 
conditions (Gottesman and Stout 1991), we tested mucoid clones for 
overproduction of this exopolysaccharide. We determined that mucoid 
clones show overproduction of colanic acid (see Appendix A, Figure A1). 
Our results clearly show that rapid evolution to change this trait can occur 
under the specific selection pressure imposed by MΦs. Contrary to what 
was found for SCVs, mucoid clones did not show increased resistant to 
antibiotics (Table 2.1). 
Genetic basis of the adaptation to macrophages  
Given the phenotypes of the MUC clones and their dynamics, we 
sought to determine the beneficial mutations responsible for their success 
along the evolutionary process. Whole genome sequencing (WGS) of 7 
clones was performed, six clones isolated from each population at the last 
time point (day 30) of the experiment (M1s, M2s, M3s, M4s, M5s, and M6s) 
and a clone sampled from M3 population at day 19 (MUC_M3_D19). WGS 
of this clone revealed that it carries two transposon insertions: an insertion 
of IS186 into the promoter region of lon and an IS1 insertion upstream of 
yrfF (see Table 2.2). Strikingly, this last transposition event occurred in all 
other sequenced clones (Table 2.2, Figure 2.3A), which shows parallelism 
at the genetic level across all independently evolved lines.   
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Figure 2.2. Phenotypic characterization of SCV and MUC clones. (A) 
Competitive fitness of SCV clones in presence of MΦs. The change in frequency 
(∆X) of the evolved bacteria against the ancestral in the intracellular (black bars) 
and extracellular (white bars) niche of the MΦs at MOI (1:1). Clones are ranked in 
the following order: SCV_M1_D8 and SCV_M3_D5. Because SCV clones revert to 
ancestral looking colonies, frequencies of those phenotypic revertant SCV_REV 
colonies are shown in grey. 
phagocytosis. Rr represents the relative abundance (Rr) of evolved clones to that 
of the ancestral. Clones M1s to M6s were sampled from each independent 
evolution. In black bars the relative abundance inside MΦs and in white bars 
outside MΦs. All evolved clones show a smaller abundance inside MΦs, 
suggesting that these are better adapted to escape MΦs phagocytosis. (C) 
Confocal microscopy images taken at 2 hours after infection of MΦs at MOI 10:1 
(10 E. coli to 1MΦ) with a 1 to 1 mixture of E. coli expressing CFP (shown in blue) 
or YFP (shown in green). From left to right: ANC clones (CFP and YFP); SCV 
(CFP) and ancestral (YFP); MUC (CFP) and ancestral (YFP). MΦs are labeled 
with LysoTrackerRed (LTR). 
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The function of yrfF is unknown in E. coli but its homologue in 
Salmonella, igaA, is known to prevent over-activation of the Rcs regulatory 
system, which regulates colanic acid capsule synthesis (Dominguez-Bernal 
et al. 2004). It is therefore likely that the insertion upstream of yrfF alters E. 
coli ability to produce colanic acid (Appendix A, Figure A1).  
Other important parallelisms were detected involving two 
transposition events: one in the coding region of yiaW and the other in the 
coding region of the pot operon. potD is one of the four genes of the 
potABCD operon, a spermidine-preferential uptake system (Igarashi and 
Kashiwagi 2010). All four genes are essential for spermidine uptake, so the 
insertions in potD detected in clones MUC_M4_D30 and MUC_M6_D30, or 
the insertion in potA observed in clone MUC_M3_D30, are likely to result in 
inability to uptake spermidine. Interestingly, during adaptation to MΦs, 
insertion in yiaW (whose function is unknown) was rapidly followed by 
insertion in potA or potD genes (see Figure 2.3B, M3, M4 and M6 
populations), indicating a potential interaction between these genes. The 
parallelism observed suggests that insertions in yiaW are an important 
adaptation of E. coli to MΦs.  
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Table 2.2. Mutations acquired by evolved clones identified through whole 
genome re-sequencing (WGS). 
Clone 
Genome 
Position 
Gene Mutation Annotation 
MUC_M3_D19 360771 clpX/lon intergenic (+88/-100) IS186 +12 bp 
 3411601 nudE/yrfF intergenic (-273/-47) IS1 +10 
M1s 2029672 yegH G→T A422S   GCC→TCC  
  3356932 fusA A→C S588A   TCC→GCC  
  3411601 nudE/yrfF intergenic (-273/-47) IS1 +10 
M2s 3356932 fusA A→C S588A   TCC→GCC  
  3411605 nudE/yrfF intergenic (-277/-43) IS1 +6 
M3s 459734 folD/sfmA G→T intergenic (-10/-461) 
  1088154 potA coding (589/1137 nt) IS1 +10 
  3411601 nudE/yrfF intergenic (-273/-47) IS1 +10 
  3640515 yiaW coding (263/324 nt) IS1 +9 
  3922002 trkH T→A L389Q   CTG→CAG  
M4s 1084946 potD 
coding (1032/1047 
nt) 
IS1 +9 
  3411601 nudE/yrfF intergenic (-273/-47) IS1 +10 
  3640515 yiaW coding (263/324 nt) IS1 +9 
M5s 1480525 ydeS/hipA 
intergenic 
(-1603/+205) 
Δ208 bp 
  2024227 wzc G→T P645T   CCG→ACG  
  3411601 nudE/yrfF intergenic (-273/-47) IS1 +10 
M6s 1084946 potD 
coding (1032/1047 
nt) 
IS1 +9 
  3411601 nudE/yrfF intergenic (-273/-47) IS1 +10 
  3640515 yiaW coding (263/324 nt) IS1 +9 
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Mutations in intergenic regions have the two flanking genes listed (e.g., clpX/lon). 
SNPs are represented by an arrow between the ancestral and the evolved 
nucleotide. Whenever a SNP gives rise to a non-synonymous mutation the amino 
acid replacement is also indicated. The symbol Δ means a deletion. For intergenic 
mutations, the numbers in the Mutation row represent nucleotides relative to each 
of the neighboring genes, here + indicates the distance downstream of the stop 
codon of a gene and - indicates the distance upstream of the gene, that is relative 
to the start codon. Insertions of IS elements are denoted by the specific IS element 
followed by the number of repeated bases caused by its insertion. 
 
 
Besides IS insertions, parallelism at the level of point mutations was 
also observed. Two clones had the same SNP in fusA, a gene coding for 
elongation factor G (EFG). EFG catalyzes the elongation and recycling 
phases of translation (Savelsbergh et al. 2009). It is known that mutations 
in fusA reduce the rate of protein synthesis and thus may have pleiotropic 
effects on bacterial physiology (Andersson and Hughes 2010).  
Dynamics of haplotypes along the adaptive walk and evidence for 
clonal interference 
To understand the dynamics of adaptation in each independent 
evolved line, we sought to determine the frequency of the mutations found 
(see Appendix A, Table A1), in clones sampled at different time points. 
Figure 2.3B shows the frequencies of the haplotypes detected along the 
evolution experiment. Figure 2.3 clearly shows that adaptation involved the 
competition between distinct haplotypes and the successive accumulation 
of beneficial mutations, mainly caused by IS insertions. Such haplotype 
dynamics is characteristic of clonal interference (Sniegowski and Gerrish 
2010), where clones carrying distinct beneficial mutations compete for 
fixation.  
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Figure 2.3. Genetic characterization of adaptive mutations and the dynamics 
of their appearance.  (A) Mutations identified in M1s to M6s clones isolated from 
M1 to M6 populations (evolved for 450 generations), represented along E. coli 
chromosome. For simplicity, the genomes are represented linearly and horizontally 
drawn. The types of mutations are represented in the following way: SNPs are 
shown as crosses, IS insertions as inverted triangles and deletions as triangles. 
Filled symbols represent mutation in the coding region of the gene and empty 
symbols in the regulatory region. (B) Emergence and spread of adaptive mutations 
in M1 to M6 populations. Dynamics of haplotype frequencies in evolving 
populations at different days of evolution experiment are represented by circles. 
The color and symbol (IS insertions are represented as circles and other mutations 
as crosses) of each sector represents different haplotypes and the area of the 
circle their frequency in the population. Grey area represents the frequency of 
clones in the population that were typed for existing mutations in the population 
and did not differ from ancestral haplotype. 
 
 
Indeed we can model this process, within the basic ecological scenario of 
our experiment, and ask if clonal interference alone is sufficient to 
reproduce the dynamics observed in Figure 2.1. In this model of clonal 
interference we make the simplifying assumption that two traits, r and am, 
the growth rate of bacteria in RPMI and their ability to escape MΦs, 
respectively, are the most important for bacterial fitness in this 
environment. Both these traits can evolve, as it is evident from the 
emergence of new morphologies (in particular mucoid morphs) and 
phenotypic tests of the evolved clones (see Methods, Figure 2.2, Figure 
2.4 and 2.5).  
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Figure 2.4. Variation in exopolysaccharide production among evolved 
clones. Amount of EPS per bacterial cell was measured for the ancestral strain 
(ANC) and six mucoid clones that evolved independently (M1s to M6s): we also 
measured the amount of EPS in MUC_M3_D19 (MUC) and in six other clones 
derived from this clone after a growth in RPMI (T136-T138, T122-T124). None of 
these derived clones have the IS186 insertion in lon promoter region and all have 
the IS1 insertion upstream of yrfF. T136-T138 are visibly mucoid and T122-T124 
show a non-mucoid colony morphology. All measurements were done in triplicate.  
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Figure 2.5. Relative abundance of evolved clones in the presence of the 
MΦs. Relative abundance (Rr) of MUC_M3_D19 (MUC) clone and six clones 
derived from this clone (T122-T124 non mucoid and T136-T138 mucoid clones) 
are represented either inside MΦs (black bars) or outside MΦs (white bars).  
 
Figure 2.6 shows the outcome of simulated evolution experiments of the 
frequency of mucoid morphs under different parameter values. These 
parameters were chosen because they are able to reproduce the initial 
infection dynamics of the ancestral strain (Appendix A, Figure A2) and its 
relation with the derived evolved clones (see Methods). We are able to find 
conditions that can reproduce the observed dynamics of morphs under a 
scenario of intense clonal interference and accumulation of multiple 
beneficial mutations (see Appendix A, Figure A3). The model is able to 
reproduce the observed changes in frequency of the mucoid and non-
mucoid phenotypes, if we assume that distinct beneficial mutations may 
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occur which will change each of the two fitness traits in both morphs. 
Specifically, we assume that a successful beneficial mutation occurs, which 
produces the first mucoid morph (the mutation upstream of yrfF). Such 
mutation increases the ability of bacteria to escape MΦs but also carries a 
cost in that it diminishes the growth rate (see Appendix A, Figure A4). This 
mucoid morph can acquire further beneficial mutations, which can alter 
those traits values, such that a new derived mucoid haplotype can have a 
reduced cost of producing colanic acid and/or an increased ability to 
escape MΦs. Importantly, we also assume that non-mucoid clones can 
acquire beneficial mutations which increase their growth rate. Experimental 
support for this assumption is provided in the supplement (Appendix A, 
Figure A5) Under these assumptions, and with the direct evidence that 
several distinct clones are segregating in the populations, complex 
dynamics are to be expected (Figure 2.3 and Appendix A, Figure A3).  
It is important to note that we cannot exclude the possible 
occurrence of other forms of selection during the evolution experiment. 
Indeed it is known that even in simple abiotic environments adaptive 
diversification, involving frequency dependent selection can repeatedly 
evolve. It is generally difficult to distinguish this form of selection from 
simple clonal interference (Herron and Doebeli 2013). However if strong 
negative frequency dependent selection would have occurred in our lines, 
it would have led to maintenance of distinct lineages along the evolutionary 
process. Such expectation seems inconsistent with the fixation of the IS 
insertion upstream of yrfF and the fixation of the mucoid phenotype in 
majority of the lines that we have observed.  
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Figure 2.6. Model of clonal interference during the evolution process. 
Simulations of the adaptive dynamics over the period of the experiment (30 days). 
The frequencies of mucoid phenotypes are plotted and can be compared to those 
observed in the experiments (Figure 2.1). The dynamics were obtained by the 
model of clonal interference described in the methods. The values of parameters 
used and the dynamics of haplotypes that compete for fixation are shown in 
Appendix A, Figure A5. 
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Emergence of a transient mutator with increased transposition rate 
An important parallelism was revealed when genotyping clones for 
determining polymorphism levels. This involved an IS186 insertion into the 
promoter region of lon. Lon (Long Form Filament) is a heat shock protease 
responsible for degradation of defective proteins in the cell. The promoter 
region of lon has been described as having a single site that is a natural 
hotspot for IS186 insertions (saiSree et al. 2001). The selection of 
independently evolved clones carrying an IS element at this site argues for 
it causing a beneficial effect and the locus being a insertion hotspot 
suggests that it could rapidly emerge. As lon mutants tend to overproduce 
colanic acid (Torres-Cabassa and Gottesman 1987), a trait that appears to 
be strongly selected for in our experiment, it is possible that this was the 
main beneficial effect caused by that insertion. However the IS186 
insertion could only be detected in two populations (M3 and M4) at 
intermediate time points in the experiment. It was no longer detected at day 
30 (see Figure 2.3B). Interestingly, lon has been reported to be a mutator 
gene in mutants that bear an IS186 insertion in its promoter, thus 
increasing the rate of IS transpositions 10- to 100-fold (Nicoloff et al. 2007). 
This happens because the stability of several transposases is dependent 
on the Lon protease (Derbyshire et al. 1990, Rouquette et al. 2004), which 
seems to regulate their transposition activity.  
In MUC_M3_D19 an IS186 inserted in -10 promoter region and 
since mutations in this position were shown to significantly decrease level 
of lon transcription (Chin et al. 1988), it is likely that this clone is a mutator 
where a burst of transposition events could have occurred during the 
adaptation. To test for increased mutagenesis in this clone, a fluctuation 
test was performed to determine number of D-cycloserine resistant 
mutants, a phenotype caused by a knock out of cycA, which can be caused 
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by IS insertions (Trindade et al. 2012). Interestingly we found a significant 
increase in the frequency of cycA mutant clones in the MUC_M3_D19 
clone relative to the ANC clone (median frequency 2.6x10-6 vs. 1x10-7, for 
the ancestral background, P=5.5x10-13, W=203.5, Mann-Whitney U test, 
Figure 2.7).  
 
 
 
Figure 2.7. Fluctuation test of evolved MUC clone (MUC_M3_D19) and ANC 
clone to test for increase in mutagenesis. Black squares (for MUC clone) and 
white squares (for ANC clone) each represent 50 independent measurements of 
the frequency of spontaneous mutants resistant to d-cycloserine. Mutation rates 
were significantly different between MUC and ANC clones (median MUC=2.6x10-6 
and ANC=1x10-7, P=5.5x10-13, W=203.5, Mann-Whitney U test).  
80 
 
Consistent with this increased mutagenesis being driven mainly by 
IS insertions we did not observe significant differences in the frequency of 
rifampicin resistant clones, which are caused by point mutations (median 
frequency 3.3x10-7 vs 6.9x10-7 for the ancestral background, P=0.1, W=21, 
Mann-Whitney U test). The presence of IS186 in the lon promoter region 
was also found to be highly unstable since a spontaneously derived non-
mucoid clone from MUC_M3_D19 (MUC_M3_D19_REV) shows a precise 
excision of this element while maintaining the IS1 insertion in regulatory 
region of yrfF (see Table 2.2). These results indicate that this IS186 
insertion visibly enhances mucoidy levels, increases mutagenesis and is 
also very unstable in this genetic background (see also Figure 2.4). The 
later may explain why it did not fix in the population. Recently, it has been 
shown that, in Salmonella, the transcription of igaA is regulated by lon 
(Garcia-Calderon et al. 2009). The dynamics of the IS186 insertion in 
populations M3 and M4 suggest that this mutation was beneficial in the 
background with an IS1 insertion upstream of igaA is present.  
Clones evolved to escape MΦs have increased pathogenicity  
Translocation of commensal E. coli from the gut can be associated 
with severe health complications (e.g. sepsis), particularly in 
immunosuppressed hosts or after surgery (MacFie et al. 1999, Russo and 
Johnson 2003). Bacteria which reach the mesenteric lymph nodes or the 
peritoneal cavity (extensively populated by MΦs) and that are able to 
escape destruction by MΦs should have a fitness advantage and 
potentially cause more severe disease. As the evolved MUC clones can 
better escape MΦs, we tested whether this adaptation leads to increased 
pathogenesis. To do so, we infected mice via the intra-peritoneal route 
(simulating peritonitis and sepsis) with different doses of ANC and MUC 
bacteria and measured survival. As can be seen in Table 2.3, the lethal 
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dose 50 (LD50) is, on average, one log lower for the MUC than for the ANC 
bacteria. Moreover, we plated samples of blood and peritoneal contents for 
all animals and observed that animals surviving to the end of the 
experiment had no bacteria in their blood and 41% had low doses of 
bacteria in the peritoneal cavity (<250 CFUs/ml). On the contrary, animals 
failing to survive infection had high bacterial densities, both in the blood 
(range: 7x105 – 9x108/ml) and in the peritoneal cavity (3.4x105 – 2x108/ml; 
Appendix A, Figure A6). Thus, our results show that the mucoidy due to 
overproduction of colanic acid, evolved during the interaction with MΦs, 
leads to increased pathogenicity. 
 
Table 2.3. LD50 estimates for the ANC and the MUC (evolved) clones. 
Estimates were obtained following KERR (see methods).  
        Morphotype       log10 LD50 (± std. error)  
Ancestral 7.51 (7.20 – 7.83) 
Mucoid 6.69 (6.55 – 6.84) 
 
Discussion 
In principle bacterial evolution towards becoming more pathogenic 
may occur through the acquisition of new genes – a gain of function 
mechanism- or modification of their current genomes, including loss of 
genes - change-of-function mechanism (Sokurenko et al. 1999). The later 
constitutes a pathoadaptation. Pathoadaptive mutations are therefore 
mutations that enhance bacterial virulence without horizontal transfer of 
specific virulence genes. For example the knock out of hemB in 
Staphylococcus aureus, increases its ability to persist intracellularly (von 
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Eiff et al. 1997) and the loss of mucA, increases Pseudomonas aeruginosa 
ability to evade phagocytosis and resist to pulmonary clearance (Yu et al. 
1998).  
We have followed the evolution of a commensal strain of E. coli 
under the selective pressure imposed by MΦ phagocytosis, to determine 
the rate of adaptive evolution and to uncover the nature of possible 
pathoadaptive mutations in E. coli. From the infection dynamics (Figure 2.1 
and 2.2) we conclude that at least two different strategies, detected by 
different colony morphology changes, emerged during adaptation to the 
selective pressure imposed by MΦs: i) an intracellular strategy evolved by 
SCV clones early in the process; ii) an extracellular strategy evolved by 
MUC clones emerging later in the evolution. The intracellular is 
characterized by increased bacterial resistance, plasticity and survival in 
the early phase of interaction with MΦs, and was accompanied by a 
reduced growth in the extracellular medium. The extracellular is 
characterized by overproduction of colanic acid and increased resistance 
to escape MΦ phagocytosis, dominated in all populations.  
The adaptive strategies emerged from commensal bacteria 
adapting to MΦs, occurred as fast as a few hundred generations and were 
characterized by traits reminiscent of those found in pathogenic bacteria. 
Indeed some clinical isolates sampled from patients suffering from 
recurrent and persistent infections, for example in the blood (Funada et al. 
1978) or urinary tract (Roggenkamp et al. 1998, Tappe et al. 2006), are 
SCVs. The distinctive traits of this phenotype are: ability to form small 
colonies, to revert to larger colony forming bacteria at high frequencies and 
increased resistance to certain antibiotics. Mucoidy is also a property that 
can be frequently observed in certain infections, for example in 
Pseudomonas aeruginosa or E. coli (Govan and Deretic 1996, Bottone 
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2010). Our results suggest that these traits can rapidly emerge due to the 
selective pressure imposed by MΦs solely, which has implications for the 
treatment of bacterial infections. Indeed we found that the increase ability 
to escape MΦs of in vitro evolved clones lead to increased pathogenesis in 
vivo, when these were tested in a mouse model. We also found that this 
rapid pathoadaptative process was characterized by three main adaptive 
paths. Although distinct in the number and type of mutations, these paths 
share an initial mutation: a IS insertion in the same exact position upstream 
of yrfF, a gene which shares 84% sequence similarity at the protein level to 
IgaA of Salmonella enterica serovar Typhimurium. In S. Typhimurium it 
was shown that the stability and responsiveness of the RcsCDB system 
depends on IgaA (Mariscotti and Garcia-Del Portillo 2008). The RcsCDB 
system controls the production of colanic acid, virulence in diverse 
pathogens (Page et al. 2001, Ferrieres and Clarke 2003, Majdalani and 
Gottesman 2005, Vianney et al. 2005, Huang et al. 2006, Majdalani and 
Gottesman 2007), modulates responses to environmental changes and is 
activated upon exposure to antimicrobial peptides (Conter et al. 2002, 
Sailer et al. 2003, Kaldalu et al. 2004, Erickson and Detweiler 2006). IgaA 
represses the RcsCDB system (Cano et al. 2002) and mutations causing 
instability of IgaA activate the RcsCDB system, leading to overproduction 
of colanic acid capsule (mucoid phenotype) (Cano et al. 2002). Given the 
repressive function of IgaA on the RcsCDB, which controls many traits 
likely to be important for bacterial fitness, it is likely that the observed IS 
insertion upstream of yrfF to be an adaptive mutation with pleiotropic 
effects. If so the adaptive path may proceed through the occurrence of new 
mutations, which may compensate for the pleiotropic effects of that first 
adaptive step. Interestingly the same amino-acid substitution in fusA 
occurred in two independent lines. FusA is an elongation factor and is part 
of the str operon of E. coli, which has 3 other genes: rpsL, rpsG and tufA. 
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Since the strain that we studied carries a mutation in rpsL that confers 
streptomycin resistance, which is costly in RPMI yet increases survival 
inside MΦs (Miskinyte and Gordo 2013), it is possible that the SNP in fusA 
could be compensatory to cost of the rpsL mutation in the milieu outside 
MΦs.  
One of the adaptive paths taken by E. coli involved insertions into 
the coding regions of yiaW and potA or potD. While the function of yiaW is 
unknown the later genes are involved in spermidine transport, which may 
affect E. coli interaction with MΦs. Spermidines are polyamines, 
polycationic molecules, which interact with nucleic acids and have been 
described as important in escape from phagolysosomes, biofilm formation 
and protection from oxidative and acidic stress amongst other traits 
important in bacterial pathogenesis (Shah and Swiatlo 2008). 
 The adaptive process was also marked by the occurrence of 
an important IS186 insertion into the promoter region of the Lon protease. 
Such insertion was not only likely adaptive (it was observed in two 
independent lineages and it increases mucoidy), but also likely leads to 
increased rates of transposition. Given that many of the adaptive mutations 
observed under the stresses imposed by MΦs were caused by ISs, the 
IS186 insertion may constitute an example of Barbara McClintock proposal 
that TE movement under stress could aid organisms to adapt to new 
environments (McClintock 1984).  
Overall our results show that E. coli can adapt to better resist to 
MΦs within a few hundreds of generations and that clones with different 
morphologies and traits similar to those of pathogenic bacteria rapidly 
emerge. 
 
85 
 
Acknowledgements  
The research leading to these results has received funding from the 
European Research Council under the European Community’s Seventh 
Framework Programme (FP7/2007 - 2013)/ERC grant agreement no 
260421 – ECOADAPT. I.G. acknowledges the salary support of LAO/ITQB 
& FCT. M. M received FCT PhD fellowship (SFRH/BD/33220/2007).  
M.M participated in planning the experiments, obtained and 
analyzed results for Figures 2.1, 2.2, 2.3, 2.4, 2.5, 2.7 and Table 2.1, and 
participated in writing the manuscript. A.S analyzed whole-genome 
sequencing results (Table 2.2), mathematical model and simulations were 
mainly performed by J.S and I.G (Figure 2.6). R.R performed and analyzed 
LD50 test (Table 2.3). I.C and S.M participated in planning the experiment. 
 
References 
Amer, A. O. and M. S. Swanson. 2002. A phagosome of one's own: a 
microbial guide to life in the macrophage. Curr Opin Microbiol 5:56-
61. 
Andersson, D. I. and D. Hughes. 2010. Antibiotic resistance and its cost: is 
it possible to reverse resistance? Nat Rev Microbiol 8:260-271. 
Barrick, J. E., D. S. Yu, S. H. Yoon, H. Jeong, T. K. Oh, D. Schneider, R. E. 
Lenski, and J. F. Kim. 2009. Genome evolution and adaptation in a 
long-term experiment with Escherichia coli. Nature 461:1243-1247. 
Black, W. P. and Z. Yang. 2004. Myxococcus xanthus chemotaxis 
homologs DifD and DifG negatively regulate fibril polysaccharide 
production. J Bacteriol 186:1001-1008. 
Bottone, E. J. 2010. Hypermucoviscous Phenotype Expressed by an 
Isolate of Uropathogenic Escherichia coli: an Overlooked and 
Underappreciated Virulence Factor. Clinical Microbiology 
Newsletter 32:81-85. 
Buckling, A. and P. B. Rainey. 2002. The role of parasites in sympatric and 
allopatric host diversification. Nature 420:496-499. 
Cano, D. A., G. Dominguez-Bernal, A. Tierrez, F. Garcia-Del Portillo, and 
J. Casadesus. 2002. Regulation of capsule synthesis and cell 
86 
 
motility in Salmonella enterica by the essential gene igaA. Genetics 
162:1513-1523. 
Chin, D. T., S. A. Goff, T. Webster, T. Smith, and A. L. Goldberg. 1988. 
Sequence of the lon gene in Escherichia coli. A heat-shock gene 
which encodes the ATP-dependent protease La. J Biol Chem 
263:11718-11728. 
Conter, A., R. Sturny, C. Gutierrez, and K. Cam. 2002. The RcsCB His-Asp 
phosphorelay system is essential to overcome chlorpromazine-
induced stress in Escherichia coli. J Bacteriol 184:2850-2853. 
Crossman, L. C., R. R. Chaudhuri, S. A. Beatson, T. J. Wells, M. Desvaux, 
A. F. Cunningham, N. K. Petty, V. Mahon, C. Brinkley, J. L. 
Hobman, S. J. Savarino, S. M. Turner, M. J. Pallen, C. W. Penn, J. 
Parkhill, A. K. Turner, T. J. Johnson, N. R. Thomson, S. G. Smith, 
and I. R. Henderson. 2010. A commensal gone bad: complete 
genome sequence of the prototypical enterotoxigenic Escherichia 
coli strain H10407. J Bacteriol 192:5822-5831. 
Denamur, E., Picard, B. and Tenaillon, O. 2010. Population Genetics of 
Pathogenic Escherichia coli.in D. F. D. A. Robinson, E. J. Feil, 
editor. Bacterial Population Genetics in Infectious Disease. . John 
Wiley & Sons, Inc., Hoboken, NJ, USA. 
Derbyshire, K. M., M. Kramer, and N. D. Grindley. 1990. Role of instability 
in the cis action of the insertion sequence IS903 transposase. Proc 
Natl Acad Sci U S A 87:4048-4052. 
Dominguez-Bernal, G., M. G. Pucciarelli, F. Ramos-Morales, M. Garcia-
Quintanilla, D. A. Cano, J. Casadesus, and F. Garcia-del Portillo. 
2004. Repression of the RcsC-YojN-RcsB phosphorelay by the 
IgaA protein is a requisite for Salmonella virulence. Mol Microbiol 
53:1437-1449. 
Elena, S. F. and R. E. Lenski. 2003. Evolution experiments with 
microorganisms: the dynamics and genetic bases of adaptation. 
Nat Rev Genet 4:457-469. 
Erickson, K. D. and C. S. Detweiler. 2006. The Rcs phosphorelay system is 
specific to enteric pathogens/commensals and activates ydeI, a 
gene important for persistent Salmonella infection of mice. Mol 
Microbiol 62:883-894. 
Feher, T., B. Cseh, K. Umenhoffer, I. Karcagi, and G. Posfai. 2006. 
Characterization of cycA mutants of Escherichia coli. An assay for 
measuring in vivo mutation rates. Mutat Res 595:184-190. 
Ferrieres, L. and D. J. Clarke. 2003. The RcsC sensor kinase is required 
for normal biofilm formation in Escherichia coli K-12 and controls 
the expression of a regulon in response to growth on a solid 
surface. Mol Microbiol 50:1665-1682. 
87 
 
Funada, H., K. I. Hattori, and N. Kosakai. 1978. Catalase-negative 
Escherichia coli isolated from blood. J Clin Microbiol 7:474-478. 
Garcia-Calderon, C. B., J. Casadesus, and F. Ramos-Morales. 2009. 
Regulation of igaA and the Rcs system by the MviA response 
regulator in Salmonella enterica. J Bacteriol 191:2743-2752. 
Glasser, A. L., J. Boudeau, N. Barnich, M. H. Perruchot, J. F. Colombel, 
and A. Darfeuille-Michaud. 2001. Adherent invasive Escherichia coli 
strains from patients with Crohn's disease survive and replicate 
within macrophages without inducing host cell death. Infect Immun 
69:5529-5537. 
Gottesman, S. and V. Stout. 1991. Regulation of capsular polysaccharide 
synthesis in Escherichia coli K12. Mol Microbiol 5:1599-1606. 
Govan, J. R. and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: 
mucoid Pseudomonas aeruginosa and Burkholderia cepacia. 
Microbiol Rev 60:539-574. 
Hegreness, M., N. Shoresh, D. Hartl, and R. Kishony. 2006. An 
equivalence principle for the incorporation of favorable mutations in 
asexual populations. Science 311:1615-1617. 
Herron, M. D. and M. Doebeli. 2013. Parallel Evolutionary Dynamics of 
Adaptive Diversification in Escherichia coli. PLoS Biol 11:e1001490. 
Huang, Y. H., L. Ferrieres, and D. J. Clarke. 2006. The role of the Rcs 
phosphorelay in Enterobacteriaceae. Res Microbiol 157:206-212. 
Hunstad, D. A. and S. S. Justice. 2010. Intracellular lifestyles and immune 
evasion strategies of uropathogenic Escherichia coli. Annu Rev 
Microbiol 64:203-221. 
Igarashi, K. and K. Kashiwagi. 2010. Modulation of cellular function by 
polyamines. Int J Biochem Cell Biol 42:39-51. 
Janny, S., F. Bert, F. Dondero, M. H. Nicolas Chanoine, J. Belghiti, J. 
Mantz, and C. Paugam-Burtz. 2012. Fatal Escherichia coli skin and 
soft tissue infections in liver transplant recipients: report of three 
cases. Transpl Infect Dis. 
Kaldalu, N., R. Mei, and K. Lewis. 2004. Killing by ampicillin and ofloxacin 
induces overlapping changes in Escherichia coli transcription 
profile. Antimicrob Agents Chemother 48:890-896. 
Kerr, D. R. and J. P. Meador. 1996. Modeling dose response using 
generalized linear models. Environmental Toxicology and 
Chemistry 15:395-401. 
MacFie, J., C. O'Boyle, C. J. Mitchell, P. M. Buckley, D. Johnstone, and P. 
Sudworth. 1999. Gut origin of sepsis: a prospective study 
investigating associations between bacterial translocation, gastric 
microflora, and septic morbidity. Gut 45:223-228. 
Majdalani, N. and S. Gottesman. 2005. The Rcs phosphorelay: a complex 
signal transduction system. Annu Rev Microbiol 59:379-405. 
88 
 
Majdalani, N. and S. Gottesman. 2007. Genetic dissection of signaling 
through the Rcs phosphorelay. Methods Enzymol 423:349-362. 
Mariscotti, J. F. and F. Garcia-Del Portillo. 2008. Instability of the 
Salmonella RcsCDB signalling system in the absence of the 
attenuator IgaA. Microbiology 154:1372-1383. 
Matz, C. and S. Kjelleberg. 2005. Off the hook--how bacteria survive 
protozoan grazing. Trends Microbiol 13:302-307. 
McClintock, B. 1984. The significance of responses of the genome to 
challenge. Science 226:792-801. 
Meyer, J. R. and R. Kassen. 2007. The effects of competition and 
predation on diversification in a model adaptive radiation. Nature 
446:432-435. 
Miskinyte, M. and I. Gordo. 2013. Increased Survival of Antibiotic-Resistant 
Escherichia coli inside Macrophages. Antimicrob Agents 
Chemother 57:189-195. 
Nicoloff, H., V. Perreten, and S. B. Levy. 2007. Increased genome 
instability in Escherichia coli lon mutants: relation to emergence of 
multiple-antibiotic-resistant (Mar) mutants caused by insertion 
sequence elements and large tandem genomic amplifications. 
Antimicrob Agents Chemother 51:1293-1303. 
Ning, Z., A. J. Cox, and J. C. Mullikin. 2001. SSAHA: a fast search method 
for large DNA databases. Genome Res 11:1725-1729. 
Obadia, B., S. Lacour, P. Doublet, H. Baubichon-Cortay, A. J. Cozzone, 
and C. Grangeasse. 2007. Influence of tyrosine-kinase Wzc activity 
on colanic acid production in Escherichia coli K12 cells. J Mol Biol 
367:42-53. 
Page, F., S. Altabe, N. Hugouvieux-Cotte-Pattat, J. M. Lacroix, J. Robert-
Baudouy, and J. P. Bohin. 2001. Osmoregulated periplasmic glucan 
synthesis is required for Erwinia chrysanthemi pathogenicity. J 
Bacteriol 183:3134-3141. 
Paterson, S., T. Vogwill, A. Buckling, R. Benmayor, A. J. Spiers, N. R. 
Thomson, M. Quail, F. Smith, D. Walker, B. Libberton, A. Fenton, 
N. Hall, and M. A. Brockhurst. 2010. Antagonistic coevolution 
accelerates molecular evolution. Nature 464:275-278. 
Perfeito, L., L. Fernandes, C. Mota, and I. Gordo. 2007. Adaptive mutations 
in bacteria: high rate and small effects. Science 317:813-815. 
Proctor, R. A., C. von Eiff, B. C. Kahl, K. Becker, P. McNamara, M. 
Herrmann, and G. Peters. 2006a. Small colony variants: a 
pathogenic form of bacteria that facilitates persistent and recurrent 
infections. Nat Rev Micro 4:295-305. 
Proctor, R. A., C. von Eiff, B. C. Kahl, K. Becker, P. McNamara, M. 
Herrmann, and G. Peters. 2006b. Small colony variants: a 
89 
 
pathogenic form of bacteria that facilitates persistent and recurrent 
infections. Nat Rev Microbiol 4:295-305. 
Roggenkamp, A., A. Sing, M. Hornef, U. Brunner, I. B. Autenrieth, and J. 
Heesemann. 1998. Chronic prosthetic hip infection caused by a 
small-colony variant of Escherichia coli. J Clin Microbiol 36:2530-
2534. 
Rouquette, C., M. C. Serre, and D. Lane. 2004. Protective role for H-NS 
protein in IS1 transposition. J Bacteriol 186:2091-2098. 
Russo, T. A. and J. R. Johnson. 2003. Medical and economic impact of 
extraintestinal infections due to Escherichia coli: focus on an 
increasingly important endemic problem. Microbes Infect 5:449-
456. 
Sailer, F. C., B. M. Meberg, and K. D. Young. 2003. beta-Lactam induction 
of colanic acid gene expression in Escherichia coli. FEMS Microbiol 
Lett 226:245-249. 
saiSree, L., M. Reddy, and J. Gowrishankar. 2001. IS186 insertion at a hot 
spot in the lon promoter as a basis for lon protease deficiency of 
Escherichia coli B: identification of a consensus target sequence for 
IS186 transposition. J Bacteriol 183:6943-6946. 
Sanz-Garcia, M., A. Fernandez-Cruz, M. Rodriguez-Creixems, E. 
Cercenado, M. Marin, P. Munoz, and E. Bouza. 2009. Recurrent 
Escherichia coli bloodstream infections: epidemiology and risk 
factors. Medicine (Baltimore) 88:77-82. 
Savelsbergh, A., M. V. Rodnina, and W. Wintermeyer. 2009. Distinct 
functions of elongation factor G in ribosome recycling and 
translocation. RNA 15:772-780. 
Schmid-Hempel, P. 2008. Parasite immune evasion: a momentous 
molecular war. Trends Ecol Evol 23:318-326. 
Shah, P. and E. Swiatlo. 2008. A multifaceted role for polyamines in 
bacterial pathogens. Mol Microbiol 68:4-16. 
Sharma, U., W. R. Schwan, and W. A. Agger. 2011. Escherichia coli 
pyomyositis in an immunocompromised host. WMJ 110:182-184. 
Sniegowski, P. D. and P. J. Gerrish. 2010. Beneficial mutations and the 
dynamics of adaptation in asexual populations. Philos Trans R Soc 
Lond B Biol Sci 365:1255-1263. 
Sokurenko, E. V., D. L. Hasty, and D. E. Dykhuizen. 1999. Pathoadaptive 
mutations: gene loss and variation in bacterial pathogens. Trends 
Microbiol 7:191-195. 
Stern, A. and R. Sorek. 2011. The phage-host arms race: shaping the 
evolution of microbes. Bioessays 33:43-51. 
Tappe, D., H. Claus, J. Kern, A. Marzinzig, M. Frosch, and M. Abele-Horn. 
2006. First case of febrile bacteremia due to a wild type and small-
90 
 
colony variant of Escherichia coli. Eur J Clin Microbiol Infect Dis 
25:31-34. 
Tenaillon, O., D. Skurnik, B. Picard, and E. Denamur. 2010. The population 
genetics of commensal Escherichia coli. Nat Rev Microbiol 8:207-
217. 
Torres-Cabassa, A. S. and S. Gottesman. 1987. Capsule synthesis in 
Escherichia coli K-12 is regulated by proteolysis. J Bacteriol 
169:981-989. 
Trindade, S., A. Sousa, and I. Gordo. 2012. Antibiotic resistance and stress 
in the light of Fisher's model. Evolution 66:3815-3824. 
Utaisincharoen, P., N. Anuntagool, P. Chaisuriya, S. Pichyangkul, and S. 
Sirisinha. 2002. CpG ODN activates NO and iNOS production in 
mouse macrophage cell line (RAW 264.7). Clin Exp Immunol 
128:467-473. 
Vianney, A., G. Jubelin, S. Renault, C. Dorel, P. Lejeune, and J. C. 
Lazzaroni. 2005. Escherichia coli tol and rcs genes participate in 
the complex network affecting curli synthesis. Microbiology 
151:2487-2497. 
von Eiff, C., C. Heilmann, R. A. Proctor, C. Woltz, G. Peters, and F. Gotz. 
1997. A site-directed Staphylococcus aureus hemB mutant is a 
small-colony variant which persists intracellularly. J Bacteriol 
179:4706-4712. 
Wilson, K. 2001. Preparation of genomic DNA from bacteria. Curr Protoc 
Mol Biol Chapter 2:Unit 2 4. 
Young, K. D. 2007. Reforming L forms: they need part of a wall after all? J 
Bacteriol 189:6509-6511. 
Yu, H., M. Hanes, C. E. Chrisp, J. C. Boucher, and V. Deretic. 1998. 
Microbial pathogenesis in cystic fibrosis: pulmonary clearance of 
mucoid Pseudomonas aeruginosa and inflammation in a mouse 
model of repeated respiratory challenge. Infect Immun 66:280-288. 
 
 
 
 
 
91 
 
Chapter 3 
Presence of innate immunity accelerates 
bacterial adaptation 
 
Migla Miskinyte1, Marie Louise Bergman1, Sara Magalhães2, Jocelyne 
Demengeot1 and Isabel Gordo1  
1Instituto Gulbenkian de Ciência, Oeiras, Portugal 
2Centro de Biologia Ambiental, Faculdade de Ciências, Universidade de 
Lisboa, Lisbon, Portugal 
 
Manuscript in preparation 
 
Summary 
Microbial populations constantly face a pressure imposed by other species 
in different environments, thus it is important to understand the rate and the 
mode of adaptation when living interactions are present. In particular, the 
rate of fitness increase and diversity are expected to increase in ever 
changing environments compared to environmental conditions that are 
static. Although recent studies emphasized the importance of biotic 
interactions in microbial experimental evolution, we are lacking studies 
addressing the pressure of the immune system in microbial evolution, a 
factor important in many bacterial isolates sampled from clinical 
specimens. It is not known how much such pressure can accelerate 
microbial adaptation. Understanding the rate and the mode of adaptation to 
the pressure imposed by the hosts’ immune system unravels the adaptive 
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potential of bacteria to both protect and kill their hosts. We use 
experimental evolution to show that in the presence of innate immune 
system cells – macrophages – the rate of adaptation of Escherichia coli 
populations is higher than in their absence. Furthermore, we show that 
clones adapted to the presence of the macrophages also bear a general 
advantage when facing predators, such as protozoa and phages, and 
cause diarrhea upon oral gavage of mice. These results show that the rate 
of fitness increase is higher in the presence of the macrophages then in 
their absence and adaptation to macrophages lead to increased fitness in 
the environments outside the host. 
 
Introduction 
The rate of adaptive evolution is a key issue in evolutionary biology 
and it is expected to vary between species and across environments 
(Gordo and Sousa 2001, Eyre-Walker 2006). In particular, the rate of 
fitness increase in a novel environment is expected to decrease with time 
when environmental conditions are static (Fisher 2000) but not in an ever 
changing environment (van Valen 1973). This latter scenario is expected to 
occur when strong biotic interactions exist superimposed to a constant 
abiotic environment. As Dobzhansky (1950) pointed out “The greater the 
diversity of inhabitants in a territory, the more adaptive opportunities exist 
in it” (Dobzhansky 1950). Adaptation can be studied in real time, in 
controlled environments imposing different selection pressures, through 
experimental evolution (Elena and Lenski 2003). Such studies have 
demonstrated that bacterial populations have an enormous potential to 
adapt even to relatively simple laboratory environments (Perfeito et al. 
2007, Sniegowski and Gerrish 2010). Recently it has been demonstrated 
that the presence of coevolving species in the environment can increase 
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the rate of adaptation and diversification considerably (Paterson et al. 
2010) and that strong biotic interactions can affect levels of adaptive 
radiation (Buckling and Rainey 2002, Meyer and Kassen 2007).   
In the previous work we have described several adaptive routes 
that commensal Escherichia coli can evolve in the presence of a strong 
biotic interaction, the presence of innate immune system cells – MΦs. For 
the first time we have demonstrated that just in a few hundred generations 
E. coli can acquire such specific adaptations, as increased survival in the 
intracellular niche of the MΦs  and ability to escape phagocytosis by MΦs  
(see Chapter 2).  
Some of those strategies to escape innate immune system cells, 
could be adaptive when bacteria face their environmental predators in the 
nature, such as protozoa, nematodes, insects and mammals (Greub and 
Raoult 2004, Toft and Andersson 2010). Studies of the interactions 
between protozoa and bacteria have revealed that many different bacterial 
traits (including cell surface antigens, motility and quorum sensing) are 
under selective pressure due to predation (Matz and Kjelleberg 2005). It is 
thought that some of the adaptations that evolved as defense mechanisms 
against predators may be important in the adaptation of bacteria to the 
immune system. For example, when Legionella pneumophila is grown in 
one of its natural protozoan hosts, it becomes more invasive to both 
epithelial and macrophage cells (Cirillo et al. 1994). Predation has also 
been shown to select for high levels of bacterial genetic diversity in certain 
loci that are antigenic. For example, Salmonella bearing certain O-antigens 
are differentially discriminated by protozoa species residing in host 
intestines (Wildschutte et al. 2004). It is not yet known if adaptation to the 
immune system would also confer a selective advantage to bacteria facing 
94 
 
its predators in nature and which types of adaptive 
extracellular/intracellular strategies are common in those environments. 
In this study we addressed hypotheses: (1) that the rate of adaptive 
evolution is higher in the presence of MΦs then in their absence, (2) the 
level of variation between populations is higher in the presence of MΦs 
and (3) that certain traits evolved in the presence of MΦ cells could lead to 
adaptation of E.coli when facing natural predators. 
 
Materials and Methods 
Ethics statement 
All experiments involving animals were approved by the Institutional 
Ethics Committee at the Instituto Gulbenkian de Ciencia (project nr. 
A009/2010 with approval date 2010/10/15), following the Portuguese 
legislation (PORT 1005/92) which complies with the European Directive 
86/609/EEC of the European Council. 
Strains and media  
The RAW 264.7 murine macrophage cell line was maintained in an 
atmosphere containing 5% CO2 at 37
oC in RPMI 1640 (Gibco) 
supplemented with 2mM L-glutamine (Invitrogen), 1mM sodium pyruvate 
(Invitrogen), 10mM hepes (Invitrogen), 100U/ml penicillin/streptomycin 
(Gibco), 50µM 2-mercaptoethanol solution (Gibco), 50µg/ml gentamicin 
(Sigma), with 10% heat-inactivated FCS (standard RPMI complete 
medium). Before infection assays, MΦs and bacteria were maintained in 
the same conditions, but instead of penicillin/streptomycin and gentamicin, 
medium was supplemented with 100µg/ml Streptomycin antibiotic (RPMI-
Strep medium).  
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Escherichia coli strains used were MC4100-YFP and MC4100-CFP 
(MC4100, galK::CFP/YFP, AmpRStrepR) which contain the yellow (yfp) and 
cyan (cfp) alleles of GFP integrated at the galK locus in MC4100 (E.coli 
Genetic Stock Center #6152) and differ only by YFP/CFP locus that is 
constitutively expressed (Hegreness et al. 2006). MC4100-CFP strain was 
used for the evolution experiment and MC4100-YFP as a reference strain 
for the fitness assays. 
Evolution experiment 
Twelve populations were founded from a single MC4100-CFP clone 
and were therefore genetically uniform in the beginning of the experiments. 
6 populations were evolved in the presence of the MΦs (1M-6M) in RPMI 
and 6 populations (1C-6C) in RPMI medium in the absence of the MΦs as 
described previously (see Chapter 2).  
Fitness measurements 
To estimate competitive fitness of each population (C1-C6 and M1-
M6), after 285 and 450 generations of evolution, samples from each 
evolved population were competed against MC4100-YFP reference strain 
in the same conditions as used in the evolution experiment. C1-C6 
populations were competed in the RPMI medium and M1-M6 populations 
were competed in the RPMI medium in the presence of MΦs.  Both 
evolved and reference strains were grown separately in RPMI-Strep, then 
diluted in PBS and inoculated simultaneously at a ratio of 1:1. The initial 
and final ratios of both strains were determined by Flow cytometry. Each 
evolved population’s relative fitness was measured 3 times and the 
ancestral strain 10 times to test for neutrality of the marker. The 
fluorescence marker was neutral, as expected. The selection coefficient, a 
measure of relative fitness increase, was estimated as:  
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Where Scoeff is a selection coefficient of the strain b against the 
reference strain a, Nfa and Nfb are the numbers of evolved (b) and 
reference (a) bacteria after competition and Nia and Nib are the initial 
numbers of evolved (b) and reference (a) bacteria, before the competition. 
Phage resistance assay 
Overnight cultures (0.1 ml) of bacteria grown in LB broth were 
inoculated in 5 ml of LB containing 0.2% glucose and 5 mM CaCl2 and 
grown for 30 min. 100 µl of P1 (MC4100) phage lysate was added to the 
cells and then incubated at 37°C for 2h in a shaker. Each tube was 
centrifuged at 13,200 rpm for 2 min, and pellets resuspended in 0.1M pH 
5.5 citrate buffer and plated on LB agar plates (Ho and Waldor 2007, 
Thomason et al. 2007). The same procedure was repeated for the control 
tubes without phage lysate.t 37 °C for 4 to 5 h with phage (approx.108/ml) 
Predation by Tetrahymena 
A sexually mature population of Tetrahymena thermophila mating 
type II (Tetrahymena Stock Center, Cornell University, NY) was grown in 
SPP medium (1% proteose peptone, 0,1% yeast extract, 0,22% glucose 
and 0,003% of EDTA ferric sodium salt) with 1% of antibiotic/antimycotic 
solution (Invitrogen/Life Technologies) (Barchetta et al. 2008). After 48 
hours at 30 ºC, T. thermophila culture, at a density of a 2.5×105 cells/mL 
(acessed by Coulter counter model Z2), was centrifuged at 2200 rpm for 5 
min and resuspended in RPMI-Strep medium. The experiment was 
performed in 48-well plates at MOI 10:1 (106 bacteria to105 Tetrahymena). 
After 7 hours, 1% Triton-X was added for 20 min, the culture centrifuged at 
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9000 rpm for 5 min, washed in PBS and overall number of bacteria was 
counted by plating. The same procedure was repeated for bacteria without 
T. thermophila.  
Mouse colonization experiments 
The classical streptomycin-treated mouse colonization model was 
used to estimate the relative fitness of E.coli strains in their natural 
environment the gut (Moller et al. 2003, Armalyte et al. 2008). Briefly, 5- to 
7-week-old C57BL/6 mice were given drinking water containing 
streptomycin sulfate (5g/l) for one week to eliminate resident facultative 
bacteria. Following 3 h of starvation for food and water, each mouse were 
gavaged with approximately 100 µl containing 108 CFU of suspended 
bacteria grown at 37°C in brain heart infusion (Difco) to early exponential 
phase (OD=2). After gavage, food and water was returned to the mice. 
Streptomycin-containing water was given to the mice throughout the 
experiment. Fecal samples were homogenized, serially diluted in PBS and 
plated onto LB agar plates. After incubation at 37oC for 16 h, plates were 
scanned with a fluorescence scanner (FLA-5100 Fujifilm) and CFUs 
counted using the ImageJ software. 
Three sets of colonization experiments were done to estimate 
fitness advantage of evolved clones in the gut: 
I. Control group: ANC-CFP with ANC-YFP at 1:1 ratio (n=5, females, 
housed in cages - mice nr. 1 with 2, 3 with 4,5 alone); 
II. SCV group: SCV-CFP (SCV_M1_D8 yqiJ::IS5,yjbS::IS1)  with ANC-
YFP at 1:1 ratio (n=6, females, housed in cages - mice nr. 6 with 7, 8 
with 9 and 10 with 11); 
III. MUC group: MUC-CFP (MUC_M3_D19: lon::IS186,yrfF::IS1)  with 
ANC-YFP at 1:1 ratio (n=6, females, housed in cages - mice nr. 12 with 
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13, 14 with 15 and 16 with 17). Diarrhea*: mouse nr. 16 at day 1 after 
colonization. 
 
* to estimate the frequency of mice that get sick after colonization with 
MUC_M3_D19 clone, experiment was complemented in the following way: 
III.1. MUC-CFP with ANC-YFP at 1:1 ratio (n=5, males, mice nr. 11 to 
15, housed all in one cage). Diarrhea: mouse nr. 12 at day 3 after 
colonization. 
III.2. MUC-CFP with ANC-YFP at 10:1 ratio (n=10, females, nr. 1 to 10, 
housed all in separate cages). Diarrhea: mouse nr. 5 at day 2, nr. 
6, 7 and 8 at day 3 after colonization. 
III.3. MUC-CFP alone (n=5, males, nr. 6 to 10, housed all in separate 
cages). Diarrhea: mouse nr. 7 at day 1 and day 2 after 
colonization. 
In total, 7 out of 26 mice developed diarrhea after colonization with 
MUC_M3_D19 clone.  
Mapping and identification of insertion sequences  
The method used to identify insertion sequences (IS) was based on the 
vectorette PCR technique, described before (Zhong and Dean 2004). The 
targets of new insertions/transposition events were determined by direct 
sequencing of extra bands generated with the vectorette PCR protocol. 
Statistical analysis 
The statistical analysis was performed using the R software: 
http://www.r-project.org/, except for the analysis of fitness increase in M 
and C populations, for which we used SAS. To test whether the rate of 
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adaptation in each treatment differed, we used the fitness of M populations 
in the biotic environment and of C populations in the abiotic environment to 
do a PROC MIXED with selection regime (with or without macrophages), 
generation and the interaction between them as fixed factors and line 
nested within selection regime and its interaction with generation as 
random factors. Given that the interaction between selection regime and 
generation was significant (cf. results) we then used the SLICE option to 
test under which selection regime was the interaction significant. We then 
repeated the same analysis, but this time using the data from fitness of 
populations from both selection regimes in the abiotic environment. 
 
Results 
Increased adaptation rate by immune pressure  
We followed the evolution of 12 E. coli populations, all founded from 
the same ancestral clone, when adapting to the two different sets of 
environmental conditions (see Chapter 2). Six populations (C1 to C6) were 
allowed to evolve in the RPMI medium without MΦs – in the C 
environment. The other six populations (M1 to M6) were evolved in the 
RPMI medium where MΦs were also present – in the M environment. The 
size of each population was counted daily and propagation of the bacterial 
populations was performed with a fixed number of bacteria, such that the 
differences in population sizes observed between the two culture 
conditions (with and without MΦs) were minimized (see Materials and 
Methods). Any observed difference in the rate of adaptation between C and 
M populations is therefore not attributed to differences in bacterial 
population size, but to the presence or absence of the MΦs. All populations 
were allowed to evolve for a period of 30 days, which corresponds to 
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approximately 450 generations. To test if the rate of adaptation is higher in 
the M pops versus C pops, we performed competitive fitness assays of the 
bacterial populations in the environments were populations had evolved. 
This was done by making head-to-head competitions of each evolved 
population against the ancestral clonal population during 24 hours, and 
determining the number of bacteria for each strain by flow cytometry: the 
ancestral carries a YFP marker and the evolved a CFP marker. Figures 
3.1A and 1B plot the relative competitive fitness of each evolved population 
at two different time points of the experiment: after 19 days (approximately 
285 generations) and 30 days (approximately 450 generations) in the 
environments where populations evolved.  
The results clearly show a fitness increase in all populations within 
a few hundred generations. More importantly, after 450 generations, the 
fitness increase was higher for the populations evolved in presence of MΦs 
than for populations evolved in their absence (P=0.01, Proc mixed, see 
Methods). This supports the hypothesis that the rate of bacterial adaptation 
is higher in presence of MΦs. On average the fitness increase observed in 
the M populations is of 0.27 (2SE=0.10), whereas that observed in the C 
populations is of 0.04 (2SE=0.02) only after 450 generations. This implies 
that presence of MΦs led to higher fitness increase. Also consistent with 
our hypotheses, Figures 3.1 A and B show that the populations evolved in 
presence of MΦs had significantly higher variation for fitness between 
populations than the C populations (F-test, P=0.03 after 285 generations; 
P=0.007 after 540 generations). We therefore conclude that the level of 
between populations variation is increased in the presence of biotic 
interactions, in the initial stages of adaptation. 
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Figure 3.1. Evidence that presence of the macrophages increase the speed 
of adaptation in the bacterial populations. Competitive fitness of the C and M 
populations relative to the ancestral clone in the C (white bars) and M (black bars) 
environments at 285 (A and C) and 450 (B and D) generations. Error bars 
correspond to two time standard errors, n = 3.  
 
We compared the fitness increase of the bacterial populations at 
two different time points of the evolution: at day 19 and at day 30. 
Interestingly no significant difference in the fitness was observed between 
285 and 540 generations (P=0.73, Proc Mixed with SLICE, see Methods) 
for the C populations, whereas a significant change was observed in the M 
populations (P=0.002, Proc Mixed with SLICE). The mean fitness observed 
for M populations was 0.10 (2SE=0.07) at generation 285 and 0.27 
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(2SE=0.10) after 450 generations. The environments experienced by both 
sets of populations are correlated because they share the same abiotic 
factor, RPMI medium. To query if the adaptation to MΦs entailed any cost 
in adaptation to the environment where MΦs are absent we performed new 
competitive fitness assays of all the evolved M populations in the abiotic C 
environment, i.e. in RPMI medium without MΦs. The average fitness 
increase observed in M or C populations in the C environment was similar 
after 285 or 450 generations (M pop 0.04 (2SE=0.02) and C pop 0.05 
(2SE=0.02) after 285 generations; M pop 0.02 (2SE=0.05) and C pop 0.04 
(2SE=0.02) after 450 generations). Therefore we did not find any 
difference in the increase in fitness between 285 and 540 generations for 
M populations in the C environment (P=0.31, Proc Mixed with SLICE).  
Fitness advantage when facing natural E. coli predators  
Bacteria have evolved conserved strategies to infect and kill various 
evolutionary distinct eukaryotic hosts, including protozoa, nematodes, 
insects and mammals (Greub and Raoult 2004, Toft and Andersson 2010). 
It is thought that the adaptive strategies of bacteria against several natural 
predators may be a prerequisite to avoid MΦs and become pathogenic 
(Matz and Kjelleberg 2005, Hilbi et al. 2007). Under this hypothesis, one 
should also expect that some adaptations evolving towards escaping 
destruction from the professional phagocytes of the innate immune system 
will also confer a selective advantage to bacteria facing other predators.  
To query if this hypothesis is correct we measured fitness related 
traits of ancestral and two evolved E. coli clones when facing common 
E.coli predators, namely protozoa and phages. We chose to study two 
clones that in the presence of MΦs acquired specific adaptations: 
increased survival inside MΦs (SCV – small colony variant clone) and 
increased resistance to escape engulfment by MΦs (MUC – mucoid 
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looking clone) (see Chapter 2). For the experiments, we chose MUC clone 
that was isolated from M3 population at day 19 of evolution experiment 
(MUC_M3_D19) and has two transposon insertions: an insertion of IS186 
into the promoter region of lon and an IS1 insertion upsteam of yrfF. 
Because our previous results demonstrated that adaptation to the MΦs 
was mainly driven by transposable element mutations in several 
independently evolved MUC clones (see Chapter 2), we sought to check 
for transposon insertions in SCV clones (see Materials and Methods and 
Appendix B, Table B1). Strikingly, we did not find common insertions 
between SCV and MUC clones and only 14 out of 60 SCV clones had new 
transposon insertions. This result indicates that adaptation to the 
intracellular niche of the MΦs could not be solely explained by acquisition 
of transposable elements. For the further experiments we chose SCV clone 
sampled from M1 population at day 8 of evolution experiment 
(SCV_M1_D8). This SCV clone has two distinct insertions: an IS1 insertion 
within the yjbS gene and an IS5 insertion within yqiJ gene. YjbS is an 
essential gene for E. coli growth in rich medium, however its function is 
unknown. YqiJ gene is predicted to code for a putative oxidoreductase and 
has a hotspot motive 5`-YTAR-3` (Y=C or T) (R=A or G) for IS5 insertion 
(Mahillon and Chandler 1998) and indeed IS5 inserted in TTAA motive. It is 
known that yqiJ gene is highly up-regulated in E. coli strains sampled from 
asymptomatic bacteriuria during biofilm formation in human urine (Hancock 
et al. 2007).  
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Figure 3.2. Adaptive value of the SCV and MUC clones in other ecosystems. 
SCV and MUC clones evolved in the presence of MΦs tested for survival under 
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predation by either the protozoa T. thermophila (A) or the phage P1 (B). *p < 0.05, 
**p < 0.01, Welch Two Sample t-test. 
 
 
Tetrahymena thermophila share many characteristics with 
macrophages, such as some of the recognition mechanism and the 
production of oxygen radicals to kill the bacteria. If bacteria acquired 
mutations that make them better adapted to defense mechanisms that are 
common to MΦs and protozoa then we should detect a fitness advantage 
of the evolved bacteria. Figure 3.2A shows that MUC clones, has a fitness 
advantage in the presence of protozoa. With SCV clones, we did not detect 
any significant difference in survival compared with the ancestral clone 
when facing protozoa.  
We also tested for fitness advantage of the evolved clones towards 
the bacteriophage of E. coli. Figure 3.2B shows that the adaptive strategy 
acquired by the MUC to escape phagocytosis by MΦs also provides a 
clear fitness advantage in the presence of phages. Other MUC clones 
sampled from M1 to M6 populations at generation 450 (day 30), also 
showed an increased resistance to the phages in a plaque assay 
(Appendix B, Figure B1). For the SCV no advantage relative to the 
ancestral bacteria was found in an environment where these specific 
predators (protozoa and phage) are the sole predator species, thus 
indicating that SCV evolved a specific adaptation towards intracellular 
environment of the MΦs.  
 
Fitness advantage of SCV clone in the mouse gut 
Finally we asked if the evolved bacteria show any selective 
advantage in an in vivo mammalian system, the mouse gut, which is a 
natural environment for E. coli. This is a complex ecosystem in which 
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competition with other species and predation by several predators occurs. 
In this environment a striking advantage was found for the SCV clone. By 
colonization of streptomycin treated mice, we show that SCV increases in 
frequency over the ancestral clone and is therefore better adapted in vivo 
(Figure 3.3). Fluorescent marker was neutral (Appendix B, Figure B2). 
 
Figure 3.3. Competitive fitness assay of SCV clone in the gut. C57BL/6 mice 
treated with streptomycin were colonized with co-culture of 1:1 ancestral 
(expressing YFP) to SCV clone (expressing CFP). An increase in the ratio of CFP 
to YFP over time indicates selective advantage of the SCV clone (empty squares). 
Filled squares represent average ratio. Linear regression on ln(CFP/YFP) provides 
an estimate of the selective advantage per day: SCV slope 0.53 (SE=0.05), 
P<0.0001 adjusted R
2
=0.7.  
 
 
 
107 
 
SCV clone evolves to MUC clone in vivo 
Strikingly, we observed the emergence of MUC colonies at 7-10 
days post colonization in several mice colonized with SCVs. These in vivo 
emerging MUC clones are derived from SCV clone because they have the 
same CFP marker. Surprisingly, we found that all MUC clones sampled 
from 3 independent mice, lost insertion in yjbS gene and acquired 
insertions in the promoter region of lon gene (Figure 3.4, Appendix B Table 
B2). Thus, this suggests that a mutation in lon gene alone or in 
combination with the mutation in yqiJ, is responsible for the transition of 
SCV clone into MUC clone in the gut. Moreover, MUC clone that evolved in 
the mouse gut also presented an increased ability to escape killing by the 
MΦs (Figure 3.5). 
 
 
 
Figure 3.4. Experimental design demonstrating SCV transition to MUC clone 
through IS insertion in lon.  
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Figure 3.5. MUC clone, derived from SCV clone in the mouse gut, escapes 
killing by the MΦs. Black bars indicate bacterial growth density in RPMI without 
MΦs and white bars indicate – bacterial density after 5h at MOI (1:1) (see 
Materials and Methods in Chapter 2). Only extracellular bacteria are counted. 
MUC (in vivo) – MUC clone that was derived from SCV_M1_D8 in the competition 
assay in vivo at 10 days post colonization (clone X12, see TableS2). Initial 
numbers of ANC and MUC (in vivo) were not significantly different (T-test, 
P>0.05). Another independent MUC clone (X23, see Table S2) that emerged from 
SCV in the competitions in vivo showed similar results (not shown). 
 
 
MUC clone does not show fitness advantage in the gut, but causes 
transient diarrhea in mice 
In contrast to SCV clone, no selective advantage was revealed in 
the competitions of the MUC versus the ANC clone (Figure 3.6) and this 
morph shows lower colonization ability (not shown). Unexpectedly, 
however, we did observe a recurrent and important manifestation of the 
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colonization of mice by this MUC clone: a statistically significant proportion 
of the mice with MUC clones developed diarrhea within the first days of 
colonization (frequency of sick mice 0.27 with 95% CI [0.1; 0.4], see 
Materials and Methods). This was observed for at most two sequential 
days. Albeit small, the deleterious effect in the host caused by this evolved 
clone is significant in relation to the ANC strain or the other evolved SCV 
clone.  
 
  
 
Figure 3.6. Competitive fitness assay of MUC clone in the gut. C57BL/6 mice 
treated with streptomycin were colonized with co-culture of 1:1 ancestral 
(expressing YFP) to MUC clone (expressing CFP). An increase in the ratio of CFP 
to YFP over time indicates selective advantage of the MUC clone (empty 
triangles). Filled triangles are average ratio in each experimental group. Linear 
regression on ln(CFP/YFP) provides an estimate of the selective advantage per 
day: MUC slope 0.23 (SE =0.15), P=0.13, adjusted R
2
=0.08. 
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Discussion 
Overall our results support the hypotheses that pressure imposed 
by the innate immunity accelerate adaptation and increase diversity. Our 
results show that populations adapting to simple abiotic environment, reach 
fitness plateau in about 285 generations. A similar pattern has been 
previously observed in populations of E. coli adapting to another abiotic 
environment composed of minimal media (Lenski 1991) but in a longer 
period of time. On the other hand M populations that are adapting to strong 
biotic environment do not show any signs of reaching a plateau in the 
tested period. Therefore the populations evolving in the presence of MΦs 
continue to increase in fitness at least until 450 generations.  
A classical model of adaptation to a novel simple abiotic 
environment with a single fitness peak is Fisher’s geometrical model 
(Fisher 2000). Under this static fitness landscape populations are expected 
to exhibit an initial rapid fitness increase, but as they become more 
adapted to the environment and approach the fitness plateau, the rate of 
fitness change should diminish. However, if the fitness landscape has 
several accessible fitness peaks, for example due to periodic 
environmental variation or the presence of biotic interactions, the rate of 
adaptation is not expected to decrease. Several other studies have shown 
that presence of strong biotic interactions, such as competition or predation 
by other species, increase adaptive radiation and lead to increase in fitness 
rates due to multiple coexisting high-fitness peaks (Poulin et al. 2000, 
Colegrave and Buckling 2005, Martin and Wainwright 2013, Williams 
2013).  
In the presence of the MΦs, due to complex fitness landscape, 
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where not only predation by MΦs, but also interspecific competition for 
existing resources occurs, variation for fitness and morphological diversity 
was observed. Some of those morphological variants that were previously 
characterized in Chapter 2 acquired specific adaptations to the presence of 
MΦs. In this study, we asked if adaptation to the MΦs would also confer a 
selective advantage to bacteria in other natural ecosystems, such as in the 
presence of bacterial predators, namely phage and protozoa or in the 
mouse gut, where multiple biotic interactions can be found.  
We have found that clone that adapted to the intracellular niche of 
MΦs has a selective advantage in vivo in the mouse gut, observation that 
was surprising, given that till now there is no direct evidence that MΦs 
reside in the gut mucosa at high densities in the healthy individuals. 
Interestingly, J. M. Rhodes proposed a possibility that even non pathogenic 
E. coli during Chron's disease, may enter the lymphoid tissue, via the M 
cells, and subsequently persist within regional MΦs (Rhodes 2007). 
However question if SCV clones have a selective advantage in vivo, 
because of this phenomenon, holds for the future investigation.   
MUC clone that evolved extracellular strategy to avoid engulfment 
by MΦs, confer resistance to predators that E.coli encounters in nature, 
namely with bacteriophages and protozoa. This demonstrates that there 
are some adaptive strategies to escape innate immunity that are fairly 
general, and can evolve very rapidly. Moreover, we observed that MUC 
clone can cause transient diarrhea in some animals.  
Another interesting observation in this study comes from the fact 
that SCV can evolve to MUC phenotype in the mouse gut. Two findings 
lead us to believe that transition between SCV and MUC phenotype can be 
explained through regulation of Lon activity in SCV genetic background. 
Firstly, ANC clone never gave rise to the MUC clone. Secondly, only MUC 
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clone and not SCV revertant clone (CFP-REV) acquired insertion in the lon 
promoter region (Figure 2.4). Thus, this suggests that mutation in lon gene 
alone or in combination with the mutation in yqiJ, is responsible for 
emergence of MUC phenotype in the mouse gut. Interestingly, the promoter 
region of lon has been described as a hotspot for IS186 insertions (saiSree 
et al. 2001), which explains the rapid acquisition of such trait in the proper 
genetic background. 
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Summary 
Mutations causing antibiotic resistance usually incur a fitness cost in the 
absence of antibiotics. The magnitude of such cost is known to vary with 
the environment. Little is known about the fitness effects of antibiotic 
resistance mutations when bacteria confront the host’s immune system. 
Here we study the fitness effects of mutations in the rpoB, rpsL and gyrA 
genes, which confer resistance to rifampicin, streptomycin and nalidixic 
acid, respectively. These antibiotics are frequently used in the treatment of 
bacterial infections. We measured two important fitness traits – growth rate 
and survival ability – of twelve Escherichia coli K-12 strains, each carrying 
a single resistance mutation, in the presence of macrophages. Strikingly, 
we found that 67% of the mutants survived better than the susceptible 
bacteria in the intracellular niche of the phagocytic cells. In particular, all E. 
coli streptomycin resistant mutants exhibit an intracellular advantage. On 
the other hand, 42% of the mutants were costly when bacteria were 
allowed to divide outside macrophages. This study shows that single non-
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synonymous changes affecting fundamental processes in the cell can 
contribute to prolonged survival in the context of an infection and are 
therefore important for the understanding of the evolution of antibiotic 
resistance and virulence in nature. 
 
Introduction 
A great deal of bacterial adaptation in the context of infectious 
diseases is their rapid evolution to tackle the immune system and 
antibiotics. Escherichia coli is both a commensal and a versatile pathogen, 
that can cause death (Denamur et al. 2010). Given these characteristics, it 
is an ideal organism to study the transition of commensalism to 
pathogenicity. E. coli colonizes the infant gastrointestinal tract within hours 
after birth, and typically a mutualistic relation builds up. However, even the 
harmless E. coli can cause an infection when gastrointestinal barriers are 
broken (Rolhion and Darfeuille-Michaud 2007) or in immunosuppressed 
hosts (Kaper et al. 2004). Healthy hosts are also susceptible to highly 
adapted E. coli pathogenic clones, which can cause many different types of 
infections. There is evidence that some of the pathogenic strains evolved 
from the commensal E. coli, through the acquisition of new genes and 
mutations (Denamur et al. 2010).  A fundamental part of the ecology of E. 
coli during infection process is its interaction with the host immune system 
cells, in particular with macrophages. It is however not known if E. coli 
harbouring antibiotic resistance can have an advantage or disadvantage in 
the context of an interaction with the immune system. This knowledge is 
important given the high frequency of antibiotic resistance within 
commensal E.coli in healthy individuals (Bailey et al. 2010, Levert et al. 
2010), which may lead to an increased risk of treatment failure during an 
infection process, because of limited therapeutic options. 
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Mutations that cause antibiotic resistance often produce associated 
fitness costs in bacteria (Andersson and Hughes 2010, MacLean et al. 
2010). When the environment contains an antibiotic, resistant bacteria 
exhibit an advantage. However when the antibiotic is absent, resistant 
bacteria typically have reduced growth rates, although this depends on the 
genetic background (Gagneux et al. 2006, Trindade et al. 2009). This is not 
surprising, since mutations which cause antibiotic resistance often target 
physiologically important functions in the cell, such as transcription and 
protein synthesis, cell wall synthesis or nucleic acid synthesis (Andersson 
and Hughes 2010). Interestingly, the fitness effect of a resistance mutation 
can be detrimental in one environment and beneficial in another (Macvanin 
et al. 2003, Paulander et al. 2009, Bataillon et al. 2011, Hall et al. 2011, 
Trindade et al. 2012). For example, Trindade et al. showed increased 
variation in fitness effects of resistant mutations in E.coli with increased 
environmental stress. Similarly, Hall et al. demonstrated that the costs of 
24 different rpoB mutations vary greatly among 41 environments with 
different carbon source. Having in mind that fitness effects of resistant 
mutations exhibit strong genotype-by-environment interactions, it is 
important to determine the effects of resistance in an environment imposed 
by the host. Despite its importance, to our knowledge there are only a few 
studies that explicitly address fitness effects of antibiotic resistant under 
conditions that are closer to the growth conditions in a host (Bjorkman et al. 
1998, Adams et al. 2011). Furthermore, it has been shown that fitness 
effects of antibiotic resistant mutations vary substantially in the different in 
vivo and in vitro models (Bjorkholm et al. 2001, Giraud et al. 2003, Enne et 
al. 2004, Luo et al. 2005). 
One important interaction that bacteria face in natural conditions is 
the interaction with cells from the immune system that are able to 
phagocytise them. There is little information available on fitness effects of 
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antibiotic resistance in this important context. The aim of the research 
reported here is to determine whether or not single point mutations 
conferring rifampicin, streptomycin and nalidixic acid resistance can affect 
reproduction and survival of commensal E.coli in the face of professional 
phagocytes. This study shows that commensal bacteria carrying specific 
resistance mutations can survive better in the intracellular environment of 
professional phagocytes. This has important consequences in designing 
therapeutic treatments and may be important to understand the spread of 
drug resistance and virulence.  
 
Materials and Methods 
Media and growth conditions 
The RAW 264.7 murine macrophage cell line was maintained in an 
atmosphere containing 5% CO2 at 37
oC in RPMI 1640 (Gibco) 
supplemented with 2 mM L-glutamine (Invitrogen), 1 mM sodium pyruvate 
(Invitrogen), 10 mM hepes (Invitrogen), 100 U/ml penicillin/streptomycin 
(Gibco), 50 µM 2-mercaptoethanol solution (Gibco), 50 µg/ml gentamicin 
(Sigma), with 10% heat-inactivated FCS (standard RPMI complete 
medium). Before infection assays, MΦs were maintained in the same 
conditions, but in antibiotic-free RPMI media (without 
penicillin/streptomycin and gentamicin). Bacterial strains were grown and 
competed in antibiotic-free RPMI media in an atmosphere containing 5% 
CO2 at 37
oC or in Luria-Bertani (LB) medium at 37oC, with aeration (Grant-
bio PHP-4 type Thermo-Shaker at 700 rpm). 
Construction of strains 
Susceptible MG1655-YFP and MG1655-CFP strains (MG1655, 
galK::CFP/YFP, ΔlacIZYA) containing yellow (YFP) and cyan (CFP) 
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fluorescent proteins under constitutive expression were created by moving 
yfp or cfp chromosomal inserts by P1 transduction from previously 
described strains (MC4100, galK::CFP/YFP, ampR (pZ12), strR (rpsl150)), 
that were kindly given by R. Kishony (Hegreness et al. 2006). To ensure 
constitutive expression of YFP or CFP fluorescent proteins the lac operon 
was deleted from MG1655 background. Ampicilin resistance (pZ12) was 
removed from the yfp or cfp locus using Wanner and Datsenko method 
(Datsenko and Wanner 2000). Mutations conferring resistance to rifampicin 
(in rpoB gene), streptomycin (in rpsL gene) and nalidixic acid (in gyrA 
gene) were previously constructed in Escherichia coli K-12 MG1655 
background (see Appendix C, Table C1, (Trindade et al. 2009)). General 
transduction using P1 bacteriophage was performed as previously 
described (Thomason et al. 2007) in order to place resistance mutations in 
the new E.coli K-12 MG1655-YFP and MG1655-CFP background. To 
confirm mutations, each antibiotic resistance target gene was amplified and 
then sequenced. The primers used to amplify part of rpoB gene were: 5′-
CGTCGTATCCGTTCCGTTGG-3′ and 5′-
TTCACCCGGATAACATCTCGTC-3′; for rpsL gene: 5′-
ATGATGGCGGGATCGTTG-3′ and 5′-CTTCCAGTTCAGATTTACC-3′ and 
for gyrA gene: 5′-TACACCGGTCCACATTGAGG-3′ and 5′-
TTAATGATTGCCGCCGTCGG-3′. Each resistant clone was grown from a 
single colony in LB medium supplemented with the respective antibiotic 
and stored in 15% glycerol at -80oC. 
Competitive fitness in conditions where bacteria can divide: test for 
effects on reproduction 
To estimate the fitness cost of resistance mutations we performed 
competition assays in three different environments: LB, RPMI and in RPMI 
with the MΦs. The resistant mutants constructed in MG1655-CFP (or in the 
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MG1655-YFP) strain were competed against a susceptible MG1655-YFP 
(or susceptible MG1655-CFP) strain in an antibiotic-free environment, at a 
ratio 1:1. For competitions in LB, both resistant and susceptible strains 
were grown separately for 48 hours for acclimatization in the media 
(bacteria were diluted at 1:103 after 24 hours) at 37oC with aeration, then 
mixed and 10 µl of 10-2 dilution was inoculated to the final volume of 150 µl 
of LB media in 96-well microtiter plates (Costar #3595) for 24 hour 
competition. Plates were arranged in a checkerboard configuration where 
half of the wells were without cells to control for well to-well and external 
contamination. For competitions in RPMI, resistant and susceptible strains 
were grown in antibiotic-free RPMI media for 48 hours (bacteria were 
diluted at 1:10-3 after 24 hours for acclimatization) at 37oC with 5% CO2. 
Competitions were performed in a 24-well cell culture tissue plates 
(containing 1 ml of culture media in each well), by inoculating 10 µl of 10-1 
dilution (approximately 5×104 bacteria). For competitions in the presence of 
the MΦs, strains were competed in the same conditions as used for 
competitions in the RPMI, except that MΦs were present. MΦs were 
seeded in a 24-well tissue culture plate at approximately 2 to 3× 105 cells 
per well and allowed to attach overnight. Cells were then washed, re-
suspended in fresh antibiotic-free RPMI media and activated with 2 µg/ml 
CpG-ODN 1826 (5´TCCATGACGTTCCTGACGTT 3´ - Sigma) for 24 
hours. After 24 hours, cells were washed from remaining CpG-ODN, fresh 
antibiotic-free RPMI media was added and macrophages were infected 
with bacteria in the manner described before. The initial and final ratios of 
resistant and susceptible strains were determined by Flow Cytometry. The 
fitness cost of each of the resistance mutation was measured four times 
(twice in YFP and twice in CFP background). The selection coefficient, a 
measure of competitive fitness, was estimated as: 
121 
 
Scoeff = Ln[(Nfb/Nfa)/(Nib/Nia)]/Ln[Nfa/Nia]
    (Maree et al. 2000)
 
Where Scoeff is a selection coefficient of the resistant strain b against 
the susceptible strain a, Nfa and Nfb are the numbers of resistant (b) and 
susceptible (a) bacteria after competition and Nia and Nib are the initial 
numbers of resistant (b) and susceptible (a) bacteria before the competition 
(results are shown in Figure 4.1B, D and F) .  
Competitive fitness inside the MΦs: test of the effect on survival 
To estimate fitness effect of the resistant mutations on survival 
inside phagocyte cells, MΦs were prepared in the manner described 
above, infected with 5×106 bacteria (1:1 of resistant to susceptible strain) 
and centrifuged at 203 × g (1000 rpm) for 5 min to enhance bacterial 
internalization. After 2 hours of infection, MΦs were washed from 
extracellular bacteria and fresh cell culture medium containing 100 µg of 
gentamicin/ml was added to kill the remaining extracellular bacteria. After 
incubation for an additional hour, the medium was removed, monolayers of 
macrophages were washed and RPMI medium containing 20 µg of 
gentamicin/ml was added (0 h post-infection time point). To determine the 
number of intracellular bacteria after 5 h and 24 h of incubation, infected 
MΦs were washed 3 times with phosphate-buffered saline (PBS), 0,1% 
Triton-X was added for 30 min at 37oC  in order to lyse the MΦs, 
centrifuged at 10600 × g (10000 rpm) for 5 min, washed in PBS and overall 
number of bacteria was counted by plating on LB agar plates. To measure 
intracellular survival after 48 h post-infection, fresh culture medium 
containing gentamicin (20 µg/ml) was added after 24 h post-infection 
period to the infected cells.  
Survival inside the macrophages was estimated as the change in 
relative frequency: 
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∆X = Nfb/(Nfa + Nfb) – Nib/(Nia + Nib), where Nfa and Nfb are the 
numbers of resistant (b) and susceptible (a) bacteria after competition and 
Nia and Nib are the initial numbers of resistant (b) and susceptible (a) 
bacteria, before the competition (results are shown in Figure 4.1A, C and 
E).   
Survival to oxidative stress of streptomycin resistant mutants 
Given that all STR resistant mutants showed a survival advantage 
inside MΦs, we sought to determine if the mutants would also show an 
advantage during nutrient limitation in the stationary growth phase and 
under oxidative stress, which are characteristics of environment inside the 
MΦs. 
To determine if STR resistant clones have differential fitness 
advantage in exponential (4 h), early stationary (24 h) and late stationary 
(48 h) phases, competition assays between STR resistant and susceptible 
strains were done. Briefly,  STR resistant and susceptible strains were 
grown in antibiotic-free RPMI media separately for 48 hours at 37oC with 
5% CO2 (bacteria were diluted at 1:10
3 after 24 hours for acclimatization), 
then mixed at a ratio of 1:1 (1 resistant to 1 susceptible strain) and 10 µl of 
10-1 dilution inoculated to 1 ml of culture media. At 4, 24 and 48 h, a 
sample of bacterial suspension was plated onto LB plates to estimate the 
frequencies of STR resistant to susceptible strain at different growth 
phases (before exposure to H2O2 (Sigma), results are shown in Figure 2A). 
To determine if STR resistant clones would show an advantage to 
survive oxidative stress during different growth phases, a mixture of STR 
resistant and susceptible strains (see description above – before exposure 
to H2O2), was treated with different concentrations of H2O2 (10 mM at 4 
hours, 20 mM at 24 hours and 40 mM at 48 hours) for 30 min at 37oC. 
Appropriate dilutions were immediately plated onto LB to determine the 
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frequencies of STR resistant to susceptible strain after exposure to H2O2. 
Different concentrations of H2O2 were chosen because of higher cell 
mortality at exponential phase in comparison to stationary phase to the 
same concentration of H2O2 (Lim. et al. 2007). Four independent replicate 
experiments were done for each strain (two in YFP and two in CFP 
background). Survival to oxidative stress was calculated dividing relative 
frequencies of STR mutant after and before exposure: 
∆X(H2O2) = (Nfb/(Nfa + Nfb)) / (Nib/(Nia + Nib)) 
Where Nfa and Nfb are the numbers of resistant (b) and susceptible 
(a) bacteria after exposure to H2O2 and Nia and Nib are the numbers of 
resistant (b) and susceptible (a) bacteria, before exposure (results are 
shown in Figure 4.2B). 
Statistical analysis 
Wilcoxon signed rank test and Wilcoxon sum rank test with 
Bonferroni correction were used for statistical analysis using the R 
software: http://www.r-project.org/. Analysis of linear regression between 
survival and reproduction of antibiotic resistant mutants in the presence of 
the MΦs (Figure 4.2) was performed using SigmaPlot 9.0 software (Systat 
Software Inc., Chicago, USA) was used. 
 
Results 
We studied twelve different antibiotic resistance mutations in rpsL, 
rpoB and gyrA , conferring resistance to streptomycin (STR), rifampicin 
(RIF) and nalidixic acid (NAL) antibiotics, respectively (see Table 1). These 
mutations had been previously studied for fitness costs in Luria Bertani 
(LB) medium, when present in another genetic background (Trindade et al. 
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2009). Because fitness of antibiotic resistant clones can depend on the 
genetic background (Gagneux et al. 2006), we measured competitive 
fitness of these twelve mutants in LB media and found that all showed a 
cost in LB. The costs of antibiotic resistant mutations were different in the 
new genetic background for 33% of cases studied in the LB media 
(Wilcoxon sum rank test, p<0.05 for four out of twelve mutations, Appendix 
C, Figure C1).  
To determine the fitness effects of antibiotic resistant clones in the 
presence of MΦs, competition experiments between the susceptible and 
the resistant mutants were performed. Two main fitness traits are important 
during the infection process: reproduction, which occurs outside MΦs, and 
survival, which is the main fitness component inside MΦs. Macrophage 
infection model has frequently been used to study virulence traits of many 
pathogenic bacteria species, where a non-pathogenic E. coli has served as 
a positive control for MΦ ability to uptake and phagocitize bacteria. 
It is known that internalized non-pathogenic E. coli does not 
replicate intracellularly and thus E. coli survival is directly influenced by 
MΦs bactericidal properties and internalization time (Hamrick et al. 2000). 
After just 2 hours of internalization, 60% of all E. coli K-12 are shown to be 
immediately killed by RAW 264.7 macrophage cell line (Frankenberg et al. 
2008). Another study also reported that a decrease in the numbers of 
viable bacteria can be observed as early as at 4 hours post-infection and 
only 5% of the initially internalized bacteria are recovered alive after 24 
hours post-infection period (Glasser et al. 2001). 
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Table 4.1. Genotypes of single-point mutations used in the study 
Gene 
Genotype 
amino acid 
change 
Nucleotide change 
Antibiotic 
Resistance1 
rpsL K 43 N AAA to AAC STR 
rpsL K 43 T AAA to ACA STR 
rpsL K 43 R AAA to AGA STR 
rpsL K 88 R AAA to AGA STR 
rpoB S 531 F TCC to TTC RIF 
rpoB H 526 Y CAC to TAC RIF 
rpoB I 572 F ATC to TTC RIF 
rpoB R 529 H CGT to CAT RIF 
rpoB S 512 F TCT to TTT RIF 
rpoB H 526 D CAC to GAC RIF 
gyrA S 83 L TCG to TTG NAL 
gyrA D 87 Y GAC to TAC NAL 
1
- STR, streptomycin; RIF, rifampicin; NAL, nalidixic acid 
 
The effects on both traits, reproduction outside the MΦs and 
survival inside the MΦs, were measured (see Materials and Methods). In 
order to estimate fitness effects of resistance in bacterial reproduction, 
competition assays in the RPMI cell culture media in the presence (+MΦs) 
and absence (–MΦs) of the MΦs were performed.  
Global survival advantage of STR resistant mutants inside the MΦs 
Figure 4.1A shows the effects on survival of E. coli strains carrying 
mutations K43N, K43T, K43R or K88R, which confer resistance to 
streptomycin. Surprisingly, all STR resistant mutants showed a survival 
advantage inside MΦs during 5, 24 and 48 hours post-infection. There was 
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no significant difference for survival effects of STR resistant mutants 
between post-infection periods (Wilcoxon signed rank sum, p>0.05). 
Contrary to the global fitness survival advantage inside MΦs, two mutants 
showed a cost and two other mutants were neutral when bacteria are 
allowed to reproduce, which was measured in competitive fitness assays 
against the susceptible strain in the presence and absence of the MΦs 
(Figure 4.1B). The cost of one mutation (K43N) differed significantly due to 
the presence of the MΦs (Wilcoxon sum rank test, p=0.04), while the costs 
of other three mutations were not different. In summary, single point 
mutations in rpsL gene, provide a survival fitness advantage in commensal 
E. coli in the intracellular niche of MΦs, leading to an increased risk of 
treatment failure during an infection process. 
Variable fitness effects in RIF resistant mutants 
Half of the RIF mutants (S512F, I572F and H526Y) showed a 
survival advantage inside the MΦs (Figure 4.1C). These were neutral or 
only slightly advantageous in competitive fitness assays where growth can 
occur outside MΦs (Figure 4.1D – white bars). Two RIF resistant mutants 
showed impaired survival inside the MΦs (R529H and H526D) and also 
showed the highest fitness costs for reproduction (Figure 4.1C and 1D). 
For the S531F mutation no effect was detected on survival, but a 
deleterious effect was measured on reproduction. There was no overall 
difference for effects on survival of RIF resistant mutants between different 
post-infection periods (Wilcoxon signed rank sum, p>0.05), except for one 
mutant (H526Y), that ceased to be advantageous for survival inside the 
MΦs at later time points (Wilcoxon sum rank test, between 5 and 48h post-
infection, p<0.05). Fitness effects on reproduction of three E. coli RIF 
resistant mutants (Wilcoxon sum rank test, p=0.01 for H526Y, p=0.009 for 
I572F, p=0.005 for H526D) were significantly different due to the presence 
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of the MΦs, while effects for reproduction of other three mutants did not 
differ between presence and absence of MΦs in the environment (Figure 
4.1D). 
 
 
Figure 4.1. Effects of resistance on survival (left panel) and reproduction (right 
panel) of mutations in rpsL (A and B), rpoB (C and D) and gyrA (E and F) in E. coli. 
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A, C and E show fitness effects on survival inside the MΦs after 5 h (black dashed 
bars), 24 h (light grey dashed bars) and 48 h (dark grey dashed bars) post-
infection. B, D and F show the effects of the mutations when bacteria can 
reproduce in the presence (white bars) and absence (black bars) of MΦs. All 
fitness effects were estimated using competition assays against a susceptible 
strain. The asterisk (*) represents significant differences (p<0.05) using Wilcoxon 
sum rank test. 
 
NAL resistant mutants are advantageous or neutral 
The fitness of S83L mutant was higher than the susceptible, for 
both, reproduction in the culture media and survival inside MΦs, while 
fitness of D87Y mutant remained neutral (Figure 4.1E and 1F). There was 
no effect on survival between different post-infection time points (Wilcoxon 
signed rank sum, p>0.05). We did not observe significant differences in 
fitness effects for reproduction for the two studied NAL resistant mutants 
(S83L and D87Y) due to the presence of the MΦs (Wilcoxon sum rank test, 
p>0.05 for both mutations) (Figure 4.1F). 
Advantage of STR mutants to oxidative stress in the stationary phase  
Given the striking survival advantage of al STR resistant mutants, 
we tried to determine if such results could be caused by the specific stress 
that bacteria face upon internalization, namely nutrient starvation and/or 
oxidative stress. To test this hypothesis, competition assays were 
performed during exponential and stationary phases of bacterial growth, 
and advantage to oxidative stress was measured during those phases, by 
addition of H2O2. While fitness cost for reproduction was the highest after 
24 hours of bacterial growth, it was relieved after 48 hours (where bacteria 
experience 24 hours growth phase in addition to 24 hours stationary 
phase) for the two most costly STR mutants – K43N and K43T (Wilcoxon 
sum rank test, p=0.03 for K43N, p=0.03 for K43T, Figure 4.2A), indicating 
that STR resistant mutations could bear an advantage during stationary 
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phase induced by nutrient limitation. Interestingly, all STR resistant 
mutants showed an increased survival to oxidative stress after 24 hours, 
but not during exponential growth phase (Figure 4.2B). The results 
therefore indicate that nutrient deprivation and oxidative stress are key 
factors on the survival advantage that these mutants exhibit inside MΦs. 
 
Figure 4.2. Starvation and oxidative stress diminish the fitness cost of STR 
resistant mutations. (A) Effects on reproduction of STR resistant mutations 
during 4, 24 and 48 hours competition assays against a susceptible strain in RPMI 
medium. (B) Advantage of STR resistant mutants against a susceptible strain after 
exposure to H2O2 at different phases of bacterial growth in RPMI medium. Bars 
above the dashed line represent an increased survival of the STR mutant against 
a susceptible strain. The asterisk (*) represents statistical significant difference 
(p<0.05) using Wilcoxon sum rank test. 
 
Correlation between survival and reproduction  
It has been proposed that resistance to stress is associated with 
reduced resource uptake, or growth rate (Ferenci 2005). This trade-off 
between self-preservation and nutritional competence, so called SPANC 
balance, has been observed in several studies (Ferenci 2005, De Paepe et 
al. 2011). Recently, SPANC trade-off has been directly linked to the growth 
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rate, stress resistance, outer membrane permeability, morphotype 
characteristics and virulence properties of antibiotic resistant E. coli 
isolates from deep and visceral infections in humans (Levert et al. 2010). In 
our study we tested for the existence of SPANC trade-off between survival 
inside the MΦs and reproduction in the presence of the MΦs (Figure 4.3). 
We did not observe a negative correlation, but, on the contrary, antibiotic 
resistant clones which survived better inside the MΦs also had a higher 
fitness advantage for reproduction (Figure 4.3). Overall, 67% (8 out of 12) 
of all studied antibiotic resistant mutants survived better than the 
susceptible inside the MΦs (see points that fall into S+ quarters). 
 
Figure 4.3. Test for correlation between the effect on survival inside MΦs 
and effect of growth rate. Intracellular survival of resistant mutants against a 
susceptible strain was measured at 5 h after bacterial internalization. Reproduction 
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in the RPMI media with the MΦs was measured after 24 h competition assay. The 
slope of the regression line (solid line) is 0.64 ± 0.2 (Std. Err) and p=0.01, with 
R
2
=0.5. The dotted lines represent 95% confidence interval of the regression line 
and dashed lines 95% prediction intervals for all data points. The graph is divided 
into quarters where R+ and R- (or S+ and S-) means advantage and disadvantage 
for reproduction (or survival), respectively. Triangles represent STR, circles RIF, 
and squares NAL mutants. 
 
Discussion 
Drug-resistant bacteria pose a significant threat to human health, 
and it is important to understand how the fitness of such bacteria can be 
impaired during infection. Here, we studied how antibiotic resistance 
affects two important fitness traits: the ability to survive and reproduce in 
the presence of MΦs. It is known that during the entry into MΦs, bacteria 
experience a set of environmental stresses, such as host-induced nutrient 
limitation, acidification, toxic peptides, osmotic stress and reactive oxygen 
species (ROS), of which the latter is believed to be the major cause of 
bacterial killing (Schlosser-Silverman et al. 2000). To our knowledge, this is 
the first study that measures fitness effects for survival of several antibiotic 
resistant mutants in the intracellular environment of the MΦs. Surprisingly, 
we found that from 3 distinct groups of resistance targets 67% of all 
mutants had increased survival inside MΦs, 17% did not show significant 
differences from the susceptible and only 16% of all mutants showed 
reduced survival. Importantly streptomycin resistance, although carrying 
substantial fitness costs for growth rate, shows a global advantage for 
survival.  
The experience of the early single use of streptomycin in 1946, for 
treating Mycobacterium tuberculosis infections indicated that resistance to 
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this drug could be acquired very rapidly (Crofton and Mitchison 1948). To 
this day STR resistant isolates have been identified in many other 
important pathogens, such as Shigella flexneri, Vibrio cholerae, 
Pseudomonas aeruginosa, and even in commensal E. coli sampled from 
healthy individuals (Tseng et al. 1972, Barreto et al. 2009, Hong et al. 
2010, Rahmani et al. 2012). High resistance incidence to this drug is 
frequently due to point mutations in rpsL gene, with the most common 
mutations at the codon K43 and K88 (Sreevatsan et al. 1996) that were 
included in this study. These mutations were shown here to be beneficial in 
the intracellular environment of MΦs in E. coli. One possible explanation 
for the fitness advantage of STR resistant mutations could be the 
approximately 7-fold improvement in the accuracy of ribosomes in rpsL 
mutants (Zaher and Green 2010). It was shown that streptomycin 
resistance mutations in rpsL gene often lead to hyper-accurate, but slower 
ribosomes (Bilgin et al. 1992). Indeed, all STR resistance mutations that 
were tested in our study are responsible for the increased fidelity of 
ribosomes (Okamoto-Hosoya et al. 2003). Though fast ribosomes are 
required in actively dividing cells, hyper-accurate ribosomes are 
advantageous in non-dividing cells during starvation, because they exhibit 
attenuated protein oxidation during growth arrest  (Ballesteros et al. 2001) 
and oxidized proteins are known to be more susceptible to proteolytic 
degradation (Cabiscol et al. 2000). This should be extremely relevant upon 
entry to the MΦs, where E. coli not only undergoes growth arrest and 
nutrient starvation, but also has to deal with ROS generated by the MΦs 
(Schlosser-Silverman et al. 2000). Consistent with this hypothesis, we 
found that STR resistant mutants have reduced fitness costs when 
nutrients are deprived and survive better than the susceptible under 
oxidative stress in stationary phase (Figure 4.2). Certainly, finding that 
most commonly identified mutations, conferring resistance to STR, 
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enhanced the survival capacity of E. coli inside the MΦs, begs the question 
if that advantage could exist in other bacterial species, such as M. 
tuberculosis and other pathogenic bacteria.  
Many bacterial pathogens (Sekiguchi et al. 2007, Liu et al. 2011, 
Yesilyurt et al. 2011) acquired resistance to RIF in the last decade. It is 
known that in 96% of RIF resistant clinical isolates of TB, resistance is due 
to the mutations in rpoB gene, with the most common mutations at the 
codon 531 and 526 in distinct geographical locations (Cavusoglu et al. 
2006, Tan et al. 2012). In this study, besides prevalent mutations in codons 
531 and 526 (S531F, H526Y, H526D), other mutations in codons 512, 529 
and 572 (S512F, R529H, I572F) were also included. The fitness effects on 
survival of RIF mutants in E. coli varied in our study. Interestingly, different 
base substitutions leading to different amino acids even at the same codon 
position (see Figure 4.1C – H526D and H526Y) gave differential outcomes 
for E. coli survival inside MΦs. The mutation at the codon 526 has been 
shown to be responsible for oxidative stress sensitivity in E. coli and 
Staphylococus aureus. However, the molecular mechanism for this 
remains unknown (Kawamura et al. 2005). Several observations suggest 
that single point mutations in the rpoB gene encoding β subunit of RNA 
polymerase, can have an effect on RNA polymerase interaction with 
several promoters and transcriptional regulators, leading to different 
phenotypes (Zhou and Jin 1998, Maughan et al. 2004, Perkins and 
Nicholson 2008). For example, in Bacillus subtilis the RNA polymerase 
complex interacts with every promoter in bacterial genome, so the 
mutations in RNA polymerase lead to global changes in gene transcription 
and, hence, affect several physiological processes, such as growth and 
metabolism, chemotaxis, competence, spore resistance and many others 
(Maughan et al. 2004).  Since RIF mutations have been found to affect 
physiological processes to different extents, it may not be surprising that 
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we found a great variation in their fitness effects of RIF mutants inside 
MΦs.  
The emergence of NAL resistant isolates during treatment of 
Shigella, Campylobacter or Salmonella infections has been of a great 
concern (Wu et al. 2002, Kumar et al. 2009, Ghosh et al. 2011). Single 
point mutations in the quinolone resistance-determining region of the DNA 
subunit gene gyrA, at a codon 83 (42% frequency) and 87 (35% frequency) 
have been attributed to the high levels of resistance to this antibiotic 
(Hopkins et al. 2007). Although the fitness costs of those mutations appear 
to be low in laboratory medium (Trindade et al. 2009), it is not known how 
resistance to this drug may affect survival and replication of these bacteria 
in the context of infection. In E. coli we found no fitness costs (for D87Y 
mutation) or even slightly enhanced fitness (for S83L mutation) of NAL 
resistant clones for survival inside the MΦs, which is compatible with those 
of the previous reports showing that NAL resistance is usually associated 
with very small fitness costs (Bjorkman et al. 1998).  
It was previously demonstrated that fitness effects for reproduction 
of antibiotic resistant bacteria generally increases under stressful 
conditions (Petersen et al. 2009, Trindade et al. 2012). Effects on 
reproduction of more than half (58%) antibiotic resistant mutants was either 
neutral or slightly advantageous in the presence of the MΦs, however this 
effect was mainly attributed to the growth in the RPMI cell culture medium 
we used for maintenance of eukaryotic cells. Still, this is altogether 
relevant, because RPMI cell culture medium is supposed to mimic abiotic 
conditions in the human host. Moreover, fitness effects for reproduction 
differed in 33% of antibiotic resistant cases, due to the presence of the 
MΦs (compare black and white bars in Figure 4.1B, D and F). It is however 
not surprising, given that MΦs not only inflict several different stresses on 
135 
 
bacteria, but can also modify composition of the extracellular media. This is 
consistent with earlier findings suggesting that fitness costs of antibiotic 
resistant mutants may vary in the different environmental conditions (Hall 
et al. 2011, Trindade et al. 2012). 
The findings made here have several medically relevant 
implications. First, this work shows that the presence of macrophages can 
have drastic consequences for the biological fitness of antibiotic resistant 
E. coli. This conclusion points towards measuring fitness costs in such 
environment in other bacterial species as well as studying mutational 
targets of widely used antibiotics in clinics. Second, this study identifies 
single point mutations that are advantageous for bacterial survival in 
macrophages because of the environmental stresses imposed by MΦs, 
such as exposure to H2O2. Taken all together, our main finding that 
stressful intracellular environment of MΦs can select for antibiotic 
resistance has important consequences for predictions of the spread of 
drug resistance. 
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Chapter 5 
Discussion 
Microbial populations constantly face a pressure imposed by hosts’ 
immune system. However, it is not known how fast and which type of 
adaptive strategies commensal bacteria can evolve to circumvent the first 
barrier of immune system. In the preceding chapters, I demonstrate that 
commensal E. coli, under constant pressure imposed by innate immune 
system cells – macrophages, can evolve remarkably fast and acquire 
specific traits that are reminiscent to those found in pathogenic bacteria. 
Specifically, at least two different strategies evolved in succession: 
increased intracellular survival (SCV clones) and ability to escape 
engulfment and killing by macrophages (MUC clones).  
SCV clones that emerged during the interaction with macrophages, 
share similar characteristics as those sampled from various bacterial 
species found in human clinical infections (Funada et al. 1978, 
Roggenkamp et al. 1998, Tappe et al. 2006). Among those are increased 
resistance to specific antibiotics, the ability to revert to ancestral 
phenotype, reduced growth in extracellular medium and longer intracellular 
survival, increased growth in the presence of hemin and negative catalase 
activity (Proctor et al. 2006). In clinical contexts, SCVs have been isolated 
after long and unsuccessful antibiotic exposure (Pranting and Andersson 
2011, Garcia et al. 2013). This is not the only mechanism potentiating the 
emergence of SCVs in several pathogens, since they can be selected in 
the intracellular milieu of eukaryotic cells in the absence of antibiotics 
(Vesga et al. 1996, Cano et al. 2003). All these studies concern the 
emergence of SCVs in pathogenic species/strains. In contrast with all 
those studies, I demonstrated that even commensal E. coli acquire SCV 
phenotype in the presence of phagocytic cells. My results suggest that this 
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mechanism is fairly general and thus can be utilized by several bacterial 
species during an infection process. Moreover, this can be a common 
strategy that bacteria employ in order to hide inside the eukaryotic cells, 
which may provide shelter from host defenses and antibiotics.  
The bacterial strategy evolved by MUC clones, is characterized by 
overproduction of EPS, increased resistance to escape macrophage 
phagocytosis, and increased pathogenesis in vivo. This increased 
pathogenesis in the mouse in vivo model is in accordance with the fact that 
MUC colony morphologies are frequently isolated from life-threatening 
infections in humans (Govan and Deretic 1996, Stollerman and Dale 2008, 
Bottone 2010, Djossou et al. 2010, Silva et al. 2011). In general, the 
mucoid phenotypes have been often associated with pathogenic 
mechanisms, such as resistance to phagocytosis, increased resistance to 
bactericidal serum factors and virulence in animal studies (Schwarzmann 
and Boring 1971, Wessels et al. 1991, Engleberg et al. 2001). For 
instance, EPS isolated from mucoid variant of Burkholderia cenocepacia, 
interfere with the function of human neutrophils in vitro, by inhibiting both 
chemotaxis and the generation of reactive oxygen species (Bylund et al. 
2006). Also, during cystic fibrosis, P. aeruginosa produce specific EPS 
alginate, which protects bacteria from macrophage engulfment and killing 
(Leid and Jeffers 2009). Moreover, even if macrophages cannot engulf P. 
aeruginosa, they are activated and hence, secrete toxic compounds that 
damage healthy host tissues. Such phenomenon is called “frustrated” 
phagocytosis. Together, this suggests that the encounter with phagocytic 
cells during the infection process may explain the acquisition of mucoidy by 
bacteria.  
To correlate phenotypic changes to genetic changes in bacterial 
populations adapting to the presence of the macrophages, several 
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randomly chosen clones from the end of experiment were sent for whole-
genome sequencing. A remarkable parallelism was observed for several 
genetic changes, such as transposable element (TE) insertions in 
regulatory region of yrfF (a predicted inner membrane protein), in coding 
regions of yiaW (a predicted transmembrane protein), in potA and potD 
genes (involved in spermidine uptake), and SNPs in fusA (an elongation 
factor) gene. Such parallelism between independently evolving populations 
suggests that E. coli evolved similar mechanisms to survive phagocytosis 
by macrophages. Several other authors, reported the acquisition of parallel 
genetic changes in bacterial populations evolving to other types of 
selective pressures, such as simple laboratory medium, antibiotic presence 
or even in the human host (Woods et al. 2006, Zdziarski et al. 2010, 
Toprak et al. 2012). It is relevant to notice that the majority of the observed 
mutations, in bacterial population adapting to the macrophages, were TE 
insertions. While TEs sometimes are viewed as genomic parasites 
(Piskurek and Jackson 2011), they can also be considered as powerful 
facilitators of evolution, because they can be advantageous in generating 
variation upon which natural selection can act in novel evolutionary niches 
(McClintock 1984, Oliver and Greene 2011). Such adaptive process driven 
by TEs has been demonstrated in several other studies, in the context of 
adaptation to a novel environment (Papadopoulos et al. 1999, de Visser et 
al. 2004, Liang et al. 2011, Dragosits et al. 2013). In particular, 
Papadopoulos et al. (1999) observed that similar IS-150-mediated 
deletions affecting rbs operon occurred in all 12 parallel populations 
adapting to minimal medium with glucose (Papadopoulos et al. 1999). 
Moreover, all rbs deletions in this study were advantageous in the 
environment where populations evolved. Altogether, these results show 
that transposable elements are important drivers in microbial evolution and 
that it may be possible to predict which genetic changes underlie 
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adaptation to some environmental pressures.  
To track the emergence of new adaptive mutations to the presence 
of the macrophages, I randomly sampled several clones at different time 
points of evolution and estimated frequencies of different haplotypes for 
mutations that are known. Surprisingly, insertion in yrfF regulatory region 
not only occurred in all clones that showed MUC morphology, but it was 
also the first mutation to be observed in all populations. After the initial 
sweep characterized by a common mutation in yrfF, populations adapting o 
the macrophages acquired other mutations, which were either distinct or 
parallel among E. coli populations. In the clones that were not MUC, but 
rather looked like ancestral phenotype (ANC), I did not detect any 
mutations that increased in frequency during the experiment in MUC 
clones. These findings strongly suggest that MUC clones acquired 
genotypes that are specific to the adaptation to macrophage environment. 
Therefore, it would be interesting to explore how each of those mutations 
alone and in combination contributes to E. coli fitness in this context.  
Finally, results in Chapter 2 suggest, that clonal interference plays a 
major role in the evolution of the E. coli adaptation to the macrophages. 
Indeed, there is a growing body of literature suggesting that clonal 
interference is an important process in the dynamics of bacterial evolution 
(de Visser and Rozen 2006, Martens and Hallatschek 2011, Hughes et al. 
2012, Herron and Doebeli 2013). And, while it is hard to exclude the 
possibility that other forms of selection may act during the evolution 
experiment, clonal interference explain reasonably well the complex 
dynamics in bacterial populations adapting to the macrophages.  
In Chapter 3, I measured and compared fitness of populations that 
evolved in the presence of macrophages with populations that evolved in a 
constant abiotic medium. I observed that, in the presence of macrophages 
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the rate of adaptation in bacterial populations is higher than in their 
absence, and that genetic variation increases. This agrees with 
Dobzhansky’s hypothesis (1950), who postulated that higher levels of biotic 
interactions are expected to exert higher selection pressures on other 
organisms than abiotic environments, leading to higher rates of adaptation 
and hence generating more diversity (Dobzhansky 1950). Surprisingly, only 
very recently such important hypothesis could be verified by several 
studies, mainly in phage-bacteria coevolutionary studies. (Paterson et al. 
2010, Gomez and Buckling 2011, Hall et al. 2011b, Stern and Sorek 2011). 
Thus my study produced results which corroborate the findings of some of 
the previous work in this field, however in different experimental setup.  
In the same chapter, I investigated if adaptation to the 
macrophages would also confer a selective advantage to bacteria in other 
natural ecosystems. I chose to address this in different ecological 
conditions, namely presence of bacteriophage and protozoa and inside the 
mouse gut, where multiple biotic interactions can be found. I demonstrated 
that SCV clones, which showed an increased survival inside macrophages, 
conferred a selective advantage in vivo in the mouse gut.  However, the 
MUC clone did not show any advantage, but caused diarrhea in some 
animals. Additional work is required to confirm if the fitness advantage of 
SCVs in vivo is a consequence of the interplay between hosts immune 
system and SCV phenotype specific properties. When I tested evolved 
clones for a survival advantage against killing by protozoa and 
bacteriophage, MUC clones showed an advantage to both, in comparison 
to the ANC and SCV clones. This indicates that strategies to escape 
phagocytosis by macrophages and killing by E. coli environmental 
predators can be fairly general. Such observation was also found in 
previous studies (Cirillo et al. 1994, Wildschutte et al. 2004), however 
generally in a reverse order.  For instance, L. pneumophila after growth in 
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one of the protozoan hosts, Acanthamoeba castellanii, becames 100-fold 
more invasive for epithelial cells and 10-fold more invasive for 
macrophages (Cirillo et al. 1994). Such coincidental evolution can be 
largely explained because of the similarities between protozoa cells and 
macrophages. For example, similar morphological events that follow 
internalization of L. pneumophila by amoebae are similar to those 
thoroughly characterized in mammalian cells (Bozue and Johnson 1996, 
Venkataraman et al. 1998, Cirillo et al. 2002). Moreover, L. pneumophila 
share many genes that are important to infect both amoebae and 
mammalian cells (Gao et al. 1997, Liles et al. 1999, Cirillo et al. 2002, 
Miyake et al. 2005). In many cases, evolutionary studies demonstrated that 
bacterial evolution in protozoa is able to select for enhanced survival and 
virulence in phagocytic cells. Interestingly, a recent study that resembles 
the experimental setup I presented in Chapter, questioned if after evolution 
with macrophages, bacteria can evolve to survive better in protozoa 
(Ensminger et al. 2012). Contrary to expectations, L. pneumophila showed 
decreased survival ability in its protozoan host after replication within 
macrophages for hundreds of generations (Ensminger et al. 2012). Such 
incompatibility between results presented by Ensminger et al. (2012) and 
my direct observations can be explained by differences in bacterial strains. 
While the E. coli strain that I used is a commensal, L. pneumophila is 
recognized as a protozoan parasite and accidental intracellular pathogen in 
humans. Thus, it is possible that initial adaptation to protozoa or 
macrophages is sufficiently general for extracellular pathogen until bacteria 
adapt to survive main intracellular stresses that are common between 
those hosts. When this happens, intracellular pathogen may become more 
specialized in protozoa or macrophages, in particular if growth is restricted 
to only one of those niches. Together, these results suggest that 
coincidental evolution theory can explain the acquisition of the virulence 
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traits in pathogenic bacteria, but cannot discriminate whether bacterial 
adaptation to environmental predators resulted in the increased 
pathogenesis in  humans, or vice versa.  
In Chapter 4, I measured fitness effects of antibiotic resistant clones 
for the ability to reproduce in the extracellular niche of macrophages and to 
survive inside the macrophages. I showed that 67% of all studied mutants 
increased survival inside macrophages, a result that is extremely relevant, 
given that antibiotics are widely used as tools to combat many infectious 
diseases. Moreover, by choosing three different antibiotics, affecting a 
broad spectrum of essential genes in the cell, I showed that this trait is not 
restricted to a specific gene, but can be quite general. Importantly, 
resistance to streptomycin antibiotic, although carrying substantial fitness 
costs for growth rate, showed a global advantage for survival inside 
macrophages. In this chapter I extend this finding by showing that the cost 
of streptomycin resistance can be alleviated during stationary phase and 
exposure to hydrogen peroxide, both of which constitute environmental 
stresses that are common in the harsh milieu of macrophages. It is known 
that entry into the stationary phase might trigger the expression of a unique 
genetic program that activates persister switch (Hu and Coates 2005, 
Lewis 2007). Herewith, persister cells are known to resist better many 
environmental challenges (Lewis 2007). It would be important to find out if 
mutations conferring streptomycin resistance could facilitate transition to 
persistent phenotype.  
Although many studies had reported that fitness effects of antibiotic 
resistance vary in different environments and genetic backgrounds (Hall et 
al. 2011a, Trindade et al. 2012), there is the need to complement this 
knowledge with experiments focusing on possible mechanisms for this 
phenomenon. One possibility is to measure the costs of resistance in the 
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environmental conditions closest to those that bacteria has to face in 
nature, such as oxygen and nutrient limitation, presence of antimicrobials 
and others. To understand how different genes conferring resistance to 
antibiotics respond to new environmental challenges, it is important to 
know how each mutation affects gene expression and metabolism of 
bacterial cell. Another important task is to account for differences in the 
genetic backgrounds within and between bacterial species and to keep in 
mind that epistasis might be acting between different targets affecting 
resistance to various antibiotics. 
The work developed in this thesis opens future avenues of research 
concerning adaptation of microbes to immune system. For example, while I 
mainly focused on E. coli adaptation to the macrophages, the 
correspondent physiological adaptation of macrophages rests unexplored. 
This is crucial, as several recent in vivo studies suggest that the functional 
phenotype of macrophages could change over time within a host when 
facing different micro-environmental signals (Stout et al. 2005, Graff et al. 
2012). And while the exact mechanism responsible for this switch has not 
been yet identified, it is clear that this transition is linked with various 
important pathologies (Mosser 2003, Kinne et al. 2007, Pollard 2009). It is 
possible that E. coli could have evolved to modify some functions of 
macrophage cells. Do macrophages respond differently to evolved SCV 
and MUC clones? If so, does the localization of evolved bacteria changes 
within macrophages or do bacteria learn to interfere with macrophage 
signaling pathways? Additional work is also required to unravel the causes 
of increased pathogenesis caused by MUC clones in the in vivo model in 
mice. What are the possible mutations responsible for this phenotype? 
What is the exact mechanism by which commensal E. coli evolves to harm 
the host? Also, why SCVs appeared in the experiment only transiently and 
what are the selective pressures responsible for the emergence of this 
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phenotype? Which genetic alterations lead to this phenotype and do they 
confer advantage to other nonphagocytic cells? It is clear that in future 
investigations it might be important to complement those findings by 
studying other commensal bacterial species and introducing other cells 
present in the host.  
In the broader context, the findings that I present here demonstrate 
the power of innate immune system as a selective pressure to help us 
understand the diversity of microorganism in terms of health and disease. 
Ultimately, such knowledge is crucial in order to predict the emergence of 
bacteria with increased pathogenic potential and resistance to antibiotics, 
and to effectively come up with new therapeutic strategies.   
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Appendices 
Appendix A 
 
Figure A1. Quantification of colanic acid in MUC_M3_D19 clone. After 
purification from the growth medium of each clone, the amount of colanic acid was 
determined by measuring non-dialyzable methylpentose (fucose) absorbance at 
396 and 427 nm after reaction with sulfuric acid and cysteine hydrochloride. 
Measurements were repeated three times for each clone. Obtained values 
(ΔA396–ΔA427) were directly correlated with fucose calibration curve and 
normalized for CFUs. 
 
Figure A2. Infection dynamics of the ancestral strain. Simulated dynamics of a 
population of bacteria dividing in the presence of macrophages for 24 hours, 
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according to the model 0( )tm
dB B
B r a M e
dt K
    (see main text), using the 
following parameter values: B0=10
6
; m0=10
6
; r=2.3; K=10
8
; am= -3.7*10
-6
; ᵟ=0.1. 
 
 
 
Figure A3. Dynamics for the different haplotypes under the model of clonal 
interference. Simulated frequencies of the different haplotypes which result in the 
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frequencies of the mucoid phenotypes of Figure 2.5. r=2.3, am =-3.7x10
-6
 and the 
other parameters used are as follows:  
 
U 
(x10
-7
) 
Uis 
(x10
-7
) 
rm 
amm 
(x10
-6
) 
Uis’ 
(x10
-7
) 
r’ 
amb 
(x10
-6
) 
rm’ 
amm’ 
(x10
-6
) 
A 3  4  2.1758 -3.23 12  2.369 -3.7 2.2171402 -3.23 
B 0.96  4.45  2.21122 -3.2 3.84 2.392 -3.7  2.2554444 -3.2  
C* 0.43 4  2.185 -3.24 1.72 
2.3609
5 
-3.7 2.2724 -3.24 
D* 0.1  10  2.1988 -3.2 5  2.4104 -3.7 2.2691616 -3.2  
E* 0.43 6.94  2.180768 -3.28 0.1075  2.346 -3.7 2.180768 -2.86 
F 3  4 2.1758 -3.23 12  2.3736 -3.7 2.2247555 -3.23  
Marked as * are dynamics where more haplotypes were assumed to reproduce the 
experimental dynamics and, therefore, additional parameters are required: 
 U’’(B’->B’’) r’’ 
amb’ 
(x10
-6
) 
Uis’’(M’->M’’) rm’’ 
amm’’ 
(x10
-6
) 
C* 4.3 x 10
-8
 2.47309513 -3.7 1.72 x 10
-7
 2.3428444 -3.24  
D* 1 x 10
-8
 2.494764 -3.7 1 x 10
-8
 2.32021774 -2.99  
E* 4.3 x 10
-8
 2.482068 -3.7    
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Figure A4. Region of parameter space theoretically expected for the invasion 
of first mucoid morph. Colored areas show the parameter region (rm/r and 
amm/am) where a mucoid genotype (mimicking the IS insertion upstream of yrfF in 
the experiment) that has emerged is able to increase in frequency so that it can 
survive the bottleneck imposed every 24 hours in the experiment. The equations 
for these simulations are:  
0
0
( )
( )
t
m
t
m mm
B MdB
B r a M e
dt K
B MdM
M r a M e
dt K




 
   
 
 
   
 
 
with initial conditions M(0)=1, B(0)= 10
6
 and the other parameter values as in 
Figure A4: M0=10
6
; r=2.3; K=10
8
; am= 3.7*10
-6
; δ=0.1.
 
Warmer colors show higher 
frequency of the mucoid genotype in the population after 24 hours of its 
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emergence as a single copy. The black dot indicates the value of rm and amm, of 
the first mucoid haplotype assumed to emerge in the 6 models that produced the 
dynamics in Figures 2. 5 and A5. 
 
 
 
 
Figure A5. Relative growth rate for clones with an ancestral colony 
morphology (non-mucoid). Multiple clones were randomly isolated from two 
populations at different time points, as indicated in the x-axis, below the clone 
numbers. Replicate measures for the maximum growth rate of each clone were 
obtained from independent cultures and divided by the mean growth rate of the 
original ancestral. The ancestral for the main experiment (Anc) is highlighted in 
red, the evolved clones whose growth rate is significantly different from the 
ancestral are highlighted in blue (P < 0.05, ANOVA; white: not significantly 
different from ancestral). Anc: 16 replicates; evolved clones: 3-4 replicates  
159 
 
 
 
Figure A6. Bacterial densities for animals that failed to survive infection. 
Bacterial counts were obtained from plated samples of blood (red) or peritoneal 
contents (blue). Mice were infected with either the ancestral (B1-B5) or a mixture 
of mucoid clones (E1-E5 and G1-G5; see methods). For some animals it was 
impossible to obtain samples for the peritoneal contents (missing blue bars).  
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Table A1. Clones that were typed for existing mutations in M1 to M6 pops. 
Population Day Morphs 
Nr. of 
clone
s 
y
rfF
 
lo
n
 
fu
s
A
 
y
e
g
h
 
y
ia
W
 
p
o
tA
 
P
o
tD
 
fo
lD
 
trk
H
 
h
ip
A
 
w
z
c
 
M1 18 ANC 10 - - - -        
 30 MUC 11 + - + +        
 30 ANC 10 - - - - - - -     
M2 5 MUC 8 + - -         
 5 ANC 2 - - -         
 30 MUC 11 + - +  - - -     
M3 18 ANC 10 - -   - -  - -   
 18 MUC 6 + -   + -  - -   
 18 MUC 2 + -   + -  - -   
 18 MUC 2 + -   - -  - -   
 30 MUC 7 + -   - -  - -   
 30 MUC 2 + -   + +  - +   
 30 MUC 1 + -   + -  - +   
 30 MUC 1 + -   + +  + +   
M4 8 MUC 8 + -   -  -     
 8 ANC 2 - -   -  -     
 16 ANC 6 - -   -  -     
 16 MUC 3 + -   -  -     
 16 MUC 1 + -   +  -     
 20 ANC 6  -   -  -     
 20 MUC 2 + +   +  +     
 20 MUC 2 + -   -  -     
 30 MUC 2 + - -  -  -     
 30 MUC 1 + - -  +  -     
 30 MUC 8 + - -  +  +     
M5 8 ANC 10 - -        - - 
 14 ANC 4 - -        - - 
 14 MUC 6 + -        - - 
 18 ANC 10 - -        - - 
 20 ANC 6 - -        - - 
 20 MUC 4 + -        - - 
 30 MUC 1 + - -  - - -   + + 
 30 MUC 5 + - -  - - -   - + 
 30 MUC 5 + - -  - - -   - - 
M6 18 ANC 10 - -   -  -     
 26 ANC 6 - -   -  -     
 26 MUC 2 - -   -  -     
 26 MUC 2 + -   +  +     
 30 MUC 1 + - -  -  -     
 30 MUC 10 + - -  +  +     
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Table A2. Primers used in this study.  
Amplified 
region 
Primers (5` - 3`) PCR product 
(bp) 
fusA F: CAATTACGGCCTGAGCAACG 
R: CTGCACCTCGACATCATCGT 
709 
yegH F: CGGATGATTGAGCGGGTACT 
R: ATCTCGCCATCCTTACGCAG 
704 
folD F: CCCGACTTCTTCACAAGCCT 
R: AGAGAGCCCCGTTAGATGAA 
518 
trkH F: CGTTGGACTACTGGTCATCTT 
R: CAGGTAGGAGGCAATCTCGC 
1500 
wzc F: CGGCTTATGAGCTGGTTTGC 
R: AAAGCCCGCAAGTACTGGAA 
883 
hipA F: ATAGCGATATCCTGCGACCT 
R: AATCATGACCGCCAACGACT 
773 
lon F: GCAATACGGGGATTTCAATG 
R: GGAAGACGTCGAAAAAGTGG 
408 
yrfF F: TTGCTCATCGTGGGATCTATGCTGT 
R: TCGGCATTCAGCGCCAGAGA 
578 
yiaW F: TCACCACACCAGTCACCTGT 
R: CCTGGACTATTTTGCACTGGGA 
547 
potA F: CATCAGCCAGTACGACCTCC 
R: CAATTGGCGGGAATTCGCAA 
1069 
potD F: GCCTTCGGTATGAATCGCGT 
R: ATTACTGGTGCTGTCGCTGG 
1314 
cycA
1
 F: TTTCCAGCCACATGATGAAA 
R: GTTTATGGGGTCTGGCAAAA 
1250 
 
1
 – primers used to amplify cycA gene to test for the increase in general mutation 
rate.  
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Appendix B 
 
 
 
Figure B1. The effect of phage lysis in different clones. On the left panel, ANC and 
representative MUC clone (MUC clone isolated at 450 generations after evolution 
in the presence of the MΦs) growth without phage, on the right side, ANC and 
MUC clone growth with phage. Assay was done on soft agar plates. Visible phage 
plaque formation is clearly seen in the ANC clone with phage, but not in the MUC 
clone with phage. 
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Figure B2. Competitive fitness assay of ANC clone in the gut. Control 
experiment (circles) to check for neutrality of the fluorescent marker was done by 
colonization of 1:1 ANC (expressing YFP) to ANC (expressing CFP). Filled 
symbols represent average ratio per day. Linear regression on ln(CFP/YFP) 
provides an estimate of the selective advantage of ANC-CFP per day: slope -0.02 
(SE =0.05), P=0.069, adjusted R
2
=0.0. 
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Table B1. Genetic characterization of SCV clones. 
Population Day 
Nr. of 
clones yqiJ
1 
yjbS
1 
ycbU
1 
pepP
1 
yrfF
2 
lon
2 
M1 8 9 - - - - - - 
 
8 2 + + - - - - 
M2 4 9 - - - - - - 
 
4 1 - - + - - - 
M3 5 5 - - - - - - 
 
5 3 + - - - - - 
 
5 1 + + - - - - 
M4 5 10 - - - - - - 
M5 8 8 - - - + - - 
 
8 2 - - - - - - 
M6 4 10 - - - - - - 
 
1
 – targets of new insertions/transposition events were determined by direct 
sequencing of extra bands generated with the vectorette PCR protocol. 
2
 – additional genes that were typed by amplification PCR (see Chapter 2 for 
primers that were used). 
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Table B2. Clones that were typed for existing mutations in 1:1 SCV to ANC 
co-inoculation. 
Mice nr. Clone Day 
Nr. of 
clone y
ia W
 
y
rf
F
 
lo
n
 
y
q
iJ
 
y
jb
S
 
- SCV-CFP 0 S61 - - - + + 
- ANC-YFP 0 X0 - - - - - 
7 MUC-CFP 10 X1 - - + + - 
7 MUC-CFP 10 X2 - - + + - 
7 MUC-CFP 10 X3 - - + + - 
7 MUC-CFP 10 X4 - - + + - 
7 MUC-CFP 10 X5 - - + + - 
7 REV-CFP 10 X6 - - - + - 
7 REV-CFP 10 X7 - - - + - 
7 REV-CFP 10 X8 - - - + - 
7 ANC-YFP 10 X9 - - - - - 
7 ANC-YFP 10 X10 - - - - - 
7 ANC-YFP 10 X11 - - - - - 
9 MUC-CFP 10 X12 - - + + - 
9 MUC-CFP 10 X13 - - + + - 
9 MUC-CFP 10 X14 - - + + - 
9 MUC-CFP 10 X15 - - + + - 
9 MUC-CFP 10 X16 - - + + - 
9 REV-CFP 10 X17 - - - + - 
9 REV-CFP 10 X18 - - - + - 
9 REV-CFP 10 X19 - - - + - 
9 ANC-YFP 10 X20 - - - - - 
9 ANC-YFP 10 X21 - - - - - 
9 ANC-YFP 10 X22 - - - - - 
10 MUC-CFP 10 X23 - - + + - 
10 MUC-CFP 10 X24 - - + + - 
10 MUC-CFP 10 X25 - - + + - 
10 MUC-CFP 10 X26 - - + + - 
10 MUC-CFP 10 X27 - - + + - 
10 REV-CFP 10 X28 - - - + - 
10 REV-CFP 10 X29 - - - + - 
10 REV-CFP 10 X30 - - - + - 
10 ANC-YFP 10 X31 - - - - - 
10 ANC-YFP 10 X32 - - - - - 
10 ANC-YFP 10 X33 - - - - - 
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Appendix C 
                   
Figure C1. Fitness of antibiotic resistant clones in LB media. The asterisk (*) 
represents statistical significant difference (p<0.05) using Wilcoxon sum rank test 
without Bonferroni correction. 
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